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CHAPTER I 
Introduction 
Thesis Organization 
 This thesis is organized into five chapters. Chapter I provides a general 
introduction and relevant to the study, establishing a context for the original work that is 
presented in Chapters III-V. Chapter II is a first author journal article published in 
Physiological Genomics 38:98-111, 2009.  Chapter III is a first author journal article that 
published in Regulatory, Integrative and Comparative Physiology 298(2):R494-507. 
Chapter IV is a first author manuscript to be submitted to Domestic Animal 
Endocrinology.  Chapter V is a summary of the work presented here and general 
conclusions.       
General Objective 
The overall purpose of this thesis project was to identify genetic mechanisms 
associated with differences in and regulation of feed intake and feed efficiency in pigs. 
The long-term goal of this research is to use this knowledge to improve feed efficiency in 
pigs, the largest variable cost in pork production, through genetic selection or 
management. The central hypothesis is that we can discover and characterize genetic 
pathways that control economically important traits related to feed intake and feed 
efficiency through transcriptional profiling of specific and relevant tissues during the 
growth period. Profiling studies were be based on two complementary animal-level 
contrasts and their interactions, including quantitative differences in a specific measure of 
feed efficiency, residual feed intake (RFI), and genetic differences for a candidate gene 
with known impact on feed intake and energy partitioning. In addition to the two 
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profiling studies, we examined the effect of RFI selection on the thyroid axis as the 
thyroid hormones are critical component for growth and development of animals.    
Literature Review 
Here, we establish the context of the study by describing the current knowledge 
and the limits in the field. We first briefly review the genetic basis for RFI followed by 
neuroendocrine control of feed intake with specific emphasis on melanocortin-4 receptor 
(MC4R). Then, we review the effect of caloric restriction on feed efficiency and 
longevity promoting mechanisms followed by the current state of microarray approach in 
understanding feed efficiency and adaptive response to fasting and caloric restriction.  
Finally, we review the effects of selections based on feed efficiency on thyroid axis.  
Some parts of the literature in this section come directly or modified from USDA-NRI-
2005-3560415618 grant proposal (Dekkers et al., 2004).   
Genetic basis for feed efficiency and RFI 
Feed accrues the largest variable cost in swine production [1, 2].Substantial 
differences in feed intake exist and ~30% of these are explained by genetics [3]. 
Although feed efficiency has improved to some degree by selection for growth and 
reduced backfat, further improvements require direct selection on feed intake. This is, 
however, prohibited by the difficulty and expense of recording feed intake on large 
numbers of animals, but possible if the genes that are responsible for differences in feed 
intake and feed efficiency are known.  
Although feed intake is genetically related to the economically important traits of 
growth and backfat, these relationships are not perfect; estimates of genetic correlations 
average 0.65 (0.32-0.89) with growth rate and 0.37 (0.08-0.59) with backfat thickness 
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[3]. Thus, a considerable variation in feed intake exists that is independent of growth and 
composition. This is referred to as residual feed intake (RFI), i.e. feed consumed over and 
above expected requirements for production and maintenance [4]. The concept of using 
RFI as a method to evaluate efficiency was published over 45 years ago [5] , much of the 
research on RFI has occurred in the last decade [6]. The advantage of using RFI as a feed 
efficiency method is that it is independent from body weight and growth. 
Variation in RFI is not utilized in genetic selection for growth and composition 
but is heritable; estimates in the pig range from 0.15 to 0.40 [7-10]. Our group has 
successfully developed pig lines that differ in RFI up to 124 g/day without 
significant change in the body composition, with an estimated heritability for RFI of 
0.33 [11]. 
Factors that contribute to genetic variation in RFI include feeding behavior, 
nutrient digestion, maintenance requirements, and energy homeostasis and partitioning 
[6]. Genetic differences in the ability to digest nutrients are small but differences in 
maintenance requirements play a major role [12]. Although reduced maintenance 
requirements are desirable for improved feed efficiency, this may result in reduced fitness 
and increases susceptibility to stressors and diseases [13].  Little is known of the genes 
that control RFI. Related data comes from mice, where a study of selection lines for high 
and low body heat production, which is related to RFI, identified several QTL regions 
[14]. A further understanding of the genetic basis of RFI is required, which can be 
developed by identifying genes that are differentially expressed between pigs that differ 
in RFI.  
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Neuroendocrine control of feed intake 
Control of feed intake and energy homeostasis involves a complex network of 
central nervous system pathways and feedback mechanisms [15]. Regulation of appetite 
and body weight in the CNS involves several neuropeptides, including neuropeptide Y 
(NPY), cortico-trophin-releasing hormone (CRH), cocaine- and amphetamine-regulated 
transcript (CART), galanin, orexin, agouti-related peptide (AGRP), and  melanin 
concentrating hormone (MCH), and peripheral signals such as leptin and insulin, which 
act to mediate hypothalamic activity [15]. Feed intake may be regulated primarily by 
NPY, pro-opiomelanocortin (POMC), and AGRP, with leptin as the primary peripheral 
signal regulating their activity. Although leptin may act as an overall modulator, by 
altering activity of orexigenic and anorexigenic neurons, circulating leptin levels do not 
change after a meal but generally reflect adipose mass. Thus, leptin may serve as a long-
term metabolic signal [16]. Recent evidence suggests that the POMC neuron located 
within the hypothalamus modulates energy homeostasis primarily by cleavage of one of 
its peptide products, α-melanocyte-stimulating hormone (αMSH), which inhibits feed 
intake and energy storage through the melanocortin system, specifically signaling 
through melanocortin-3 and -4 receptors (MC3R and MC4R) [17, 18] 
In humans and rodents, the melanocortin system plays a pivotal role in food 
intake regulation. In particular, MC4R, a G protein-coupled seven-transmembrane 
receptor, integrates and relays key signals controlling food intake [19, 20]. In pigs, 
central administration of the MC4R agonist NDP-αMSH suppresses feed intake [21], and 
a missense variant N298 of the MC4R gene was associated with increased feed intake, 
growth, and backfat [22]. Studies on the effects of N298 on MC4R function indicate that 
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the D298 variant may be required for normal receptor signaling [23]. Interestingly, HEK-
293 cells transfected with the D298 variant stimulated cAMP production in response to 
NDP-αMSH, but no stimulation was observed for the N298 variant in this model system 
[23]. These reports indicate that the role of MC4R in food intake control extends to the 
porcine species. 
Effect of caloric restriction and longevity 
Efficient feed utilization has also been achieved with caloric restriction caloric 
restriction in cattle and chickens [24, 25]. When given 10% of ad libitum feed, a 
significant improvement in feed to gain ratio was observed at 12 weeks in hens. During 
caloric restriction, homeostatic shift occurs to conserve energy, yielding efficient 
utilization of food energy.  
The motivation to understand biological mechanisms underlying response caloric 
restriction extends beyond feed efficiency in livestock species. Caloric restriction 
prolongs lifespan in virtually all species, including mammals, and recent reports suggest 
that caloric restriction is the most compelling cancer-prevention regimen in the 
carcinogenesis models [26, 27]. Translation of the caloric restriction phenomenon to 
human health is critical considering that obesity, a major risk factor for several types of 
cancers and age-associated chronic diseases, is alarmingly increasing in the Western 
world [28].  Transcriptional profiling of caloric restriction to elucidate pathways involved 
in longevity promoting mechanisms in rodents has been investigated [29-31]; however, 
the pig is a better suited model for the human energy homeostatic system than rodents 
and has contributed to improved knowledge of human metabolic disorders such as 
obesity and diabetes [32, 33]. Understanding efficient feed utilization in pigs will also 
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lead to improved agricultural economy as pork is used as a major human food source 
worldwide and the cost of feed amounts to the largest variable cost in pork production, 
making up 68% of the total variable cost [1]. 
Microarray approach to studying feed efficiency  
The physiology underlying RFI differences has been studied mainly in poultry 
and in beef cattle, in which whole-genome SNP analyses and microarray approaches have 
been undertaken [34-37]. For example, transcriptomic analysis of liver biopsies from 
Angus bulls identified 163 differentially expressed genes between animals with high and 
low RFI [36]. These genes represented several cellular pathways such as growth, 
proliferation, protein synthesis, lipid metabolism, and carbohydrate metabolism [36]. 
Roles of specific metabolic genes during fasting and caloric restriction have been 
studied [38, 39], but global transcriptional profiling of the adaptive fasting or caloric 
restriction response has not been reported in the porcine species. Several transcription 
factor and nuclear receptors are known to mediate the fasting response [40], and their 
function appears to regulate specific metabolic adjustments within each peripheral organ 
and to coordinate intertissue communication for homeostasis. Previous studies have 
established regulatory roles for several transcription factor in fat and/or liver tissues, such 
as sterol regulatory element binding factor 1 and 2 (SREBF1 and SREBF2) [41], 
CCAAT/enhancer binding protein alpha [42], hypoxia inducible factor 1, alpha subunit 
(HIF1A) [43], peroxisome proliferator activated receptors gamma (PPARG) [44], and 
alpha (PPARA) [45]. However, previous large-scale transcriptional profiling reports on 
caloric restriction or fasting [30, 36, 46] have not included global analysis of key 
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regulatory transcription factor that may be responsible for the differentially expressed 
genes.  
Involvement of thyroid axis and feed efficiency 
Thyroid hormones (TH) play a critical role in growth and development, yet the 
contribution of TH in controlling feed efficiency remains to be understood. Previous 
reports indicate that TH concentration is affected by selection for growth parameters such 
as body size in rats [47] and rate of gain and thickness of backfat in swine [48]. Sows 
selected for increased lean growth on restricted feeding showed more placid behavior 
[49], likely due to reduced activity of thyroid hormone that correlates with decreased 
energy requirement for activity driven maintenance.  
Currently, a limited number of reports are available on the thyroid function in 
response to selection based on RFI in chicken and the results are inconsistent. In one 
study, T3 concentration was found to be greater in the low RFI than the high RFI group 
in both fed and fasted state, whereas in another study [50], T3 level was lower in the low 
RFI chicken in fed state and not-significantly different in the fasted state.    
Majority of the literatures on RFI based selections approach TH for its calorigenic 
actions and interpret the TH levels in relation to basal rate metabolism.  Although 
calorigenic actions of TH are well recorded, TH have plethora of physiological effects 
such as potentiation of growth hormone actions and mediation of nutrient sensing. 
Currently, there is no literature that describes thyroid hormone levels in RFI selection 
experiment where the body compositions (backfat and body weight) of the pigs were kept 
constant.  Lines that are selected for leanness have piglets with lower concentration of 
plasma T3 and T4 at birth than do piglets from fatter control lines [51, 52], however 
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when 4 month-old genetically obese and lean gilts were compared thyroid hormone 
profiles showed opposite direction such that lean pigs had higher circulating 
triiodothyronine (T3) than the control pigs and there was no difference in the free or the 
total T4 levels [53].   
Furthermore, dietary triiodothyronine (T3) and thyroxine (T4) can increase feed 
efficiency and growth characteristics in chicken [54, 55] and in pigs [56]. Administration 
of thyrotropin releasing hormone (TRH) produces an increase in TH levels and yields 
positive performance in beef-heifers and in lactating sows[57, 58]. In one study, 
0.1mg/kg dietary T3 was shown to improve growth and muscle protein accumulation in 
chicken [54]. However, this improvement was dose-specific meaning that increased dose 
such as 0.5 mg/kg depressed growth; enforcing the idea that thyroid hormone can be 
either anabolic or catabolic depending on the concentration.  Administration of T4 at the 
level of 1.2 ppm was shown to produce higher feed efficiency and greater muscle protein 
synthesis in broiler chickens [55].  In pigs, small increase in TH can be anabolic, whereas 
large increase is catabolic [59]. Another study injected 0.1 mg/day of T4 for 4 days to 21 
day-old starter pigs and showed slight increase in the average daily growth and energy 
digestibility [56].  Taken together, TH seem to improve feed efficiency given the 
appropriate dose and the elevated level of TH in the feed efficient line may contribute to 
improved growth and development. 
In the series of study that are presented in Chapters II-IV, our overall goal was to 
ascertain genetic basis for feed intake and feed efficiency mechanisms in pigs. In Chapter 
II, we aimed to identify series of genes and pathways that respond to fasting and to a 
missense mutation in MC4R. In Chapter III, we endeavored to find genes and pathways 
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responsible for RFI differences and for adaptive response to acute caloric restriction. 
Finally, in Chapter IV, we specifically looked at the effect of RFI selection and feed 
restriction on the thyroid axis of pigs.  
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ABSTRACT 
Transcriptional profiling coupled with blood metabolite analyses were used to 
identify porcine genes and pathways that respond to a fasting treatment or to a D298N 
missense mutation in the melanocortin-4 receptor (MC4R) gene. Gilts (12 homozygous 
for D298 and 12 homozygous for N298) were either fed ad libitum or fasted for 3 days. 
Fasting decreased body weight, backfat, serum urea concentration and increased serum 
non-esterified fatty acid. In response to fasting, 7,029 genes in fat and 1,831 genes in 
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liver were differentially expressed (DE). MC4R genotype did not significantly affect 
gene expression, body weight, backfat depth, and any measured serum metabolite 
concentration. Pathway analyses of fasting-induced DE genes indicated that lipid and 
steroid synthesis was down-regulated in both liver and fat. Fasting increased expression 
of genes involved in glucose sparing pathways, such as oxidation of amino acids and 
fatty acids in liver, and in extracellular matrix pathways, such as cell adhesion and 
adherens junction in fat. Additionally, DE transcription factors (TF) were identified that 
regulate many DE genes. This confirms the involvement of TF, such as PPARG, 
SREBF1 and CEBPA, that are known to regulate the fasting response and implicates 
additional TF, such as ESR1. Interestingly, ESR1 controls several fasting induced genes 
in fat that are involved in cell matrix morphogenesis. Our findings indicate a 
transcriptional response to fasting in two key metabolic tissues of pigs that was 
corroborated by changes in blood metabolites; and the involvement of novel putative 
transcriptional regulators in the immediate adaptive response to fasting.       
INTRODUCTION 
Energy homeostasis is an essential physiological component of all living 
organisms and when disrupted can lead to complicated conditions such as diabetes, 
obesity, and anorexia. The pig is a major source of human food worldwide and is also 
well suited as a model for investigations into human homeostatic mechanisms (54, 63). 
Thus, understanding the mechanisms that regulate food intake can contribute knowledge 
relevant to human health and improve agricultural economy, as feed is the largest 
variable cost in pork production, ranging from 57-68% of the total variable cost (29, 44).  
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In humans and rodents, the melanocortin system plays a pivotal role in food 
intake regulation. In particular, the melanocortin-4 receptor (MC4R), a G protein-coupled 
seven-transmembrane receptor, integrates and relays key signals controlling food intake 
(2, 78). In pigs, central administration of the MC4R agonist NDP-MSH suppresses feed 
intake (4) and a missense variant N298 of the MC4R gene was associated with increased 
feed intake, growth and backfat (41). Studies on the effects of N298 on MC4R function 
indicate that the D298 variant may be required for normal receptor signaling (42). 
Interestingly, HEK 293 cells transfected with the D298 variant stimulated cAMP 
production in response to NDP-αMSH, but no stimulation was observed for the N298 
variant in this model system (42). These reports indicate that the role of MC4R in food 
intake control extends to the porcine species.  
Recent advances have been made in swine transcriptomics (23, 74), where 
transcriptional profiling was successfully employed to probe several porcine tissues such 
as adipose (31), muscle (50), lung (82), and neural (59) tissues. Studies with rodent 
models have reported transcriptional responses to fasting in heart (70), hypothalamus 
(48), muscle (73), liver, and adipose (7, 49, 55) tissues.  Several groups have investigated 
the roles of specific metabolic genes during fasting (5, 28, 67), but global transcriptional 
profiling of the fasting response has not been reported in the porcine species. Fasting 
studies in rodent species have also not included global analysis of key regulatory 
transcription factors (TF) that may be responsible for the differentially expressed (DE) 
genes. Several TF and nuclear receptors are known to mediate the fasting response (13, 
18, 46) and their function appears to regulate specific metabolic adjustments within each 
peripheral organ and to coordinate inter-tissue communication for homeostasis. Previous 
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studies have established regulatory roles for several TF in fat and/or liver tissues in 
rodents and pigs, such as sterol regulatory element binding factor 1 and 2 (SREBF1 and 
SREBF2) (40), CCAAT/enhancer binding protein alpha (C/EBPα) (53), peroxisome 
proliferator activated receptors beta (77), gamma (PPARγ) (76), and alpha (PPARα) (13, 
39).  
We hypothesize that transcriptional profiling of over 24,000 genes in key 
metabolic tissues of pigs, corroborated by blood metabolite analyses, will identify 
pathways and transcriptional networks of genes responding to fasting or MCR4 genotype. 
The results may implicate candidate genes to improve feed efficiency in pigs. We report 
7,029 genes in adipose tissue and 1,831 genes in liver to be DE (q≤0.05) due to a 3-day 
fast. We also report on ensuing key biological processes. Major regulators of responding 
genes to fasting were identified by assessing the connection of DE TF to the DE genes. 
This study reports [1] the first global study on feed deprivation using transcription 
profiling of key tissues in pig, [2] identification of key TF in global fasting response, and 
[3] analysis of shared biological pathways in the fasting response between fat and liver. 
 
MATERIALS AND METHODS 
Animals and feed treatments. Six-month old Yorkshire gilts from a line selected for high 
feed efficiency, based on low residual feed intake (9) were used. Animals were fed ad 
libitum a crude protein standard swine diet with 20% crude protein until weaning (Kent 
Feeds Inc., Muscatine, IA, USA) and with 16-17.5% crude protein diet after weaning 
(Mid-State Milling Inc., State Center, IA, USA).  Pigs were genotyped for the MC4R 
variant D298N (41) and 12 animals homozygous for N298 and 12 animals homozygous 
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for D298 were randomly assigned to treatments. Starting at 06:00 on day 1, gilts were fed 
ad libitum with continuous access to feed until ~08:00 on day 4 or had feed removed for 
3 days in a randomized complete block design with a 2 x 2 factorial arrangement of 
treatments. A total of six animals was used for each combination of genotype and feed 
treatment across the four blocks that were defined as animals that underwent treatment on 
the same day. Each block contained at least one animal from each combination of 
genotype and feed treatment. All animals received water ad libitum. On day 4 (09:00-
11:30), pigs were sacrificed by electric stunning and samples of hepatic tissue and the 
10th rib middle layer of backfat were rapidly collected, frozen in liquid nitrogen, and 
stored at -80°C until RNA isolation. Pre-treatment blood samples were collected the day 
before start of the feeding treatment from the jugular vein. Terminal blood samples were 
collected during postmortem exsanguinations. Blood samples were allowed to clot at 4°C 
overnight, centrifuged at 1,200 × g for 30 min, and serum was collected and stored at -
20°C. The protocol for animal experiments was in accordance with guidelines of the 
Institutional Animal Care and Use Committee of Iowa State University (Protocol # 12-
04-5797-S).  
Body weight, backfat, liver glycogen, and blood parameters. Pre- and post-treatment 
body weight and 10th rib backfat depth were measured on days 0 and 4 (16:00-18:00). 
Backfat depth was measured by ultrasound (9) using an Aloka 500V SSD ultrasound 
instrument fitted with a 3.5-MHz, 12.5-cm, linear-array transducer (Corometrics Medical 
Systems Inc., Wallingford, CT, USA). Liver glycogen was determined as reported 
previously (25). Briefly, samples of liver tissue (0.45 g) were extracted in cold perchloric 
acid (0.5 mol/L) using a Tissue Tearor homogenizer. Duplicate samples (300 µL) of each 
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homogenate were then prepared for glycogen hydrolysis with 0.3 g/L amyloglucosidase 
(Sigma-Aldrich, St Louis, MO USA) for 120 min at 38°C. The incubation was stopped by 
the addition of 0.6 mol/L perchloric acid and the samples clarified by centrifugation (1,500 x 
g, 15 min at 4°C). Glucose (HK) assay kits (Sigma-Aldrich, St Louis, MO USA) were used 
to determine total micromolar glycosyl units (glucose, glucose-6-P, and glucose from 
glycogen) from the clarified samples and from the original homogenate (glucose, glucose-6-
P only). Results were expressed as mg glycosyl per g wet tissue. Post-treatment serum 
samples were assayed for concentrations of glucose (hexokinase assay, Roche 
Diagnostics, Indianapolis, IN, USA), urea (UREA/BUN kit by Roche Diagnostics), and 
triglyceride (TG, Cat# 236-99, Diagnostics Chemicals Ltd., Oxford, CT, USA). Non-
esterified fatty acids (NEFA) concentration was measured on both pre- and post-
treatment samples (HR Series-NEFA HR (2), Wako Diagnostics, Richmond, VA, USA).   
RNA isolation and microarray hybridization. Total RNA was isolated and purified from 
liver and adipose tissues using the Qiagen RNeasy midi kit and the Qiagen RNeasy lipid 
tissue kit (Qiagen, Valencia, CA, USA). Quality and quantity of RNA were determined 
by electrophoresis and spectrophotometry with the Agilent 2100 Bioanalyzer (Foster 
City, CA, USA). Average RNA integrity numbers were 9.0 ± 0.5 for liver RNA and 8.2 ± 
0.5 for fat RNA samples. Microarray target sample processing, target hybridization, 
washing, staining, and scanning steps were completed according to manufacturer’s 
instructions (Affymetrix, Santa Clara, CA, USA). Briefly, 10 µg of total RNA from liver 
and adipose tissues was used to synthesize cDNA using a one-cycle cDNA synthesis kit. 
Resulting cDNA from each sample was used to transcribe biotinylated cRNA by T7 RNA 
polymerase and further fragmented and applied to the Affymetrix GeneChip Porcine 
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Genome Array that contains 24,123 probesets. Following hybridization at 45°C for 16 h, 
the array was washed and stained with strepavidin-phycoerythrin at an Affymerix 
GeneChip Fluidics Station 450 and fluorescent signals were scanned using an Affymetrix 
GeneChip Scanner 3000 (3). Each tissue was assigned to one fluidics station to remove 
potential station effects for within-tissue comparisons and four modules within each 
station were intentionally confounded with the blocks.  
Transcriptome. The Affymetrix GeneChip Porcine Genome Array probeset contains 11 
paired perfect match [PM] and mismatch [MM] 25-mer probes (3). The probe-pair (PM-
MM) data were used to determine the detection call (present call, marginal call, and 
absent call) by the modified Wilcoxon signed rank test of the MAS 5.0 software (50). For 
each tissue, probesets with absent calls for all replicates in all treatments were removed 
and the remaining probesets were declared as expressed and established the transcriptome 
for that tissue.           
Statistical analyses 
Animal performance, blood parameters, and liver glycogen: Body weight, average daily 
feed intake, backfat change, liver glycogen content, and blood parameters were analyzed 
by a mixed linear model with genotype, feed treatment, and their interactions as fixed 
effects and block as a random effect using the Mixed procedure of SAS/STAT software 
version 9.1.3 (SAS Institute Inc., Cary, NC, USA). The values for NEFA were natural log 
transformed to improve normality and homoscedasticity.  Residual diagnostics identified 
no obvious concerns about the models used in all tests.   
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Gene expression:  Affymetrix GeneChip® Operating Software (GCOS) version 1.4.0 was 
used to obtain .CEL files at the GeneChip® Facility at Iowa State University. Data were 
deposited in the NCBI Gene Expression Omnibus (Series accession # GSE13528; 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13528) and examined at the 
probe level with BioC version 2.0 (27) in R (60). All 24,123 probes, including absent 
calls were analyzed. Three of 48 chips showed minor imaging artifacts. Probe level 
measures were summarized into probe set level expression measures according to the 
MAS 5.0 algorithm (3) using the "affy" package (36) in R, except that the final step of 
aligning the trimmed means on the log scale was omitted because it was redundant with 
the median centering that was implemented in later steps. By replacing the PM and MM 
values with the corresponding probe set level measures, pseudo array images were 
constructed and visual data quality check indicated that previous imaging artifacts were 
successfully corrected at the probe set level. Base 2 logarithms were taken and the 
median expression measures from each chip were examined for treatment effects by 
fitting an analysis of variance model with genotype, feed treatment, their interaction, and 
block as fixed effects. Median centering normalization (81) was performed by  
subtracting the median expression from all expression measures on each chip on the 
logarithmic scale.   
To determine the proper model for analysis of the expression data, 81 alternative 
mixed linear models were fitted to the normalized expression measures for each tissue 
and each gene separately using the Mixed procedure in SAS/STAT® software version 
9.1.3 (SAS Institute Inc. Cary, NC, USA). Models included MC4R genotype, feed 
treatment, and their interaction as fixed effects, but differed from each other by including 
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any subset of block (four levels), chip hybridization day (three levels), the process batch 
during washing of the chips (three levels), and fluidics station final stage as recorded in 
the .XML files from GCOS (two levels), as either fixed or random effects.  Variance 
components were estimated by the method of maximum likelihood, with non-negativity 
boundary constraints.  The model with block and hybridization day as random effects was 
selected based on gene-averaged SAS reported information criteria, the gene-averaged 
standardized prediction sums of squares from leave-one out cross validation, specifics of 
the experimental design, and histograms of p-values of contrasts of interest.   
For the final model, variance components were re-estimated with the method of 
residual maximum likelihood with non-negativity boundary constraints. Fixed effect 
estimates and least squares means were obtained using generalized least squares and 
fixed effects contrasts were tested using Wald-type F-tests with Kenward-Roger's 
correction (38).  The positive false discovery control procedure (68) was used on each set 
of p-values of contrasts of interest to compute q-values. Genes with q-values less than or 
equal to 0.05 were considered to be DE. 
Affymetrix probe annotation. To obtain homologues and improved annotation, 
Affymetrix probe consensus sequences were used to BLAST against the well-curated 
NCBI's RefSeq database. Highest scores were used with a conservative cutoff of 1e-10 
for the E-value. In total, 17,798 (73.8% of all) probes on the Affymetrix GeneChip 
Porcine Genome Array were assigned RefSeq annotation (Couture et al., manuscript in 
preparation). 
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Pathway analysis with Gene Ontology and KEGG. DE (q≤0.05) genes in fat and liver 
were divided into genes that were down- or up-regulated in fat or liver as a result of 
fasting, creating four categories of genes. Using DAVID, an open access web-based 
functional annotation and clustering program (17), the four categories of genes were 
analyzed for overrepresented (p≤0.05) biological process categories based on Gene 
Ontology’s (GO) Biological Process and Kyoto Encyclopedia Genes and Genomes 
(KEGG) data bases.  The p-values for overrepresentation were computed by a modified 
Fisher’s exact test, using the transcriptome for each tissue as background. The biological 
process categories were clustered using Functional Annotation Clustering (17), where the 
enrichment score for each cluster was computed as the negative log of the geometric 
mean of p-values in the cluster. Additionally, the top 50 DE genes (q≤0.05) based on fold 
change in each of the four categories were functionally annotated to determine pathways 
that were populated with genes with high fold changes.   
Pathway Studio Analyses. DE genes (q≤0.05) in fat or liver tissues were analyzed with 
Pathway Studio 5.0 (57), a text mining tool that detects relationships among genes, 
proteins, cell processes, and diseases as recorded in the PubMed database (Ariadne 
Genomics, Rockville, MD, USA).  The previously defined four categories of DE genes 
were assessed for reported (PubMed) associations with common regulatory TF and 
nuclear receptors based on regulation, direct regulation, binding and/or promoter binding. 
Genes satisfying these criteria were counted for each regulatory TF. Because of the 
limited processing capacity of Pathway Studio, only DE genes with a fold change equal 
to or greater than 2 were used in this analysis. 
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Real-time quantitative PCR for verification of DE genes. Real-time quantitative PCR 
(qPCR) was used to verify fasting-induced differential expression of seven genes in 
adipose tissue and eight genes in liver. Total RNA was isolated from backfat of pigs that 
were arrayed by Affymetrix Genechip Porcine Genome Array as described above and 
reverse transcribed to cDNA using SuperscriptTM II reverse transcriptase (Invitrogen, 
Carlsbad, CA, USA) and oligo(dT) (16). Real-time PCR was performed in duplicate 
using 100 ng cDNA (RNA equivalent) per 25 µl reaction or per well with the Brilliant kit 
(Stratagene, La Jolla, CA, USA) on BioRad MyiQ Single Color Real Time PCR 
Detection System (BioRad). All probes and primers for real-time TaqMan PCR were 
designed (Supplementary Table 1) using Primer Express 2.0 (Applied Biosystems, Foster 
City, CA, USA), as previously described (16). The probes contained 3’Iowa Black FQ 
quencher and 5’ 6-FAM reporter (Integrated DNA Technologies, Coralville, IA, USA). 
The PCR conditions were 50°C for 2 min, 95°C for 10 min, 40 cycles of 95°C for 15 s 
and 60°C for 1 min, then 4°C. Because variation in the expression of commonly used 
housekeeping genes such as GAPDH, HMBS, HPRT, SDHA, RPL32, YWHAZ, and 
UBC (75) were observed with a 3-day fasting treatment in one or both tissues, we 
normalized gene expression based upon the constant amount of RNA and cDNA 
amplified.  This method has been proposed as the most reliable standardization of 
quantitative measurement of mRNA expression given that accurate estimation of total 
RNA is made with tools such as Agilent Bioanalyzer (8).  
Quantification of gene expression was analyzed as previously reported (16). 
Briefly, Ct values averaged across duplicate readings were analyzed by a mixed linear 
model with genotype, feed treatment, and their interactions as fixed effects, and block as 
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a random effect, using the Mixed procedure of SAS/STAT software version 9.1.3 (SAS 
Institute Inc.,Cary, NC, USA). A value of p≤0.05 was considered statistically significant. 
Fold change in expression was calculated as 2∆Ct for each gene, where ∆Ct is the 
difference between least square mean Ct values for the fasting and ad libitum groups.  
RESULTS 
Fasting and MC4R genotype effects on body weight, backfat, liver glycogen, and 
serum metabolites. The effects of a 3-day fast and MC4R genotype on body weight, 
backfat change, liver glycogen content, and serum metabolites are in Table 1. Fasted 
animals lost 5.5 kg or 6.7% of their body weight, whereas those fed ad libitum gained 2.5 
kg or 3.2%. No evidence of a significant effect of MC4R genotype on body weight 
(p=0.75) was noted.  Pigs homozygous for N298 were previously reported (41) to have 
higher average daily feed intake (p<0.05) than pigs homozygous for D298; however we 
observed an opposite trend (p=0.09) in our study.   
Pre-treatment backfat depth was not significantly different (p=0.17) between 
feeding treatments but was significantly higher (p=0.05) for pigs homozygous for N298 
than for pigs homozygous for D298, which agrees with a previous report (41). Therefore, 
within-individual change in backfat depth due to fasting treatment was analyzed rather 
than post-treatment backfat depth to account for the initial backfat difference due to 
MC4R genotype (Table 1).  Fasted pigs had on average greater backfat loss than the fed 
group (Ad libitum=0.77 mm, Fasted=-0.49 mm, p=0.022), indicating that body lipid 
stores were mobilized as an energy source during feed deprivation.  
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Fasted pigs had ~67% less glycogen content as compared to the fed group (Ad 
libitum=13.8 ng/mg,  Fasted=4.6 ng/mg) (Table 1).  Pre-treatment NEFA concentration 
did not differ between the fasted and fed groups (p=0.16); however, post-treatment serum 
NEFA concentrations were 127% greater (p=0.0002) in fasted than ad libitum fed 
animals. Post-treatment serum concentration of blood urea nitrogen was ~24% lower in 
fasted pigs (p=0.006) but neither fasting nor MC4R genotype had a significant effect on 
post-treatment blood glucose or TG concentrations.  
Fasting and MC4R effects on expression of genes in fat and liver. Of 24,123 probesets 
evaluated by microarray analysis, 19,885 and 19,162 provided data indicating the 
transcripts represented by these probesets were expressed in fat and liver tissue, 
respectively. In response to a 3-day fasting treatment, 7,937 transcripts were identified to 
be DE (q≤0.05, p≤0.029) in fat, with 3,722 being up-regulated and 4,215 down-regulated. 
In liver, 1,832 transcripts were identified to be DE (q≤0.05, p≤0.006), of which 1,287 
were up-regulated and 545 down-regulated (Supplementary Tables 2A and 2B). An 
improved annotation of probesets on the Affymetrix GeneChip Porcine Genome Array 
(Couture et al., manuscript in preparation) assigned gene names (BLASTN expectation 
score <1e-10) to 90% and 83% of DE transcripts (q≤0.05) due to fasting in liver and in 
fat, respectively.  For simplicity, the changes in RNA levels detected by these annotated 
probesets are referred to as gene expression differences for the rest of the paper.  The 
gene-by-gene analysis that was conducted did not identify evidence of effects of MC4R 
genotype or of the interaction between genotype and feeding treatment at q≤0.05; thus, 
only the effects of fasting on gene expression were considered in further analyses. 
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Microarray data validation by qPCR. Expression patterns of seven genes representing the 
lipid biosynthetic pathways in subcutaneous adipose tissue and of eight genes in liver 
representing the gluconeogenesis, fatty acid oxidation, ketogenesis, or steroid synthesis 
pathways were verified by qPCR in fasted vs. ad libitum treatments (Fig. 1, 
Supplementary Table 3). For all tested genes, expression fold changes (Ad libitum vs. 
Fasted) were consistent in direction with the microarray results (Fig. 1). Statistical 
significance of fold changes (Ad libitum vs. Fasted) was also confirmed by qPCR 
(p≤0.05) for all genes except for insulin-like growth factor 1 (IGF1, p=0.13) and IGF1 
receptor (IGF1R, p=0.94) in fat and for hydroxyacyl-Coenzyme A dehydrogenase 
(HADHA, p=0.09) in liver. IGF1 and IGF1R had low fold changes in microarray analysis 
(-1.35 and 1.84, respectively) and low expression levels in adipose tissue in comparison 
to the other four genes, whose absolute expression fold changes ranged from 2.5 to 27.4 
in microarray analysis. Overall, the results obtained from microarray were statistically 
confirmed for 80% of the tested genes in liver and fat.  
Biological processes affected by fasting in fat and liver. To identify biological processes 
that respond to fasting, lists of DE genes in liver and fat were explored for 
overrepresentation of GO Biological Process categories, and the resulting 
overrepresented terms were clustered (Supplementary Tables 4A,B,C,D). In addition, the 
KEGG biological pathway database was used to identify specific biological pathways 
that were overrepresented by genes that responded to fasting (p≤0.05). A summary of 
KEGG annotations are shown in Fig. 2 and described further in the following sections.  
Fasting effects in fat. Subcutaneous adipose tissue underwent significant gene expression 
changes that were reflected by the large number of DE genes (7,937), in comparison with 
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liver (3,722). Indicative of a metabolic switch toward energy conservation in response to 
fasting, genes involved in direct energy-generating processes, such as oxidative 
phosphorylation, ATP synthesis, and TCA cycle, were down-regulated in fasted pigs. 
Likewise, genes involved in energy-intensive biosynthetic and catabolic processes were 
down-regulated in the fasted pigs (Fig. 2, Supplementary Table 4A). This included genes 
encoding biosynthetic pathways, such as steroid and lipid biosynthesis, fatty acid 
synthesis, protein translation, amino acid synthesis, and ubiquinone biosynthesis, as well 
as genes encoding enzymes involved in catabolic processes, such as glucose metabolism, 
proteolysis, amino acid degradation, and pyruvate metabolism. Fasting induced up-
regulation of adipose genes involved in cytoskeleton reorganization, such as actin 
polymerization and cell-to-cell adhesion machinery, as well as genes involved in signal 
transduction pathways, such as adipocytokine signaling (Fig. 2, Supplementary Table 
4B). 
Fasting effects in liver. Liver is a primary site of glucose generation and sparing 
processes during fasting, such as gluconeogenesis and ketogenesis. Fasting induced up-
regulation of genes in gluconeogenesis as well as genes involved in energy derivation 
processes, such as fatty acid metabolism, glycolysis, pyruvate metabolism, proteasome, 
and amino acid degradation (Fig. 2, Supplementary Table 4C). Similar to what was 
observed for fat, liver down-regulated expression of genes involved in lipid and steroid 
biosynthetic processes in response to fasting (Fig. 2, Supplementary Table 4D). 
Genes and pathways that responded to fasting in both fat and liver. Genes found to be 
DE in both liver and adipose tissues (Fig. 3A) and KEGG pathways overrepresented 
(p≤0.05) in these genes were identified (Fig. 3B). In response to fasting, both liver and 
28 
 
 
adipose tissues down-regulated synthesis of steroids. When the top 50 significantly 
(q≤0.05) down-regulated genes based on highest fold change in fat and in liver were 
analyzed, the steroid biosynthesis pathway was also the most significantly populated in 
both tissues (p=8.7e-05 in fat, p=2.8e-10 in liver) (Fig. 4). Within these top 50 down-
regulated liver genes were seven genes that encode enzymes involved in biosynthesis of 
steroids. These had fold changes ranging from 2.6 to 7.6 (3-hydroxy-3-methylglutaryl-
coenzyme A reductase, 7-dehydrocholesterol reductase, sterol isomerase, isopentenyl-
diphosphate δ isomerase 1, mevalonate decarboxylase, squalene epoxidase, and sterol-
C5-desaturase-like).  Similarly, the top 50 down-regulated genes in fat contained four 
genes involved in steroid biosynthesis (mevalonate kinase, sterol isomerase, isopentenyl-
diphosphate delta isomerase 1, and mevalonate decarboxylase), with fold changes 
ranging from 4.0 to 6.5.  
  Of 13 genes annotated by KEGG to encode enzymes in the steroid synthesis 
pathway, 12 are represented by probesets on the Affymetrix GeneChip Porcine Genome 
Array. Ten of these genes, including the rate limiting enzyme 3-hydroxy-3-
methylglutaryl-coenzyme reductase, were significantly down-regulated (q≤0.05) in 
response to fasting in both fat and liver tissues. Exceptions were farnesyl diphosphate 
farnesyltransferase 1, which was significantly down-regulated in liver but not in fat, and 
geranylgeranyl diphosphate synthase, which was down-regulated in fat but not in liver 
(Table 3). 
Pathways with an opposite fasting response in liver and fat. Fasting induced five KEGG 
biological pathways in a distinct tissue-dependent manner, in which they were 
significantly down-regulated (p≤0.05) in fat but up-regulated in liver (Fig. 3B). Two of 
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these five pathways were glucose sparing (branched chain amino acids and propanoate 
metabolism) and were overrepresented among the 50 up-regulated liver genes with the 
highest fold changes (Fig. 4). Genes in the propanoate metabolism and pyruvate 
metabolism pathways, which lead to succinyl CoA and acetyl CoA, respectively, were 
up-regulated in liver and down-regulated in fat. These provide starting and intermediate 
materials for the TCA cycle, indicating that fasting affected the TCA cycle in fat and 
liver in different fashions. Energy derived via the TCA cycle in liver likely was used for 
gluconeogenesis, which is energetically costly.   
Key transcriptional regulators of fasting response. Most of the changes in RNA levels 
are likely due to changes in levels of transcription. To understand the main transcriptional 
regulation involved in the fasting response, genes that were up- and down-regulated in 
liver and fat (q≤0.05) were analyzed for their connections to common TF or nuclear 
receptor regulators by using Pathway Studio 5.0. Connections between DE (q≤0.05) TF 
and their targets within the four DE gene lists were populated based on literature 
evidence of at least one of four interaction categories provided by Pathway Studio 5.0, 
which were promoter binding, binding, regulation, and direct regulation. Common 
regulators with the highest number of target genes across all four categories were 
determined (Fig. 5) and their target genes were functionally annotated (KEGG 
overrepresentation p≤0.05).  
The most connected TF for down-regulated genes in fat due to fasting was E2F 
transcription factor 1 (E2F1), which is known to regulate cell cycle and DNA replication. 
As expected, down-regulated fat genes involved in cell cycle processes were 
overrepresented among the E2F1 targets (Fig. 5). In addition, several of the 10 most 
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connected TF of down-regulated fat genes are known to modulate homeostatic responses, 
including PPARγ (regulator of adipose differentiation and glucose metabolism), C/EBPα 
(adipogenesis, leptin expression), and SREBF1 (lipid and steroid synthesis). The most 
connected TF of down-regulated liver genes due to fasting was tumor protein p53, whose 
target gene annotations were primarily in the cell cycle pathway, indicating decreased 
cell proliferation in response to fasting. Also, several of the 10 most prominent 
transcriptional regulators of down-regulated liver genes are TF known to be involved in 
the fasting response; i.e., peroxisome proliferator activated receptor gamma coactivator-1 
and SREBF2 (58, 65).  
Among the four categories shown in Fig. 5, estrogen receptor 1 (ESR1) had the 
most target genes of all other identified common regulators of DE genes. Pathway 
analysis showed that adherens junction and focal adhesion pathways were 
overrepresented in the up-regulated adipose target genes of ESR1, indicating that fasting 
induced ESR1-mediated adipocyte remodeling of the cytoskeleton and interaction with 
the extracellular matrix. Forkhead box O1A was also among the top 10 common 
regulators of up-regulated genes in fat, and has been associated with metabolic adaptive 
response and in negative feedback signaling of insulin (62). The most connected TF of 
the up-regulated genes in liver due to fasting was nuclear receptor co-repressor 1 
(NCOR1), which is involved in repression of transcription by nuclear receptors (37). The 
target genes of NCOR1, however, did not result in significant overrepresentation of any 
KEGG category. 
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DISCUSSION 
This is the first study to employ transcriptional profiling to investigate the global 
effects of fasting or MC4R genotype in the pig. Some reports are available on 
transcriptional profiling of fasting response using rodent models (49, 55), but the pig 
model more closely resembles human homeostatic mechanisms than rodents (54, 63). 
Our main findings demonstrate transcriptional responses across liver and adipose tissue 
with congruent changes in serum metabolites. Although changes in RNA expression do 
not always correspond to changes in protein expression or activity, we suggest that 
systemic changes in the expression of genes that belong to overrepresented GO or KEGG 
categories imply functional change.   
Congruent to studies using rats  (49, 55)  we observed that, in response to fasting, 
fat and liver tissues down-regulated energy-costly biosynthetic processes and up-
regulated genes involved in efficient energy utilization and conservation pathways, such 
as gluconeogenesis and β-oxidation of fatty acids in liver (41). Fasting increased release 
of free fatty acid into circulation and decreased protein degradation, as indicated by 
decreased serum urea concentrations, consistent with findings in a separate study with a 
3-day fast of pigs (67).  
Contrary to a previous report (41), average ad libitum feed intake of pigs 
homozygous for allele D298 tended to be greater (p=0.09) than intake of pigs 
homozygous for N298, although our results are based on a very small number and should, 
therefore, be interpreted with caution. In a preliminary study, feed intake of pigs from the 
same population as used in this study (9) did not change in response to 
intracerebroventricular injection of NDP-MSH, a potent activator of MC4R (C. R. Barb 
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unpublished data). In addition, a recent study demonstrated that cAMP accumulation did 
not differ between cells transfected with D298 and N298 variants (21), in contrast to the 
previous report on functional significance of D298N mutation (42). These results suggest 
that lack of evidence for MC4R effect on gene expression, body weight, backfat depth, 
and blood parameters in our study occurred perhaps due to lack of functional significance 
of D298N variant or the small sample size that was used in this study. 
Fasting induced up-regulation of genes in cell adhesion and angiogenesis pathways in 
fat. A novel finding in our study is that fasting induced up-regulated expression of fat 
genes involved in the morphology and structure of adipocytes, as indicated by three main 
biological process clusters of cytoskeletal organization, vasculature development, and 
branching structure development being overrepresented among these genes 
(Supplementary Table 4B). Further, three KEGG terms corresponding to adherens 
junction, cell adhesion molecules, and Notch signaling (Fig. 2) were also overrepresented 
among up-regulated genes in fat. The fold changes, q, and p-values of genes involved in 
fasting-induced angiogenesis and morphological changes are summarized in Table 2. No 
previous report has indicated that changes in cell-to-cell or cell-to-matrix pathways are 
associated with fasting.  Interestingly, a recent whole genome SNP analysis in cattle has 
implicated similar pathways, such as cell adhesion and extracellular matrix, in controlling 
efficiency of feed utilization (6). 
Metabolic response to feed deprivation has been divided into three phases 
according to changes in protein and lipid utilization (15). Our study falls into phase I, 
which involves a period of adaptation resulting in glycogen breakdown and lipid 
mobilization, as indicated by our finding of increased NEFA release into the bloodstream 
33 
 
 
and loss of 67% of liver glycogen content (Table 1). As free fatty acids are a major 
source of energy during fasting, capillaries embedded in subcutaneous adipose tissue 
likely require larger surface to ensure efficient transportation of free fatty acids. 
Angiogenic growth factors are released from tissues upon need for new blood vessel 
formation from pre-existing vessels.  In accordance with this, the expression of critical 
angiogenic genes, such as those encoding angiogenin (ANG), angiogenic factor with G 
patch and FHA domains 1 (AGGF1), and vascular endothelial growth factor (VEGF), 
were significantly up-regulated in fat by fasting in our study. Several cytokines and 
growth factors have been investigated for their involvement in angiogenesis. The 
inflammatory cytokine, interleukin 8 (IL-8), has been shown to contribute to human 
melanoma progression by functioning as a mitogenic and angiogenic factor (61), and 
neutralizing antibodies of IL-8 inhibit angiogenesis and tumor growth (35).  Fasting up-
regulated IL-8 expression 2.5-fold in the adipose tissue in the present study. Lee et al. 
(47) have investigated the angiogenic properties of IGF-II in an in-vitro model and 
demonstrated that it directly induced angiogenesis by stimulating migration and 
morphological differentiation of endothelial cells. Thus, our study indicates that a number 
of angiogenic factors, including VEGF, ANG, AGGF1, IL-8, and IGF-II, were 
significantly up-regulated with fasting in the pig model.  
Transcription factors endothelial PAS domain protein 1 (EPAS-1) and forkhead 
box C2 (FOXC2) have been identified as transcriptional regulators of angiogenic genes 
(72, 80). In response to fasting in pigs in our study, EPAS-1 and FOXC2 were 
significantly up-regulated 1.4 and 1.7-fold, respectively. EPAS-1 is a basic helix-loop-
helix/PAS domain TF that is expressed most abundantly in highly vascularized organs 
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(79). EPAS-1 promotes angiogenesis via transactivation of VEGF and its receptor (72, 
79), which agrees with our finding of fasting induced VEGF expression. FOXC2 was 
studied in a transgenic mouse model and increased expression of FOXC2 in adipose 
tissue promotes angiogenesis and vascular patterning (33, 80). FOXC2 directly targets 
integrin beta 3 (ITGB3), hairy and enhancer of split-related protein 2 (HEY2), and ANG2 
(80) to promote angiogenesis; ITGB3 was up-regulated 1.26-fold (q=1.79E-06 ), while 
HEY2 had tendency to be up-regulated 1.21-fold (q=0.07) with fasting (Table 2).  
Angiopoetin-like peptides (ANGPTL) such as ANGPTL 3, 4, and 6, have been 
shown to be involved in lipid, glucose, and energy metabolism independent of angiogenic 
effects (30). Of these ANGPTL, the Affymetrix array contained a transcript for only 
ANGPTL4, which was >2-fold up-regulated in fasted pigs. Angiopoetin-like 4 has been 
shown to increase plasma TG levels via direct inhibition of lipoprotein lipase (51, 69) and 
may explain the tendency for increased levels (p=0.07) of TG in the fasted group. The 
role of ANGPTL4 in angiogenesis is not clear and may have both pro- and anti-
angiogenic effects (11, 45). Although angiogenesis has been suggested to be an indicator 
for adipogenesis (10, 32), our data indicate decreased lipid biosynthesis (i.e. 
adipogenesis).  Angiogenesis may have a negative relationship with adipogenesis during 
fasting-induced responses in growing animals, as the positive relationship between 
angiogenesis and adipogenesis has been established only during fetal fat mass 
development (10, 32). Taken together, fasting appears to induce expression of a number 
of genes in the pathway leading to angiogenesis.  
Fasting induced up-regulation of genes involves cell-to-cell and cell-to-matrix 
communication in fat. Successful vascular development depends on efficient cell-to-cell 
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and cell-to-matrix communication and cytoskeletal reorganization (64). We found that 
genes such as cadherin-associated protein, epidermal growth factor receptor (EGFR), 
fibroblast growth factor receptor 1 (FGFR1) in the adherens junction, notch signaling, 
cell adhesion, and cytoskeletal organization pathways were significantly up-regulated in 
fat of fasted pigs (Fig 2, Supplementary Table 4B). Fasting induced expression of genes 
involved in morphological changes in adipose tissue and these changes may have been 
partially mediated by ESR1, as many of its target genes were overrepresented in these 
pathways and consisted of genes such as EGFR, FGFR1, and E1A binding protein. 
Expression of ESR1 was increased 1.8-fold (Ssc.12290, q=1.18E-05, p=1.09E-04) in fat 
in response to fasting. No study has yet reported fasting induced increases in ESR1 RNA 
levels in any tissue, although several metabolic syndromes, such as type II diabetes and 
atherosclerosis have been linked to polymorphisms of ESR1 (26, 34). Coupled with our 
finding, this suggests a potential role of ESR1 in homeostatic mechanisms that regulate 
fasting-induced changes of adipocyte cell-to-cell interactions. 
Fasting-induced lipolysis in fat. Fat serves as the main TG storage site, which, in the face 
of feed deprivation, provides free fatty acids in the circulation as a source of energy by 
other tissues and for glycerol to be converted to glucose in liver. The greater 
concentration of circulating NEFA in fasted pigs and the significant decrease in backfat 
provide evidence for depletion of TG from the adipose tissue. While fasting induced 
depletion of TG, the expression of genes involved in synthesis of lipids decreased with 
fasting in both tissues and were verified by qPCR (Fig. 1) 
Fasting-induced lipolysis in pigs differs from that in humans and in rodents and is 
not associated with increases in glucagon (66), epinephrine, or norepinphrine (56). 
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Increased sensitivity of adipose tissue to β-adrenergic agonists during fasting in pigs has 
been noted (66) and our results suggest that the mechanism behind this may involve RNA 
level changes, as we found fasting to induce up-regulation of the β-adrenergic receptor 
gene (Table 3). However, the expression of hormone sensitive lipase (HSL) was not 
altered due to fasting (Table 3). This result may be species specific, as transcription of 
HSL was up-regulated in adipose tissue after a 3-day fast in rats (71). Fasting-induced 
lipolysis in pigs may therefore be mediated via a previously described HSL-independent 
pathway (24). Paradoxically, TF FOXC2, which is known to increase sensitivity to 
cAMP/PKA-dependent signals and induce HSL expression (12), was increased 1.7-fold 
due to fasting (Table 3). Thus, the role of FOXC2 in mediating lipolysis may extend 
beyond regulation of HSL expression.      
Liver up-regulated gluconeogenesis and fatty acid oxidation. The main goal of the fasting 
response is to maintain sufficient glucose concentration in the bloodstream, primarily 
through the liver, such that the nervous system has enough fuel. As with a previous 
fasting study in pigs (67), glucose concentration in the serum after 3 days of fasting was 
maintained at a similar concentration as that of ad libitum fed pigs. This glucose 
homeostasis was likely mediated via gluconeogenesis and glycolysis pathways, because 
the genes encoding enzymes involved in these pathways, such as pyruvate carboxylase 
(PC), cytosolic and mitochondrial phosphoenolcarboxykinase 2, and the rate limiting 
enzyme fructose-1,6-bisphosphatase (FBP1),  were up-regulated with fasting (Table 3). 
Although PC has not been implicated to be the rate-limiting step of hepatic 
gluconeogenesis (52), its 3.7-fold induction by fasting was higher than that of FBP1 
(Table 3) and this was confirmed by qPCR (Fig. 1B). In addition, increased expression of 
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genes involved in oxidation of fatty acids such as acyl-CoA dehydrogenase, enoyl CoA 
hydratase 1, and hydroxyacyl-CoA dehydrogenase, was observed in liver (Table 3) and 
these were confirmed by qPCR (Fig. 1B). The energy derived from fatty acid oxidation 
likely provided fuel for gluconeogenesis during fast. Furthermore, up-regulation of 
branched amino acid degradation pathway genes in the liver suggests the accumulation of 
gluconeogenic and ketogenic precursors, utilizing amino acids derived from degradation 
of proteins by the proteasomal pathway.  As adipose tissue does not serve as the primary 
site of glucose sparing during fasting, these pathways were down-regulated in fat. 
A key transcriptional regulator of fatty acid oxidation, PPARα, has previously 
been implicated in the fasting adaptation of liver in pigs (14).  Congruent with fasting-
induced activation of fatty acid oxidation in the liver, PPARα was upregulated 1.4-fold in 
our fasted animals.  Also, degradation of amino acids and pyruvate for gluconeogenesis 
was evidenced by up-regulation of genes encoding enzymes in the TCA cycle, such as 
succinate dehydrogenase complex subunits B and D, and isocitrate dehydrogenases 1 and 
3. During fasting in pigs, the TCA cycle is likely facilitated by acetyl CoA derived 
mainly from amino acids and glycerol precursors, rather than from glucose, because the 
expression of genes encoding the pyruvate dehydrogenase complex components, such as 
E2 component, α and β subunits and pyruvate dehydrogenase kinase-4 was not altered 
(Table 3).  
Fasting effects on ketogenesis and hepatic cell cycling. With feed deprivation, the 
increased demand for β-oxidation of fatty acids in the liver results in ketogenesis. 
However, in our study, genes encoding enzymes involved in ketogenesis, such as acetyl 
CoA actyltransferase 2 and 3-hydroxymethylglutaryl-CoA synthase 1 (HMGCS1), were 
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down-regulated (Table 3) and the expression was verified for HMGCS1 by qPCR (Fig 
1B). In addition, the serum concentrations of 3-hydroxybutyrate (p=0.40) and acetate 
(p=0.26) were not significantly altered after fasting (data not shown). Depletion of only 
about 67% of liver glycogen content was observed in our fasted pigs (Table 1), as 
compared to rodents that show complete liver glycogen depletion after 3-day fasting. 
This partly explains the lack of evidence for ketogenesis because glucose derived from 
glycogenolysis and gluconeogenesis during the 3-day fast may have been sufficient to 
fuel the nervous system. Differences between rats and pigs in ketone body generation in 
response to feed deprivation have been reported previously (1), and have been attributed 
to the low rate of β-oxidation in pigs compared to rodents.   
During fasting, rat hepatocytes undergo decreased cell proliferation (43), which is 
consistent with our finding that, liver genes involved in cell cycling were significantly 
down-regulated. Common regulators of down-regulated liver genes due to fasting 
included tumor protein 53, E2F1, and C/EBPδ, and their target genes were involved in 
cell cycle or cell proliferation, such as cyclin-dependent kinase 2 and cyclin E1. This 
indicates that a decrease in proliferation of the hepatocytes to preserve energy during 
fasting likely occurred in pigs, as previously seen in rats. 
Fasting down-regulated steroid biosynthesis in both liver and fat. In rats, hepatic 
biosynthesis of steroids was decreased 10-fold after 48-h fasting (19) and expression of 
genes encoding enzymes involved in the steroid biosynthesis pathway was also 
significantly down-regulated (55). In pigs, a tissue level decrease in cholesterol due to 
fasting, combined with an increased serum cholesterol concentration, has been reported 
(22). Our finding of down-regulation of 12 genes encoding enzymes involved in steroid 
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biosynthesis, in part, explains these results. The protein SREBF2, which stimulates 
transcription of genes that encode enzymes involved in cholesterol synthesis (20) was 
down-regulated 2.7-fold in liver and 1.23-fold in fat in response to fasting in our study 
(Table 3). SREBF2 was also one of the 10 TF with the greatest connectivity to the down-
regulated liver genes and the 18th most connected among TF of down-regulated fat genes, 
emphasizing the importance of SREBF2 and steroid synthesis in the adaptive response to 
fasting.      
Conclusions. A series of genes and biological pathways that respond to fasting in pigs 
were identified. A fasting-induced switch to a conservation mode of energy utilization by 
down-regulating costly lipid, steroid and protein biosynthetic processes was established. 
Fasting up-regulated genes involved in angiogenesis and cell-to-cell signaling in fat and 
up-regulated pathways involved with efficient energy utilization and conservation in 
liver, such as gluconeogenesis and β-oxidation of fatty acids. Our study implicates 
involvement of several known and several new TF in the adaptive fasting response in 
pigs, including PPARγ, C/EBPα, SREBF1, and EPAS-1, FOXC2, and ESR1. Our results 
support that during the early fasting stage, lipid stores are predominantly utilized and fat 
undergoes morphological changes that promote angiogenesis. Enhanced angiogenesis 
likely provides efficient lipid mobilization into the bloodstream and such morphological 
changes that target cell-to-cell and cell-to-matrix interactions are, in part, 
transcriptionally controlled by ESR1.        
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FIGURE LEGENDS 
 
Fig. 1. Microarray data validation on a subset of differentially expressed genes (q≤0.05) 
by qPCR in liver and fat. 1A: Representative genes in the lipid biosynthesis pathway in 
adipose tissue 1B. Representative genes in the gluconeogenesis, fatty acid oxidation, 
ketogenesis, or steroid synthesis pathways in liver. Official gene symbols were used as 
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abbreviations. ACACA, acetyl-coenzyme A carboxylase alpha; ACSL-1, acyl-CoA 
synthetase long-chain family member 1; FASN, fatty acid synthase; ACO1, aconitase 1; 
SREBF1, sterol regulatory element binding factor 1; IGF1, insulin-like growth factor 1; 
HADHA, hydroxyacyl-Coenzyme A dehydrogenase; PC, pyruvate carboxylase; ACADL, 
acyl-Coenzyme A dehydrogenase, long chain; DHCR7, 7-dehydrocholesterol reductase; 
SQLE, squalene epoxidase; HMGCR, 3-hydroxy-3-methylglutaryl-Coenzyme A 
reductase; ECH1, enoyl Coenzyme A hydratase 1; HMGCS1, 3-hydroxy-3-
methylglutaryl-Coenzyme A synthase 1.  MA=microarray. Fold changes are expressed as 
(Fasted/Ad lib.), in which negative fold changes indicate down-regulation while positive 
fold changes indicate up-regulation of expression due to fasting. 
Fig. 2. Functional annotation of liver and adipose tissue-specific fasting response by 
identifying overrepresented KEGG biological pathways (p≤0.05) in differentially 
expressed genes. Biological processes were subdivided according to KEGG pathway 
maps.  
Fig. 3. Genes and pathways responding to fasting in liver and fat with either the same or 
opposite pattern in response to fasting. 3A. Venn diagram of overlapping up-and down-
regulated genes (q≤0.05) between liver and adipose tissue. 3B. Shared up- and down-
regulated pathways and their functions (KEGG p≤0.05) in response to fasting across 
adipose and liver tissues.        
Fig. 4. Fold change distribution of differentially expressed genes due to fasting in fat and 
in liver.  The functional annotation of the 50 most up- and down-regulated genes based 
on fold change in fat and in liver (KEGG p≤0.05) shows that the biosynthesis of steroids 
pathway was most significantly overrepresented by the 50 most down-regulated genes in 
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both tissues.  The highest, lowest, and the average fold changes were 5.7, 2.3, and 2.8 for 
the 50 most up-regulated  genes in fat; -3.96, -27.4, -6.61 for the 50 most down-regulated 
genes in fat; 12.7, 2.02, and 3.3 for the 50 most up-regulated genes in liver; -2.6, -22.7, -
4.8 for the most 50 down-regulated genes in liver. 
Fig. 5. Ten highest connected transcription factors (TF) for fasting response in the up- 
and down-regulated genes in fat and liver and the pathways overrepresented (KEGG 
p≤0.05) by the target genes of the most connected TF in each list. Official gene symbols 
for the TF and nuclear receptors were used as abbreviations. CBFB, Putative C-module-
binding factor; CBX5, chromobox homolog 5; CEBPA, CCAAT/enhancer binding 
protein alpha;  CEBPD, CCAAT/enhancer binding protein delta; DNMT3, DNA 
(cytosine-5)-methyltransferase 3 beta; E2F1, E2F transcription factor 1; ESR1, estrogen 
receptor 1; FOS, FBJ murine osteosarcoma oncogene; FOXM1, forkhead box M1; 
GTF2B, general transcription factor IIB; HDAC2, histone deacetylase  2; HIF1A, 
hypoxia inducible factor 1, alpha subunit; HMGY, high mobility group AT-hook 1; 
HSF1, heat shock factor 1; MADH2, MAD homolog 2; MCM2, cell division control 
protein 21; MITF, microphthalmia-associated transcription factor; NCOA1, nuclear 
receptor coactivator 1; NCOR1, nuclear receptor co-repressor 1; NFE2L2, nuclear factor 
(erythroid-derived 2)-like 2; NR1H3, nuclear receptor subfamily 1, group H, member 3; 
NR1H4, nuclear receptor subfamily 1, group H, member 4; PER1, period homolog 1; 
PER2, period 2; PPARG, peroxisome proliferator-activated receptor gamma; PGC1, 
peroxisome proliferator activated receptor gamma coactivator-1; RUNX1, runt-related 
transcription factor 1; SPI1, spleen focus forming virus proviral integration oncogene; 
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SREBF1, sterol regulatory element binding factor 1; SREBF2, sterol regulatory element 
binding factor 1; TP53, tumor protein p53. 
TABLE LEGENDS 
Table 1. Values are least square means and standard errors (SE) pooled across 
treatments, n=6 per genotype by feeding treatment combination. The p-values correspond 
to the main effect of feeding treatment. The effects of MC4R genotype and feed by 
genotype interaction were non-significant for all traits (p≥0.09) except for initial backfat 
depth (p=0.05). Least square means within the same line that do not share the same 
superscript letter are significantly different at p<0.05.  * Feed intake was averaged over 
the 3-day treatment period and only pigs fed ad libitum were used to test the genotype 
effect. †Non-esterified fatty acid (NEFA) concentration data were natural log 
transformed.  
Table 2. *Fold changes are expressed as (Fasted/Ad lib.), in which positive fold changes 
indicate up-regulation of expression due to fasting. 
Table 3. *Fold changes are expressed as (Fasted/Ad lib.), in which negative fold changes 
indicate down-regulation, while positive fold changes indicate up-regulation of 
expression due to fasting 
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Table 1. Body weights, backfat changes and serum parameters in pigs fed at ad libitum 
and fasted and that are homozygous for MC4R variant D298 or variant N298 
  
Fed at ad 
libitum   Fasted   Feeding 
Trait D298 N298   D298 N298 SE p value 
Feed intake, kg/day* 2.4a 2.2a  0 0 0.2 - 
Initial body weight, kg 81.0a 80.4a  82.0a 81.6a 1.8 0.4634 
Final body weight, kg 83.5a 83.0a  76.5b 76.0b 2.2 0.0002 
Initial backfat, mm 11.0a 13.2b  12.8a,b 13.2b 0.7 0.1738 
Backfat [post-pre] change, mm  0.89a 0.64a  0.30a -1.27b 0.5 0.0219 
Glycogen in liver (ng/mg of liver) 14.2a 13.6a  4.2b 4.9b 2.0 <0.0001 
Glucose, mg/dl 89.4a 78.0a  92.0a 90.7a 6.9 0.2444 
Triglyceride, mg/dl 33.8a 29.0a  39.2a 40.2a 4.3 0.0708 
Pre-treatment NEFA ln(mEq/ml)† 4.7a 4.7 a  4.9 a 5.22 a 0.2 0.1589 
Post-treatment NEFA, ln(mEq/ml) 5.2a 5.4a  6.2b 6.0b 0.2 <0.0001 
Urea, mg/dl 16.7a, b 17.1a   13.2b,c 12.5c 1.8 0.0056 
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Table 2.  The statistical values of genes involved in the fasting induced morphological 
changes in the fat 
Pathways Gene description GenBank 
symbol 
Affymetrix 
ID 
*Fold 
change q value p value 
Angiogenesis Interleukin 8 IL8 Ssc.658 2.53 3.05E-02 1.54E-02 
 Insulin-like growth factor 2 IGF2 Ssc.9365 1.16 2.15E-02 9.75E-03 
 
Natriuretic peptide receptor 
A/Guanylate cyclase A NPR1 Ssc.24926 1.30 1.21E-03 2.55E-04 
 Angiogenin ANG Ssc.4679 1.93 7.08E-06 2.97E-07 
 Endothelial PAS domain protein 1 EPAS1 Ssc.8965 1.39 1.19E-02 4.62E-03 
 Vascular endothelial growth factor C VEGFC Ssc.12790 1.42 3.66E-02 1.95E-02 
 Laminin, alpha 5 LAMA5 Ssc.15173 1.46 3.39E-04 5.02E-05 
 Forkhead box C2 FOXC2 Ssc.19569 1.72 2.51E-02 1.19E-02 
 
Angiogenic factor with G patch and 
FHA domains 1 AGGF1 Ssc.26953 1.14 4.05E-03 1.19E-03 
 NMDA receptor regulated 1 NARG1 Ssc.12421 1.45 1.54E-03 3.44E-04 
 Angiopoitin-like 4 ANGPTL4 Ssc.8980 2.36 6.41E-04 1.14E-04 
  
B-Cell translocation gene 1, anti-
proliferative BTG1 Ssc.6833 1.19 3.94E-04 6.08E-05 
 Integrin,beta 3 ITGB3 Ssc.7556 1.26 1.79E-06 2.57E-05 
 
Hairy and enhancer of split-related 
protein 2 HEY2 Ssc.24610 1.21 0.076992 0.05356 
Adherens 
junction Mothers against DPP  SMAD2 Ssc.24402 1.28 3.82E-03 1.10E-03 
 Catenin (Cadherin-associated protein) CTNNB1 Ssc.14003 1.12 1.23E-03 2.60E-04 
 
Protein tyrosine phosphatase, receptor 
type, F PTPRF Ssc.2337 1.26 8.98E-03 3.22E-03 
 Wiskott-Aldrich syndrome-like WASL Ssc.21951 1.14 2.61E-04 3.63E-05 
 Epidermal growth factor receptor EGFR Ssc.55 1.73 8.08E-05 7.99E-06 
 
V-Yes-1 Yamaguchi sarcoma viral 
oncogene YES1 Ssc.6801 1.27 1.78E-02 7.72E-03 
 WAS protein family member 3 WASF3 Ssc.4177 1.29 2.87E-03 7.68E-04 
 Partitioning defective 3 homolog PARD3 Ssc.1382 1.57 4.38E-04 6.93E-05 
 Fibroblast growth factor receptor 1 FGFR1 Ssc.17773 1.41 1.95E-01 2.00E-01 
  Transcription factor 7-like 2 TCF7L2 Ssc.19409 1.41 9.77E-05 1.03E-05 
Cell adhesion 
molecules 
Activated leukocyte cell adhesion 
molecule ALCAM Ssc.13385 1.61 2.21E-03 5.47E-04 
 CD276 antigen CD276 Ssc.2042 1.51 2.10E-04 2.74E-05 
 CD34 antigen CD34 Ssc.15747 1.20 2.02E-02 9.04E-03 
 CD99 antigen CD99 Ssc.3205 1.29 8.12E-04 1.54E-04 
 Claudin 3 CLDN3 Ssc.9102 1.53 3.22E-02 1.65E-02 
 Claudin 5 CLDN5 Ssc.4227 2.04 3.36E-04 4.98E-05 
 Huel-interacting protein ESAM Ssc.23336 1.44 4.48E-04 7.12E-05 
 F11 receptor F11R Ssc.29060 1.20 4.37E-04 6.90E-05 
 
Major histocompatibility complex, 
class I, A HLA-A Ssc.13780 1.52 9.76E-03 3.58E-03 
 
Major histocompatibility complex, 
class II, DM alpha 
HLA-
DMA Ssc.13777 1.14 4.03E-02 2.22E-02 
 
Intercellular adhesion molecule 1 
(CD54) ICAM1 Ssc.11187 1.31 8.54E-03 3.03E-03 
 Integrin, Beta 8 ITGB8 Ssc.23798 2.63 2.22E-03 5.53E-04 
 Junctional adhesion molecule 2 JAM2 Ssc.9217 1.49 2.14E-04 2.81E-05 
 Neural cell adhesion molecule 1 NCAM1 Ssc.6092 1.41 1.79E-02 7.76E-03 
51 
 
 
Table 2. (continued) 
Pathways Gene description GenBank 
symbol 
Affymetrix 
ID 
*Fold 
change q value p value 
 
Platelet/endothelial cell adhesion 
molecule (CD31) PECAM1 Ssc.14558 1.24 1.07E-02 4.01E-03 
 
Protein tyrosine phosphatase, 
receptor type, F PTPRF Ssc.2337 1.26 8.98E-03 3.22E-03 
 Syndecan 2 SDC2 Ssc.2485 1.51 9.36E-07 1.54E-08 
 Numb homolog NUMB Ssc.20190 1.13 3.63E-03 1.03E-03 
 E1A binding protein EP300 Ssc.22177 1.13 3.24E-02 1.66E-02 
 CREB binding protein CREBBP Ssc.17277 1.16 4.14E-03 1.22E-03 
 SNW domain containing 1 SNW1 Ssc.17288 1.21 4.25E-02 2.39E-02 
 
Notch homolog 1, trasnlocation-
associated NOTCH1 Ssc.26169 1.32 5.34E-03 1.68E-03 
 KIAA1528 protein DTX2 Ssc.26800 1.31 3.07E-03 8.38E-04 
 C-terminal binding protein 2 CTBP2 Ssc.27641 1.95 1.29E-06 2.77E-08 
 Notch homolog 2 NOTCH2 Ssc.19892 1.29 3.99E-04 6.18E-05 
  Mastermind-like 2 MAML2 Ssc.27051 1.37 4.10E-04 6.39E-05 
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Table 3.  The statistical differential expression values of genes and pathways referred in 
the results 
Pathways Gene description GenBank 
symbol  
Affymetrix 
ID Tissue 
*Fold 
change  q value p value 
Gluconeogenesis fructose-1,6-bisphosphatase   FBP1 Ssc.5127 Liver 1.30 3.35E-04 3.96E-06 
 phosphoenolcarboxykinase 2 PCK2 Ssc.19382 Liver 1.44 8.70E-03 4.30E-04 
 pyruvate carboxylase  PC Ssc.17347 Liver 3.73 2.56E-10 6.49E-14 
Lipolysis β-adenergic receptor gene  ADRB1 Ssc.16075 Fat 1.30 4.00E-02 2.00E-03 
 hormone sensitive lipase  HSL Ssc.6784 Fat 1.05 3.00E-01 4.30E-01 
 forkhead box C2 FOXC2 Ssc.19569 Fat 1.70 2.50E-02 1.20E-02 
Adipogenesis 
peroxisome proliferator-
activated receptor gamma PPARγ Ssc.15274 Fat -1.32 2.39E-04 6.00E-03 
 
CCAAT/enhancer binding 
protein, alpha C/EBPα Ssc.15991 Fat -1.44 9.60E-03 3.50E-03 
 
sterol regulatory element 
binding factor 1 SREBF1 Ssc.15992 Fat -2.57 4.75E-04 7.69E-05 
Fatty acid 
oxidation 
acyl-CoA dehydrogenase, long 
chain ACADL Ssc.14530 Liver 2.34 9.43E-07 2.79E-09 
 enoyl CoA hydratase 1 ECH1 Ssc.5099 Liver 2.27 2.83E-07 5.39E-10 
 
hydroxyacyl-CoA 
dehydrogenase HADHA Ssc.11580 Liver 2.43 1.08E-06 3.31E-09 
 acetyl CoA acyltransferase ACAA1 Ssc.1225 Liver 1.50 1.73E-05 9.59E-08 
 
carnitine palmitoyltransferase 
1A CPT1A Ssc.8974 Liver 1.64 7.70E-03 3.63E-04 
 
peroxisome proliferator-
activated receptor alpha PPARα Ssc.9348 Liver 1.40 5.80E-03 2.28E-04 
Glucose 
metabolism 
E2 component of pyruvate 
dehydrogenases PDCE2 Ssc.14134 Liver 1.10 1.80E-01 5.10E-02 
 
α subunit of pyruvate 
dehydrogenase PDHA1 Ssc.16248 Liver 1.00 6.60E-01 9.60E-01 
 
β subunit of pyruvate 
dehydrogenase PDHB Ssc.7604 Liver 1.03 5.00E-01 4.50E-01 
 
pyruvate dehydrogenase 
kinase-4 PDK4 Ssc.1121 Liver 1.04 5.90E-01 6.70E-01 
Ketogenesis 
3-hydroxymethyl-3-
methylglutaryl-CoA lyase HMGCL Ssc.27317 Liver -1.30 1.50E-02 9.80E-04 
 
3-hydroxymethylglutaryl-CoA 
synthase 1 HMGCS1 Ssc.11126 Liver -7.33 1.02E-08 1.12E-11 
 acetyl CoA acetyltransferase 2 ACAT2 Ssc.4426 Liver -9.10 1.94E-07 3.10E-10 
Biosynthesis of 
steroid 
3-hydroxy-3-methylglutaryl-
coenzyme A reductase HMGCR Ssc.16088 Fat -1.54 8.10E-03 2.84E-03 
 7-dehydrocholesterol reductase DHCR7 Ssc.5455 Fat -3.45 3.50E-04 5.30E-05 
 sterol isomerase EBP Ssc.5045 Fat -4.04 5.29E-06 1.99E-07 
 
isopentenyl-diphosphate delta 
isomerase 1 IDI1 Ssc.6714 Fat -5.60 1.01E-06 1.77E-08 
 sterol-C5-desaturase SC5DL Ssc.15727 Fat -3.57 2.70E-07 2.12E-09 
 mevalonate kinase MVK Ssc.3345 Fat -4.95 2.25E-04 3.01E-05 
 mevalonate decarboxylase MVD Ssc.4685 Fat -6.50 4.43E-05 3.62E-06 
 squalene epoxidase SQLE Ssc.8385 Fat -1.44 3.07E-02 1.55E-02 
 
geranyl geranyl diphosphate 
synthase GGPS1 Ssc.14178 Fat -1.22 1.78E-03 4.15E-04 
 
farnesyl diphosphate 
farnesyltransferase 1 FDFT1 Ssc.6418 Fat 1.09 1.61E-01 1.50E-01 
 
sterol regulatory element 
binding factor 2 SREBF2 Ssc.16976 Fat -1.23 3.40E-02 1.80E-02 
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Table 3. (continued) 
Pathways Gene description GenBank 
symbol  
Affymetrix 
ID Tissue 
*Fold 
change  q value p value 
Biosynthesis 
of steroid 
3-hydroxy-3-methylglutaryl-
coenzyme A reductase HMGCR Ssc.16088 Liver -6.70 3.74E-07 7.88E-10 
 
 7-dehydrocholesterol reductase DHCR7 Ssc.5455 Liver -5.72 1.24E-08 1.45E-11 
 sterol isomerase EBP Ssc.5045 Liver -3.69 2.56E-10 9.46E-14 
 
isopentenyl-diphosphate delta 
isomerase 1 IDI1 Ssc.6714 Liver -9.94 2.56E-10 3.20E-14 
 sterol-C5-desaturase SC5DL Ssc.15727 Liver -3.36 4.26E-09 3.67E-12 
 mevalonate kinase MVK Ssc.3345 Liver -1.74 9.89E-03 5.21E-04 
 mevalonate decarboxylase MVD Ssc.4685 Liver -4.35 3.49E-04 4.17E-06 
 squalene epoxidase SQLE Ssc.8385 Liver -7.61 1.02E-08 1.14E-11 
 
farnesyl diphosphate 
farnesyltransferase 1 FDFT1 Ssc.6418 Liver -1.71 8.28E-05 6.63E-07 
 
geranyl geranyl diphosphate 
synthase GGPS1 Ssc.14178 Liver -1.11 4.14E-01 2.94E-01 
 
sterol regulatory element 
binding factor 2 SREBF2 Ssc.15889 Liver -2.70 3.70E-02 3.50E-03 
Cell cycle 
regulation E2F transcription factor 1 E2F1 Ssc.1859 Liver -1.95 4.17E-03 1.43E-04 
 
CCAAT/enhancer binding 
protein, delta C/EBPδ Ssc.10025 Liver -1.47 1.55E-02 1.01E-03 
 tumor protein p53 TP53 Ssc.15917 Liver -1.31 4.13E-02 4.29E-03 
 cyclin-dependent kinase 2 CDK2 Ssc.27616 Liver -1.24 4.60E-02 5.00E-03 
 cyclin E1 CCNE1 Ssc.18187 Liver -1.43 4.00E-02 4.00E-03 
 E2F transcription factor 1 E2F1 Ssc.1859 Fat -2.09 1.18E-05 5.90E-07 
 cyclin-dependent kinase 2 CDK2 Ssc.27616 Fat -1.27 1.89E-03 4.50E-04 
  cyclin E1 CCNE1 Ssc.18187 Fat -1.34 6.01E-03 1.96E-03 
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Figure 1A. 
 
Figure 1B. 
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Figure 4. 
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Supplementary Table 1. Primers and probes used for Taqman qPCR analysis 
 
Gene 
name Forward primer Probe 5’ 6-FAMTM  3’ Iowa Black FQTM Reverse primer 
GenBank Acc. 
No./TIGR TC 
IGF1 5-CTGGTGGACGCTCTTCAGTTC-3 5-TGGGCTTGTTGAAATAAAAGCCCCTGT-3 5-GATCACAGCTCCGGAAGCA-3  TC204530  
FASN 5-GTTCTTCCAGGACGTCAGTAAGC-3 5-CCTCCCGGGTCACCCTGTCCAG-3 5-CGGAGGAGAAGATCACGAAGTAG-3 TC302928 
ACSL-1 5-CCTGTGGCTCAGGTGTTTGTC-3 5-CTATGAGAAATGCCTGCAAGCTCTCTCCG-3 CTCAACGTCTGGAACCACAATC-3 AY690660 
ACACA 5-TCCACATGAACAGGCTTCCA-3 5-TCCAAGCTACCATGCCAATCTCATTTCCT-3 5-ATTCCGGACTTTTAAGGGACATT-3 AF175308 
ACO1 5-GAGAAGTGCTTGACGTGTTCGA-3 5-CTGCCCAGTCTCGGGAGCTGCCA-3 5-AGCCTTGATTCCCAACAGGAA-3 TC202124  
SREBF1 5-TGTACAGCGTGGCTGGGAA-3  5-CCAGTGGACCCCCTGGCCC-3 5-GTGTTCACGGAACAACTGAGTCA-3   TC238210  
IGF1R 5-CATTGCCTCGGAGCTAGAGAA-3  5-CACGTAGCCCGTCACCACCTCGAT-3 5-TGGGAGTGGCGGATCTTC-3  TC233908  
HADHA 5-GCATTCGGGCAGACAAAGCAAA-3 5-ACCAACTGGTGGAACCGCTGGGACCAGGAT-3 5-TTGTCCGTTCCTCTGGAGGTTT-3 NM_213962 
PC 5-ATTCCCTGCTGGTCAAGGTCAT-3 5-TTGCCGAGTTCCGAGTCCGAGGCGTCAAGA-3 5-AGGAACTGCTGGTTGTTGAGCA-3 NM_214349 
ACADL 5-TGTCTCCAGCTGCATGAAACGA-3 5-TCTGGAGTCTGCCGCTGCTTCCATGGCAA-3 5-AGCTGCACACAGTCATAAGCCA-3 NM_213897 
DHCR7 5-TGGACCCTCATCAACCTGTCCTT-3 5-AGCAGCAGCTCTACGGCCACGTCACCAACT-3 5-TCCAGAAGAAGTCCAGCACGTAGA-3 TC378393 
SQLE 5-CCCACAACTACCTGATCACCTGAA-3 5-TGCCAGCAAGCTTCCTCCCTTCTTCGCCA-3 5-TGCCTCATGTTATGTGCATCTCCC-3 NM_001101026 
HMGCR 5-GGTTCCAATGGCAACAACAGAAGG-3 5-AGCAATTGGTCTTGGTGGAGGCGCCAGCA-3 5-AGTCATGCCATCTGCGAGGATT-3 NM_001122988 
ECH1 5-AGAGAGATGGTGGTGTGCTTCAAC-3 5-TGTCGTGCGGTGGTGATCTCTGGTGCAGGA-3 5-ATGTCCGAAGCCATGTCCACAA-3 NM_001044607 
HMGCS1 5-ATCTCAGTGCATTAGATCGCTGCT-3 5-ACCGCAAGAAATCCATGCCCGGTGGCA-3 5-CTGAACCAGTTTACAATAGGGTGAGTGG-3 TC318858 
     
Official gene symbols were used as abbreviations. ACACA, acetyl-coenzyme A carboxylase alpha; ACSL-1, acyl-CoA 
synthetase long-chain family member 1; FASN, fatty acid synthase; ACO1, aconitase 1; SREBF1, sterol regulatory element 
binding factor 1; IGF1, insulin-like growth factor 1; HADHA, hydroxyacyl-Coenzyme A dehydrogenase; PC, pyruvate 
carboxylase; ACADL, acyl-Coenzyme A dehydrogenase, long chain; DHCR7, 7-dehydrocholesterol reductase; SQLE, 
squalene epoxidase; HMGCR, 3-hydroxy-3-methylglutaryl-Coenzyme A reductase; ECH1, enoyl Coenzyme A hydratase 1; 
HMGCS1, 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1. 
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Supplementary Table 3. Average Ct values and standard errors (SE) obtained from qPCR 
 
  
 
Genes Fed at ad libitum (Ct) 
Fasted  
(Ct) SE 
Adipose tissue    
 
ACACA 22.03 25.3 0.37 
 
ACO1 24.4 25.96 0.31 
 
ACS 19.46 21.86 0.34 
 
FASN 25.28 31.76 0.33 
 
IGF1 27.07 27.83 0.4 
 
IGF1R 24.86 24.83 0.57 
 
RPL32 17.19 17.61 0.24 
 
SREBF1 29.27 31.85 0.38 
Liver     
 
ACADL 25.1 23.64 0.46 
 
DHCR7 23.05 25.62 0.33 
 
ECH1 24.18 23.24 0.42 
 
HADHA 22.99 22.57 0.29 
 
HMGCR 23.5 26.7 0.52 
 
HMGCS1 23.45 26.74 0.5 
 
PC 33.09 30.66 0.43 
 
RPL32 19.68 19.7 0.31 
 
SQLE 23.6 27.32 0.43 
 
Official gene symbols were used as abbreviations. ACACA, acetyl-coenzyme A 
carboxylase alpha; ACSL-1, acyl-CoA synthetase long-chain family member 1; FASN, 
fatty acid synthase; ACO1, aconitase 1; SREBF1, sterol regulatory element binding 
factor 1; IGF1, insulin-like growth factor 1; HADHA, hydroxyacyl-Coenzyme A 
dehydrogenase; PC, pyruvate carboxylase; ACADL, acyl-Coenzyme A dehydrogenase, 
long chain; DHCR7, 7-dehydrocholesterol reductase; SQLE, squalene epoxidase; 
HMGCR, 3-hydroxy-3-methylglutaryl-Coenzyme A reductase; ECH1, enoyl Coenzyme 
A hydratase 1; HMGCS1, 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1. 
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 Supplementary Table 4A. Main themes of clusters and corresponding GO Biological 
Process terms for down-regulated genes (q≤0.05) in fat tissue in response to fasting      
Clusters themes  
Enrichment 
score GO terms p-values 
Biosynthesis  19.48 biosynthesis 2.81E-30 
  cellular biosynthesis 8.99E-25 
  protein biosynthesis 6.21E-13 
  macromolecule biosynthesis 7.49E-13 
Oxidative phosphorylation  12.91 oxidative phosphorylation 8.02E-22 
  ATP synthesis coupled electron transport 9.16E-12 
  ATP synthesis coupled electron transport  3.01E-11 
  mitochondrial electron transport, NADH to ubiquinone 1.06E-09 
Metabolism of organic acid 9.14 carboxylic acid metabolism 1.51E-13 
  organic acid metabolism 2.14E-13 
  amino acid and derivative metabolism 2.73E-09 
  amino acid metabolism 3.11E-08 
  nitrogen compound metabolism 1.31E-07 
  amine metabolism 3.91E-07 
TCA cycle  8.8 cellular respiration 1.85E-12 
  aerobic respiration 1.78E-11 
  coenzyme catabolism 8.25E-11 
  acetyl-CoA catabolism 8.22E-10 
  tricarboxylic acid cycle 8.22E-10 
  acetyl-CoA metabolism 8.52E-10 
  cofactor catabolism 1.01E-08 
  tricarboxylic acid cycle intermediate metabolism 2.66E-03 
Cofactor and coenzyme 
metabolism  7.29 cofactor metabolism 1.70E-22 
  oxidative phosphorylation 8.02E-22 
  coenzyme metabolism 1.87E-21 
  cofactor biosynthesis 3.33E-12 
  coenzyme biosynthesis 2.35E-10 
  nucleoside triphosphate metabolism 1.53E-08 
  nucleoside triphosphate biosynthesis 4.21E-08 
  purine ribonucleoside triphosphate metabolism 8.24E-08 
  ribonucleoside triphosphate metabolism 8.24E-08 
  purine nucleoside triphosphate metabolism 8.24E-08 
  purine ribonucleoside triphosphate biosynthesis 9.90E-08 
  ribonucleoside triphosphate biosynthesis 9.90E-08 
  purine nucleoside triphosphate biosynthesis 9.90E-08 
  ATP metabolism 2.31E-07 
  ATP biosynthesis 2.72E-07 
Functional clustering analysis used GO biological processes in DAVID and clusters with enrichment score 1.3 or more 
were reported.  Enrichment scores were calculated by DAVID software as the negative log10 of the geometric mean of 
p-values in the cluster.   
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Supplementary Table 4A. (continued)      
Clusters themes  
Enrichment 
score GO terms p-values 
  purine nucleotide metabolism 1.82E-06 
  purine ribonucleotide metabolism 2.60E-06 
  ribonucleotide biosynthesis 2.60E-06 
  ribonucleotide metabolism 3.05E-06 
  ATP synthesis coupled proton transport 3.83E-06 
  purine nucleotide biosynthesis 4.40E-06 
  purine ribonucleotide biosynthesis 6.31E-06 
  nucleotide metabolism 8.11E-06 
  nucleotide biosynthesis 5.56E-05 
Transport  5.86 proton transport 1.22E-04 
  hydrogen transport 1.85E-04 
  monovalent inorganic cation transport 3.23E-01 
  cation transport 7.01E-01 
  ion transport 7.82E-01 
  transport 3.59E-07 
  establishment of localization 2.01E-06 
  localization 3.59E-06 
Lipid metabolism  5.4 cellular lipid metabolism 1.23E-06 
  lipid metabolism 4.07E-06 
  lipid biosynthesis 1.22E-05 
  metabolism 1.43E-09 
Cellular metabolism  4.81 cellular metabolism 4.89E-08 
  cellular physiological process 3.50E-06 
  macromolecule metabolism 3.83E-06 
  physiological process 1.11E-05 
  primary metabolism 3.90E-02 
  cellular process 5.61E-01 
  oxidative phosphorylation 8.02E-22 
Phosphorylation  4.55 phosphorylation 1.40E-01 
  phosphorus metabolism 4.05E-01 
  phosphate metabolism 4.05E-01 
  protein amino acid phosphorylation 1.00E+00 
  translation 6.05E-08 
Translation  4.48 tRNA aminoacylation 7.28E-05 
  tRNA aminoacylation for protein translation 7.28E-05 
  amino acid activation 7.28E-05 
  tRNA metabolism 1.77E-03 
  establishment of cellular localization 2.42E-07 
Cellular localization  3.98 cellular localization 3.63E-07 
  intracellular transport 7.06E-07 
  intracellular protein transport 1.89E-05 
  establishment of protein localization 1.02E-03 
  protein transport 1.05E-03 
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Supplementary Table 4A. (continued)           
Clusters themes  
Enrichment 
score GO terms p-values 
Cellular localization  protein localization 1.99E-03 
  protein targeting 3.86E-03 
  cell organization and biogenesis 1.73E-01 
Amino acid biosynthesis  3.82 nitrogen compound biosynthesis 1.28E-04 
  amine biosynthesis 1.28E-04 
  amino acid biosynthesis 2.15E-04 
Glucose metabolism 3.75 alcohol metabolism 4.13E-07 
  cellular carbohydrate metabolism 1.29E-06 
  glucose catabolism 2.08E-04 
  carbohydrate metabolism 2.47E-04 
  alcohol catabolism 2.78E-04 
  glucose metabolism 3.18E-04 
  hexose metabolism 3.24E-04 
  carbohydrate catabolism 3.91E-04 
  cellular carbohydrate catabolism 3.91E-04 
  monosaccharide metabolism 5.67E-04 
  hexose catabolism 6.28E-04 
  monosaccharide catabolism 9.28E-04 
  glycolysis 3.99E-03 
Steroid metabolism 2.79 sterol biosynthesis 1.68E-04 
  sterol metabolism 6.25E-04 
  steroid biosynthesis 6.25E-04 
  cholesterol biosynthesis 4.19E-03 
  cholesterol metabolism 6.69E-03 
  steroid metabolism 1.01E-02 
Proteolysis 2.72 catabolism 2.16E-08 
  cellular catabolism 1.48E-07 
  macromolecule catabolism 5.19E-05 
  cellular macromolecule catabolism 3.09E-03 
  biopolymer catabolism 3.75E-03 
  protein catabolism 5.18E-03 
  modification-dependent protein catabolism 1.33E-01 
  ubiquitin-dependent protein catabolism 1.33E-01 
  cellular protein catabolism 1.68E-01 
  proteolysis during cellular protein catabolism 1.68E-01 
  proteolysis 2.64E-01 
Protein metabolism  2.3 macromolecule metabolism 3.83E-06 
  cellular macromolecule metabolism 1.08E-04 
  protein metabolism 1.34E-04 
  cellular protein metabolism 1.99E-04 
  primary metabolism 3.90E-02 
  biopolymer metabolism 9.45E-01 
  biopolymer modification 1.00E+00 
  protein modification 1.00E+00 
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Supplementary Table 4A. (continued)           
Clusters themes  
Enrichment 
score GO terms p-values 
Secretory pathway  2.06 Golgi vesicle transport 4.78E-04 
  ER to Golgi vesicle-mediated transport 6.15E-04 
  secretory pathway 1.54E-02 
  secretion 8.14E-02 
  vesicle-mediated transport 1.44E-01 
Regulation of biosynthesis 2.05 translation 6.05E-08 
  regulation of translation 7.64E-03 
  regulation of protein biosynthesis 1.49E-01 
  regulation of biosynthesis 1.60E-01 
  regulation of cellular biosynthesis 2.02E-01 
  regulation of protein metabolism 2.38E-01 
Spindle organization and 
biogenesis  1.98 spindle organization and biogenesis 3.04E-03 
  microtubule-based process 4.23E-03 
  microtubule cytoskeleton organization and biogenesis 1.27E-02 
  mitotic spindle organization and biogenesis 7.12E-02 
Mitotic cell cycle  1.76 mitotic cell cycle 2.99E-03 
  M phase of mitotic cell cycle 9.93E-03 
  mitosis 1.42E-02 
  cell division 5.70E-02 
  M phase 6.41E-02 
Serine family amino acid 
metabolism  1.57 serine family amino acid metabolism 5.03E-03 
  serine family amino acid biosynthesis 9.30E-03 
  L-serine metabolism 9.12E-02 
  L-serine biosynthesis 1.18E-01 
Heme metabolism  1.55 heterocycle metabolism 8.90E-03 
  pigment biosynthesis 1.44E-02 
  porphyrin biosynthesis 1.59E-02 
  heme biosynthesis 1.91E-02 
  secondary metabolism 3.76E-02 
  pigment metabolism 4.71E-02 
  porphyrin metabolism 6.63E-02 
  heme metabolism 8.43E-02 
Fatty acid biosynthesis 1.4 carboxylic acid biosynthesis 2.56E-02 
  organic acid biosynthesis 2.56E-02 
  fatty acid biosynthesis 9.49E-02 
Amine catabolism  1.39 branched chain family amino acid metabolism 9.30E-03 
  branched chain family amino acid catabolism 2.62E-02 
  amino acid catabolism 6.16E-02 
  amine catabolism 7.79E-02 
  nitrogen compound catabolism 9.67E-02 
Protein targeting to 
mitochondrion 1.3 protein targeting to mitochondrion 2.96E-05 
  mitochondrial membrane organization and biogenesis 4.28E-02 
  mitochondrion organization and biogenesis 5.60E-02 
  protein import into mitochondrial inner membrane 6.55E-02 
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Supplementary Table 4A. (continued)           
Clusters themes  
Enrichment 
score GO terms p-values 
Protein targeting to 
mitochondrion  inner mitochondrial membrane organization and biogenesis 1.18E-01 
  membrane organization and biogenesis 3.89E-01 
  sensory perception of sound 4.16E-01 
    sensory perception of mechanical stimulus 4.16E-01 
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Supplementary Table 4B. Main themes of clusters and corresponding GO Biological 
Process terms for up-regulated genes (q≤0.05) in fat tissue in response to fasting 
Clusters themes  
Enrichment 
score GO terms p-values 
Transcription  13.84 transcription 1.86E-17 
  regulation of metabolism 1.64E-16 
  regulation of cellular metabolism 1.66E-16 
  
regulation of nucleobase, nucleoside, nucleotide and nucleic acid 
metabolism 1.90E-16 
  regulation of transcription 2.70E-16 
  transcription, DNA-dependent 5.38E-15 
  regulation of transcription, DNA-dependent 8.37E-15 
  regulation of cellular physiological process 4.39E-14 
  regulation of cellular process 5.19E-13 
  regulation of physiological process 1.13E-12 
  regulation of biological process 1.65E-11 
  nucleobase, nucleoside, nucleotide and nucleic acid metabolism 1.67E-10 
Negative regulation of 
transcription  2.9 negative regulation of cellular physiological process 1.87E-04 
  negative regulation of cellular process 5.05E-04 
  negative regulation of physiological process 5.54E-04 
  negative regulation of transcription 6.91E-04 
  negative regulation of metabolism 1.37E-03 
  negative regulation of transcription, DNA-dependent 1.53E-03 
  
negative regulation of nucleobase, nucleoside, nucleotide and nucleic 
acid metabolism 2.09E-03 
  negative regulation of cellular metabolism 2.10E-03 
  negative regulation of biological process 2.69E-03 
  
negative regulation of transcription from RNA polymerase II 
promoter 1.03E-02 
Signal transduction  1.74 signal transduction 6.86E-03 
  cell communication 2.17E-02 
Cytoskeleton 
organization  1.61 actin filament-based process 2.13E-02 
  cytoskeleton organization and biogenesis 2.34E-02 
  actin cytoskeleton organization and biogenesis 2.56E-02 
  actin polymerization and/or depolymerization 2.94E-02 
 
Functional clustering analysis used GO biological processes in DAVID and clusters with enrichment score 
1.3 or more were reported.  Enrichment scores were calculated by DAVID software as the negative log10 of 
the geometric mean of p-values in the cluster.   
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Supplementary Table 4B. (continued) 
Clusters themes  
Enrichment 
score GO terms p-values 
Metabolism  1.55 primary metabolism 5.69E-04 
  cellular process 2.49E-02 
  cellular metabolism 3.52E-02 
  cellular physiological process 4.34E-02 
  metabolism 4.70E-02 
  physiological process 5.26E-01 
Vasculature development  1.5 vasculature development 2.65E-02 
  blood vessel morphogenesis 2.65E-02 
  blood vessel development 2.65E-02 
  organ morphogenesis 4.10E-02 
  angiogenesis 4.37E-02 
RNA processing  1.37 mRNA metabolism 8.55E-03 
  RNA processing 1.06E-02 
  mRNA processing 1.47E-02 
  RNA metabolism 2.59E-02 
  RNA splicing 8.90E-02 
  
RNA splicing, via transesterification reactions with bulged adenosine 
as nucleophile 1.52E-01 
  nuclear mRNA splicing, via spliceosome 1.52E-01 
  RNA splicing, via transesterification reactions 1.52E-01 
Branching structure 
development  1.34 tube development 5.53E-03 
  tube morphogenesis 3.92E-02 
  morphogenesis of a branching structure 1.41E-01 
  branching morphogenesis of a tube 1.41E-01 
Protein modification  1.31 biopolymer modification 6.82E-03 
  protein modification 6.98E-03 
  protein amino acid phosphorylation 1.21E-02 
  phosphorylation 2.55E-01 
  phosphorus metabolism 3.11E-01 
    phosphate metabolism 3.11E-01 
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Supplementary Table 4C. Main themes of clusters and corresponding GO Biological 
Process terms for up-regulated genes (q≤0.05) in liver in response to fasting 
Clusters themes  Enrichment score GO terms p-values 
Macromolecule biosynthesis  8.55 macromolecule biosynthesis 8.34E-20 
  protein biosynthesis 8.93E-19 
  cellular biosynthesis 5.65E-17 
  biosynthesis 5.01E-15 
  primary metabolism 5.66E-03 
  cellular macromolecule metabolism 9.97E-03 
  cellular protein metabolism 1.29E-02 
  macromolecule metabolism 1.66E-02 
  protein metabolism 4.25E-02 
Amine metabolism 3.05 organic acid metabolism 4.31E-06 
  carboxylic acid metabolism 8.03E-06 
  nitrogen compound metabolism 6.19E-03 
  amine metabolism 8.81E-03 
  amino acid and derivative metabolism 1.55E-02 
  amino acid metabolism 1.80E-02 
Metabolism  2.21 cellular physiological process 2.65E-04 
  metabolism 1.59E-03 
  cellular metabolism 5.64E-03 
  primary metabolism 5.66E-03 
  physiological process 6.73E-03 
  macromolecule metabolism 1.66E-02 
  cellular process 2.37E-01 
Glucose metabolism  1.88 alcohol catabolism 4.96E-03 
  glucose metabolism 8.12E-03 
  glucose catabolism 9.66E-03 
  carbohydrate metabolism 1.16E-02 
  alcohol metabolism 1.19E-02 
  hexose metabolism 1.22E-02 
  cellular carbohydrate metabolism 1.35E-02 
  carbohydrate catabolism 1.49E-02 
  cellular carbohydrate catabolism  1.49E-02 
  
  
  monosaccharide metabolism 1.52E-02 
  hexose catabolism 2.25E-02 
  glycolysis 2.30E-02 
  monosaccharide catabolism 2.61E-02 
Functional clustering analysis used GO biological processes in DAVID and clusters with enrichment score 
1.3 or more were reported.  Enrichment scores were calculated by DAVID software as the negative log10 of 
the geometric mean of p-values in the cluster.   
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Supplementary Table 4C. (continued)  
Clusters themes  Enrichment score GO terms p-values 
Fatty acid oxidation  1.88 fatty acid beta-oxidation 4.18E-03 
  fatty acid metabolism 1.01E-02 
  fatty acid oxidation 5.56E-02 
Transport / Organization  1.41 protein transport 8.81E-03 
  secretory pathway 1.33E-02 
  establishment of protein localization 1.62E-02 
  protein localization 2.84E-02 
  secretion 3.17E-02 
  intracellular transport 3.70E-02 
  establishment of cellular localization 4.76E-02 
  cellular localization 5.83E-02 
  intracellular protein transport 6.99E-02 
  cell organization and biogenesis 6.76E-01 
Secretion  1.38 secretory pathway 1.33E-02 
  Golgi vesicle transport 1.70E-02 
  secretion 3.17E-02 
  ER to Golgi vesicle-mediated transport 8.63E-02 
  vesicle-mediated transport 2.03E-01 
TCA cycle  1.33 acetyl-CoA metabolism 1.02E-02 
  acetyl-CoA catabolism 3.85E-02 
  tricarboxylic acid cycle 3.85E-02 
  aerobic respiration 3.89E-02 
  coenzyme catabolism 5.56E-02 
  cellular respiration 6.25E-02 
  cofactor catabolism 8.88E-02 
   
tricarboxylic acid cycle intermediate 
metabolism 1.17E-01 
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Supplementary Table 4D. Main themes of clusters and corresponding GO Biological 
Process terms for down-regulated genes (q≤0.05) in liver in response to fasting 
Clusters themes  Enrichment score GO terms p-values 
Lipid synthesis 12.58 sterol biosynthesis 2.77E-20 
  sterol metabolism 2.61E-17 
  steroid biosynthesis 5.06E-16 
  cholesterol biosynthesis 2.53E-15 
  alcohol metabolism 2.76E-13 
  cholesterol metabolism 3.65E-13 
  lipid biosynthesis 1.04E-12 
  steroid metabolism 2.73E-12 
  cellular lipid metabolism 1.29E-10 
  lipid metabolism 2.73E-09 
  biosynthesis 4.28E-06 
Amine metabolism  2.7 carboxylic acid metabolism 2.72E-05 
  organic acid metabolism 2.88E-05 
  amine metabolism 2.93E-04 
  nitrogen compound metabolism 8.16E-04 
  amino acid and derivative metabolism 1.35E-03 
  amine biosynthesis 3.80E-03 
  nitrogen compound biosynthesis 3.80E-03 
  amino acid metabolism 1.02E-02 
  amino acid biosynthesis 1.61E-02 
  serine family amino acid metabolism 4.95E-02 
  serine family amino acid biosynthesis 6.98E-02 
Vitamin metabolism  2.1 water-soluble vitamin biosynthesis 1.97E-03 
  vitamin biosynthesis 2.67E-03 
  water-soluble vitamin metabolism 1.72E-02 
    vitamin metabolism 4.19E-02 
 
Functional clustering analysis used GO biological processes in DAVID and clusters with enrichment score 
1.3 or more were reported.  Enrichment scores were calculated by DAVID software as the negative log10 of 
the geometric mean of p-values in the cluster.   
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ABSTRACT 
Residual feed intake (RFI) is a measure of feed efficiency, where low RFI denotes 
improved feed efficiency. Caloric restriction (CR) is associated with feed efficiency in 
livestock species and to human health benefits such as longevity and cancer prevention. 
We have developed pig lines that differ in RFI and we are interested in identifying the 
genes and pathways that underlie feed efficiency. Prepubertal Yorkshire gilts with low 
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RFI (n=10) or high RFI (n=10) were fed ad libitum or fed at restricted intake of 80% of 
maintenance energy requirements for 8 days. We measured serum metabolites and 
hormones and generated transcriptional profiles of liver and subcutaneous adipose tissue 
on these animals. Overall, 6,114 genes in fat and 305 genes in liver were differentially 
expressed (DE) in response to CR, and 311 genes in fat and 147 genes in liver were DE 
due to RFI differences.  Pathway analyses of CR-induced DE genes indicated a dramatic 
switch to a conservation mode of energy usage by down-regulating lipogenesis and 
steroidogenesis in both liver and fat. Interestingly, CR altered expression of genes in 
immune and cell cycle/apoptotic pathways in fat, which may explain part of the CR-
driven lifespan enhancement. In-silico analysis of transcription factors revealed ESR1 as 
a putative regulator of the adaptive response to CR, as several targets of ESR1 in our DE 
fat genes were annotated as cell cycle/apoptosis genes. The lipid metabolic pathway was 
overrepresented by down-regulated genes due to both CR and low RFI. We propose a 
common energy conservation mechanism, which may be controlled by PPARA, PPARG, 
and/or CREB in both CR and feed efficient pigs.  
INTRODUCTION 
Genetic mechanisms that control feed intake (FI) and feed efficiency are not well 
understood. Differences in feed efficiency arise due to factors such as variations in body 
composition, feeding patterns, digestibility, activity, thermoregulation, and tissue 
metabolic rates (68).  Residual feed intake (RFI) has been broadly accepted as a reliable 
method of measuring feed efficiency and is defined as the feed consumed above or below 
what is required for growth and maintenance (47, 54). Pigs with low RFI (LRFI) 
consume less food than the population average without a significant loss in growth 
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parameters such as body weight and composition, and therefore are more feed efficient. 
Our group has successfully developed pig lines that differ in RFI up to 124 g/day without 
significant change in the body composition, with an estimated heritability for RFI of 0.33 
(12).  The physiology underlying RFI differences has been studied mainly in poultry and 
in beef cattle, in which whole-genome SNP analyses and microarray approaches have 
been undertaken (6, 9, 74).  For example, transcriptomic analysis of liver biopsies from 
Angus bulls identified 163 differentially expressed genes between animals with high and 
low RFI (16). These genes represented several cellular pathways such as growth, 
proliferation, protein synthesis, lipid metabolism, and carbohydrate metabolism (16).           
Efficient feed utilization has also been achieved with caloric restriction (CR) in 
cattle and chickens (67, 69). The motivation to understand biological mechanisms 
underlying response to CR extends beyond feed efficiency in livestock species. Caloric 
restriction prolongs lifespan in virtually all species, including mammals, and recent 
reports suggest that CR is the most compelling cancer-prevention regimen in the 
carcinogenesis models (2, 38). Translation of the CR phenomenon to human health is 
critical considering that obesity, a major risk factor for several types of cancers and age-
associated chronic diseases, is alarmingly increasing in the Western world (80). 
Transcriptional profiling of CR to elucidate pathways involved in longevity 
promoting mechanisms in rodents has been investigated (76, 83, 85); however, the pig is 
a better suited model for the human energy homeostatic system than rodents and has 
contributed to improved knowledge of human metabolic disorders such as obesity and 
diabetes (59, 72). Understanding efficient feed utilization in pigs will also lead to 
improved agricultural economy as pork is used as a major human food source worldwide 
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and the cost of feed amounts to the largest variable cost in pork production, making up 
68% of the total variable cost (33). Significant advances have been made in swine 
transcriptomics in recent years (79) and gene expression profiling has been employed in 
several porcine tissues, including adipose and liver tissues (52). 
Several transcription factors (TF) and nuclear receptors are known to mediate the 
response to CR (22) and they regulate specific metabolic adaptations within each 
peripheral organ and coordinate inter-tissue communication for energy homeostasis. 
Previous studies have established regulatory roles for several TF in fat and/or liver 
tissues, such as CCAAT/enhancer binding protein alpha (15), hypoxia inducible factor 1, 
alpha subunit (HIF1A) (42), peroxisome proliferator activated receptors gamma 
(PPARG) (82), and alpha (PPARA) (57).  However, previous large-scale transcriptional 
profiling reports on CR or RFI (16, 73, 83) have not included global analysis of key 
regulatory TF that may be responsible for the differentially expressed (DE) genes. 
Our objective was to identify pathways and transcriptional networks of genes 
responding to CR or to differences in RFI using transcriptional profiling of over 24,000 
genes in key metabolic tissues of pigs that is corroborated by blood metabolite analyses. 
Our hypothesis was that such results may implicate candidate genes to improve feed 
efficiency in pigs as well as elucidate some of the longevity promoting mechanisms 
associated with CR. We report 6,114 genes in adipose tissue and 305 genes in liver to be 
DE (q≤0.05) due to 8-day CR and 311 fat genes and 147 liver genes to be DE due to 
differences in RFI. Major potential regulators of genes responding to CR were identified 
by assessing the known regulatory connections of TF to the DE genes. This study reports 
1) the first global transcription profiling study on the effects of CR and differences 
75 
 
 
between high and low RFI groups of pigs, 2) identification of key TF in the global 
response to CR or to RFI group differences, and 3) analysis of shared genes and 
biological pathways between the responses to CR and RFI group differences. 
MATERIALS AND METHODS 
Animals and feeding treatments. Six-month old Yorkshire gilts from either a line 
selected for three generations for improved feed efficiency, based on low RFI (12) or 
from a control line were used. Animals were fed ad libitum (AL) standard swine diet with 
20% crude protein until weaning (Kent Feeds Inc., Muscatine, IA, USA) and with 16-
17.5% crude protein diet after weaning (Mid-State Milling Inc., State Center, IA, USA). 
To exclude potential effects of genotype for MC4R D298N, which has been reported to 
be associated with FI, backfat, and growth (45), pigs were genotyped for this MC4R 
variant and 90 heterozygous gilts, 45 from each line, were placed on the FIRE electronic 
feeders starting at ~35 kg until pigs weighed ~75 kg. Subsequently, pigs were evaluated 
for average daily FI, average daily gain (ADG), and RFI using procedures described 
previously (12). Ten animals with the highest RFI from the control line and 10 animals 
with the lowest RFI from the selection line were randomly assigned to feeding treatments 
and individually penned. Henceforth, we refer to the RFI differences between high and 
low RFI groups as the RFI difference.  Starting at 06:00 h on day 1, gilts were fed AL 
with continuous access to feed until ~08:00 on day 9 or were fed twice daily with feed 
equivalent to 80% of maintenance energy requirements for 8 days in a randomized 
complete block design with a 2 (RFI group) × 2 (feed) factorial arrangement of 
treatments. Maintenance energy requirements were estimated as 110 kcal of digestible 
energy per kg of metabolic weight, which was defined as body weight raised to the 0.75 
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power (18). Digestible energy content of the feed was 3,600 kcal/kg. Blocks were defined 
as animals that underwent treatment on the same day and each block contained at least 
one animal from each combination of RFI group and feed treatment (Supplementary 
Table 1). A total of five animals were used for each combination of RFI group and feed 
treatment. Tissues from 10 pigs were harvested in the fall and from another 10 in the 
following spring. All animals received water AL. On day 9 (09:00-11:30 h), pigs were 
sacrificed by electric stunning and exsanguinations. Samples of hepatic tissue and the 10th 
rib middle layer of backfat were rapidly collected, frozen in liquid nitrogen, and stored at 
-80°C until RNA isolation. Blood samples were collected during postmortem 
exsanguinations. Blood samples were allowed to clot at 4°C overnight, centrifuged at 
1,200 × g for 30 min, and serum was collected and stored at -20°C. The protocol for the 
animal experiments was reviewed and approved by the Institutional Animal Care and Use 
Committee of Iowa State University (12-04-5797-S) 
Feed intake, body weight, backfat, loin eye area, and blood parameters. During the 8-
day treatment period the FI of each pig was recorded daily. Pre- and post-treatment body 
weight, 10th rib backfat depth, and loin eye area were measured on days 0 and 8 around 
16:00- 18:00 (day 1 was designated as the start of feeding treatment). Backfat depth was 
measured by ultrasound (12) using an Aloka 500V SSD ultrasound instrument fitted with 
a 3.5-MHz, 12.5-cm, linear-array transducer (Corometrics Medical Systems Inc., 
Wallingford, CT, USA). Post-treatment serum samples were assayed for concentrations 
of glucose (Hexokinase assay, Roche Diagnostics, Indianapolis, IN, USA), insulin 
(Porcine Insulin Kit, Cat # PI-12K Linco Research, Inc., St. Charles, MS, USA), 
triglyceride (TG, Cat # 236-99, Diagnostics Chemicals Ltd., Oxford, CT, USA), non-
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esterified fatty acids (NEFA, HR Series-NEFA HR-2, Wako Diagnostics, Richmond, 
VA, USA), cortisol (Cortisol I125 RIA Kit, Cat # 07-221102, MP Biomedicals), leptin 
(Multi-species Leptin Kit, Cat # XL85-K, Linco Research Inc.),  thyroxine, and 
triiodothyronine (T4, Cat # 06B-254030 and T3 Cat # 06B-253216, MP Biomedicals, 
Irvine, CA, USA).   
RNA isolation and microarray hybridization. Total RNA was isolated and purified from 
liver and adipose tissues using the Qiagen RNeasy midi kit and the Qiagen RNeasy lipid 
tissue kit (Qiagen, Valencia, CA, USA). Quality and quantity of RNA were determined 
by using the Agilent 2100 Bioanalyzer (Foster City, CA, USA). Average RNA integrity 
numbers were 9.5 ± 0.3 (mean ± standard deviation) for liver RNA and 8.4 ± 0.7 for fat 
RNA samples. Microarray target sample processing, target hybridization, washing, 
staining, and scanning steps were completed according to manufacturer’s instructions 
(Affymetrix, Santa Clara, CA, USA) at two different times (fall and spring). RNA from 
liver and adipose tissue samples of 10 pigs that were harvested in the fall were hybridized 
in the fall, with exception of RNA samples from two pigs that were hybridized in the 
spring along with the RNA from 10 pigs that were harvested in the spring. Briefly, 10 µg 
of total RNA from liver or adipose tissue was used to synthesize cDNA using a one-cycle 
cDNA synthesis kit. Resulting cDNA from each sample was used to transcribe 
biotinylated cRNA by T7 RNA polymerase and further fragmented and applied to the 
Affymetrix GeneChip Porcine Genome Array (hereafter called the Porcine GeneChip) 
that contains 24,123 probesets. Following hybridization at 45°C for 16 h, the array was 
washed and stained with strepavidin-phycoerythrin at an Affymetrix GeneChip Fluidics 
Station 450 and fluorescent signals were scanned using an Affymetrix GeneChip 
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Scanner 3000 (1). Each tissue was assigned to one fluidics station to remove potential 
station effects for within-tissue comparisons and four modules within each station were 
intentionally confounded with the blocks.  
Transcriptome 
The transcriptome for each tissue was established as described previously (52). The 
probe-pair data were used to determine the detection call by the modified Wilcoxon 
signed rank test of the MAS 5.0 software (51). For each tissue, probe sets with absent 
calls for all replicates in all treatments were removed, and the remaining probe sets were 
declared as expressed and established the transcriptome for that tissue. 
Statistical analyses 
Animal performance and blood parameters: Post-treatment body weight, backfat depth, 
loin eye area, pre-treatment RFI, ADG, FI during treatment, and blood parameters were 
analyzed by a mixed linear model with RFI group, feed treatment, and their interactions 
as fixed effects, block as a random effect, and their pre-treatment values (except for RFI) 
as a linear covariate. Analyses were performed by the Mixed procedure of SAS/STAT 
software version 9.1.3 (SAS Institute Inc., Cary, NC, USA).  
Gene expression: CEL files generated by the Affymetrix GeneChip® Operating Software 
at the GeneChip® Facility at Iowa State University were used as the raw data for 
statistical analysis. Data were deposited in the NCBI Gene Expression Omnibus (Series 
accession # GSE18359; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= 
GSE18359) and data quality was examined with BioC version 2.0 (31) in R (66). All 
24,123 probes sets, including those with absent calls, were analyzed. Probe level 
measures were summarized into probe set level expression measures using the 
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"simpleaffy" package (84) in R according to the MAS 5.0 algorithm (1). However, the 
final step of aligning the trimmed means on the log scale was replaced by median 
centering normalization (86), i.e., subtracting the median expression from all expression 
measures on the logarithmic scale for each chip separately. Since the mean within-chip 
variability was different between the two sets of chips that were hybridized in two time 
periods, scale normalization (86) was further applied to match the within-chip median 
absolute deviations (MADs) to the geometric mean of MADs across all chips by a 
multiplicative scaling on the logarithmic scale for each chip. Both the median centering 
and the scale normalization were performed for each tissue separately.  
To determine the proper model for analysis of the expression data, 405 candidate 
mixed linear models were fitted to the normalized expression measures for each tissue 
and each gene separately using the Mixed procedure in SAS/STAT® software version 
9.1.3 (SAS Institute Inc. Cary, NC, USA). All candidate models included RFI group, CR, 
and their interaction as fixed effects, but differed from each other by including any 
combination of the following nuisance factors in the model: (i) tissue harvest season (fall 
or spring), with or without interaction with other treatment effects of interest, was 
included as fixed or random effect, or excluded from the model; (ii) blocks of pigs in 
each harvesting season (four levels) were broken up into five levels by coding as an 
additional group consisting of two pigs that were harvested in fall but hybridized at the 
same time as the pigs that were harvested in spring; and the resulting five-level factor 
was included as fixed or random effect, or excluded from the model; (iii) chip 
hybridization day (five levels), (iv) the process batch during washing of the chips (two 
levels) on the day after hybridization, and (v) module (four levels) in the Fluidics Station 
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450 were each included as fixed or random effects, or excluded from the model. Based on 
overall evaluation of gene-averaged SAS reported information criteria, the gene-averaged 
standardized prediction sums of squares from leave-one-out cross-validation, 
experimental design, and histograms of p-values of contrasts of interest, the selected 
model included harvesting season, chip hybridization day and block of pigs (five levels) 
as random effects for both tissues. For fat, since the p-value histogram indicated a non-
detectable interaction between RFI group and CR, this interaction term was dropped from 
the model.  
In the selected model for each tissue, variance components were estimated with 
the method of residual maximum likelihood under non-negativity boundary constraints.  
Fixed effect estimates and least squares means were then obtained using generalized least 
squares and fixed effects contrasts were tested using Wald-type F-tests with Kenward-
Roger's correction (44). The positive false discovery control procedure (77) was used on 
each set of p-values of contrasts of interest to estimate q-values. Genes with q values 
≤0.05 were declared to be DE due to caloric restriction and q values ≤0.2 were declared 
to be DE due to RFI. A less stringent threshold was used for RFI because of the lower 
power of this aspect of the experiment. 
Affymetrix probe annotation. To obtain orthology information and improved annotation 
of the Porcine Genechip probesets, Affymetrix consensus sequences were used with 
BLASTN against the well-curated NCBI RefSeq database. Highest scores were used with 
a conservative cutoff of 1e-10 for the E-value. In total, 17,798 (73.8% of all) probesets 
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were assigned RefSeq annotation (Couture O, Callenberg K, Kaul N, Pandit S, Younes R, 
Hu Z, Dekkers J, Reecy J, Honavar V, Tuggle C. In Press, Mamm Genome). 
Pathway analysis with Gene Ontology and KEGG. Genes in liver and subcutaneous fat 
that were DE due to CR (q≤0.05) or RFI group (q≤0.2) were divided into genes that were 
down- or up-regulated due to caloric restriction, creating 8 categories of genes. Using 
DAVID, an open access web-based functional annotation and clustering program (21), 
the 8 categories of genes were analyzed for overrepresented (p≤0.05) Biological Process 
categories based on Gene Ontology (GO) or Kyoto Encyclopedia Genes and Genomes 
(KEGG) pathway categories (63).  The p-values for overrepresentation were computed by 
a modified Fisher’s exact test, using the transcriptome for each tissue as background. The 
biological process categories were clustered using Functional Annotation Clustering (21), 
where the enrichment score for each cluster was computed as the negative log of the 
geometric mean of p-values in the cluster.  
Pathway Studio Analyses. Four categories of gene lists made of DE genes in fat or liver 
tissues due to CR (q≤0.05) or RFI (q≤0.2) were analyzed with Pathway Studio 5.0 (63), a 
text mining tool that detects relationships among genes, proteins, cell processes, and 
diseases as recorded in the PubMed database (Ariadne Genomics, Rockville, MD, USA).  
Common regulatory transcription factors and nuclear receptors of DE genes were 
obtained based on reported (PubMed) interactions, which were defined as regulation, 
direct regulation, binding and/or promoter binding. For each regulatory TF that satisfied 
these criteria, target DE genes were counted.  Because of the very large size of the list of 
genes DE due to CR in fat, we tested in Pathway Studio only those genes with a fold 
change equal or greater than two.  
82 
 
 
Real-time quantitative PCR for verification of DE genes. Real-time quantitative PCR 
(qPCR) was used to verify differential expression due to either CR or RFI for 8 genes in 
each tissue. Total RNA was isolated from backfat of pigs that were assayed using the 
Porcine Genechip as described above and reverse transcribed to cDNA using 
SuperscriptTM II reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and oligo(dT) 
(20). Real-time PCR was performed in duplicate using 100 ng cDNA (RNA equivalent) 
per 25 µl reaction or per well with the Brilliant kit (Stratagene, La Jolla, CA, USA) on 
BioRad MyiQ Single Color Real Time PCR Detection System (Bio-Rad, Hercules, CA, 
USA). All probes and primers for real-time TaqMan PCR were designed 
(Supplementary Table 2) using Primer Express 2.0 (Applied Biosystems, Foster City, 
CA, USA), as previously described (20). The probes contained 3′ Iowa Black FQ 
quencher and 5′ 6-FAM reporter (Integrated DNA Technologies, Coralville, IA, USA). 
The qPCR conditions were 50°C for 2 min, 95°C for 10 min, 40 cycles of 95°C for 15 s 
and 60°C for 1 min, then 4°C. Because variation in the expression of commonly used 
housekeeping genes such as GAPDH, SDHA, RPL32, and YWHAZ (81) were observed 
in either a tissue or treatments in the Porcine Genechip, we normalized gene expression 
based upon the constant amount of RNA and cDNA amplified. This method has been 
proposed to be the most reliable standardization of quantitative measurement of mRNA 
expression, provided that accurate estimation of total RNA is made with tools such as 
Agilent Bioanalyzer (11).  
Quantification of gene expression was analyzed as previously reported (20). 
Briefly, Ct values averaged across duplicate readings were analyzed by a mixed linear 
model with feed treatment, RFI, and their interactions as fixed effects, and block as a 
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random effect, using the Mixed procedure of SAS/STAT software version 9.1.3 (SAS 
Institute Inc., Cary, NC, USA). A value of p≤0.05 was considered statistically significant 
for CR or RFI group effect. Fold change in expression was calculated as 2∆Ct for each 
gene, where ∆Ct is the difference between least square mean Ct values for the CR and AL 
groups.  
RESULTS 
Caloric restriction and RFI effects on body weight, ADG, FI, backfat, loin eye 
area, and serum metabolites. The effects of RFI group and 8-day CR on pre-treatment 
RFI and pre-and post-treatment body weight, ADG, FI, backfat, loin eye area are 
summarized in Table 1.  The average RFI of the LRFI group was 0.3 kg/day less than that 
of the high RFI group (HRFI, p<0.0001). The LRFI pigs tended to weigh less than the 
HRFI pigs at the beginning of treatment (LRFI=79.2 kg, HRFI=83.6 kg, p=0.07).  Pre-
treatment backfat depth was 2.9 mm less in the LRFI group than the HRFI group 
(p=0.009), without a significant pre-treatment loin eye area difference (p=0.56).  At the 
end of the 8-day feeding treatment, the body weights did not significantly differ between 
LRFI and HRFI pigs (p=0.35); however, the backfat depth was less in the LRFI than the 
HRFI pigs (p=0.015).  
Eighty percent of maintenance caloric requirement was roughly equivalent to 25% 
of the AL feed, which was ~2.85 kg/day.  Pigs weighed ~81.4 kg before the feeding 
treatment and their body weight (p=0.64), backfat depth (p=0.8), and loin eye area 
(p=0.46) did not significantly differ between CR and AL groups.  During the treatment, 
AL pigs gained 0.98 kg/day, whereas CR pigs lost 0.56 kg/day (AL vs. CR, p<0.0001), 
which resulted in the CR pigs weighing ~12 kg less than the AL fed pigs (p<0.0001) at 
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the end of treatment.  The CR group’s post-treatment backfat was 3.9 mm (p<0.0001) and 
loin eye area was 250 mm2 (p=0.017) less than those of AL group.                
Several blood parameters were measured in the post-treatment serum samples and 
these results are shown in Table 2.  Serum concentration of NEFA tended to be higher in 
the CR than the AL group (p=0.075).  Thyroxine concentration was 22.6% lower in the 
CR than the AL pigs (p=0.023) and the triiodothyronine concentration tended to be 
18.5% lower in the CR than the AL pigs (p=0.076). No significant effect of CR was 
noted for serum concentrations of glucose, insulin, TG, cortisol, and leptin.  The serum 
triiodothyronine concentration in LRFI pigs was 31% higher than that of HRFI pigs 
(p=0.024).  The effect of RFI was not significant for serum concentrations of glucose, 
insulin, TG, thyroxine, cortisol, and leptin.  A significant interaction between RFI and CR 
was observed for the serum concentration of leptin (p=0.027), in which leptin 
concentration tended to decrease in response to CR in the HRFI group, but the opposite 
trend was present in the LRFI pigs  
Caloric restriction and RFI effects on expression of genes in fat and liver. Of 24,123 
probe sets evaluated by microarray analysis, 20,058 and 18,787 provided data indicating 
that the transcripts represented by these probe sets were expressed in fat and liver tissue, 
respectively. In response to an 8-day CR treatment, 6,114 transcripts in fat were DE 
(q≤0.05, p≤0.024), of which 2,845 were up-regulated and 3,269 down-regulated 
(Supplementary Table 3A).  In liver, 305 transcripts were identified to be DE (q≤0.05, 
p≤0.0009), of which 156 were up-regulated and 149 down-regulated (Supplementary 
Table 3B).  We considered transcripts with false discovery rate less or equal to 20% 
(q≤0.2) to be DE as a result of difference between RFI groups.  Due to RFI difference 
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between groups, 311 transcripts in fat (p<0.003, Supplementary Table 3C) and 147 
transcripts in liver (p<0.0015, Supplementary Table 3D) were declared to be DE (q≤0.2). 
An improved annotation of probesets on the Affymetrix GeneChip Porcine Genome 
Array (Couture O, Callenberg K, Kaul N, Pandit S, Younes R, Hu Z, Dekkers J, Reecy J, 
Honavar V, Tuggle C., In Press, Mamm Genome) assigned gene names (BLASTN 
expectation score <1E-10) to 84% and 81% of all DE transcripts due to either CR or RFI 
in liver and in fat, respectively.  For simplicity, the changes in RNA levels detected by 
these annotated probesets are referred to as gene expression differences for the remainder 
of the paper.   
Microarray data validation by qPCR. Expression patterns were verified by qPCR for 
seven genes in either fat or liver, which were predicted to be DE due to CR (q≤0.05); 
these were selected to represent the lipid biosynthetic pathways in subcutaneous adipose 
tissue and gluconeogenesis in the liver (Fig. 1A). Similarly, seven of nine tested genes 
(q≤0.2) representing lipid and amino acid metabolic processes in fat and cell proliferation 
and energy metabolism in liver were validated as DE in LRFI vs. HRFI pigs (Fig. 1B). 
For all tested genes, expression differences were consistent in direction with the 
microarray results (Fig. 1A and 1B). Statistical significance of effects of CR treatment or 
RFI (p<0.05) was confirmed by qPCR for all genes, except for SLC7A9 (p=0.09) and 
ITGA6 (p=0.2) in liver of HRFI vs. LRFI pigs (Fig 1B).  The results obtained from 
microarray were statistically confirmed for 88% of the tested genes in liver and fat.  
Biological processes affected by CR and RFI 
To identify biological processes that respond to CR or RFI, lists of up- or down-regulated 
DE genes in liver and fat were explored for overrepresentation of GO Biological Process 
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categories. Lists of genes with overrepresented terms were further clustered by similarity 
of the associated GO term to increase sensitivity. Only pathways overrepresented by the 
CR-induced DE genes in fat and liver resulted in significant clusters (Enrichment score 
≥1.3, Supplementary Tables 4A-D). In addition, the KEGG database was used to identify 
specific pathways that were overrepresented by genes that responded to RFI or CR 
treatments (p≤0.1) in liver or adipose tissues.  KEGG annotations that were 
overrepresented by CR-induced DE genes in fat or liver (Fig. 2) and by RFI-induced 
genes in fat (Table 3) are summarized and described further in the following sections. 
The 147 liver genes DE between RFI groups did not result in any significant KEGG term.   
Caloric restriction effects in fat. Subcutaneous adipose tissue underwent major 
transcriptional changes in response to 8-day CR that were reflected by the large number 
of DE genes (6,114), in comparison with the corresponding DE genes in liver (305). 
Caloric restriction caused down-regulation of adipose genes involved in direct energy 
generation pathways, such as oxidative phosphorylation, TCA cycle, and ATP synthesis. 
Indicative of metabolic changes that occurred in response to CR, adipose genes in many 
of the metabolic pathways, including the metabolism of carbohydrate, amino acid, and 
lipid were down-regulated (Fig 2, Supplementary Table 4A). Genes involved in lipid 
biosynthesis such as steroid and fatty acid synthesis were down-regulated, as were genes 
in degradation of branched chain amino acids and glycolysis.  Lipid and steroid pathways 
were also overrepresented when a list of the 50 DE genes with the highest fold change 
was analyzed (Supplementary Table 5). Caloric restriction increased expression of genes 
involved in gene regulation, such as establishment and maintenance of chromatin 
architecture, DNA packaging, and RNA splicing; as well as genes in several immune 
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response pathways such as T cell receptor signaling, natural killer cell mediated 
cytotoxicity, complement and coagulation cascades, and the adipocytokine signaling 
pathway (Fig. 2, Supplementary Table 4B).  
Caloric restriction effects in liver.  In response to the 8-day CR, genes involved in the 
biosynthesis of macromolecules such as steroid and protein synthesis were down-
regulated in liver.  Caloric restriction also resulted in down-regulation of genes in protein 
secretion and transport in liver (Fig 2, Supplementary Table 4C).  Transport and 
localization pathways were also overrepresented when a list of the 50 liver genes with the 
highest fold changes was analyzed (Supplementary Table 5). Caloric restriction also 
induced up-regulation of genes in genetic information processing pathways such as 
ribosome and proteasome as well as ion transport processes, namely phosphate transport 
(Fig 2, Supplementary Table 4D).   
Effects due to RFI differences in fat.  In LRFI animals, genes involved in lipid metabolic 
pathways, such as short chain fatty acid and monocarboxylic acid metabolism were 
down-regulated. Genes involved in cellular homeostasis were down-regulated in 
subcutaneous fat of LRFI pigs along with genes in generation of precursor metabolites 
and energy pathways (Table 3). Compared to HRFI pigs, genes in carbohydrate 
metabolism were up-regulated in adipose tissue of LRFI pigs (Table 3).          
 Shared genes and pathways between treatments or tissues 
Commonly shared up- or down-regulated genes either between liver and adipose tissues 
within the same treatment or between different treatments within the same tissue were 
identified (Fig. 3AB). These commonly shared genes were then analyzed for 
overrepresented GO categories (p≤0.05) (Fig. 3AB).     
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Genes and pathways that responded to CR in both fat and liver. Of genes responding to 
CR in liver, ~29% were also DE in fat. In response to CR, a total of 52 genes were down-
regulated in both liver and adipose tissues and they were overrepresented in the steroid 
and cholesterol biosynthesis pathways (Fig. 3A). Likewise, 34 genes were up-regulated 
due to CR in both liver and fat, which resulted in overrepresentation of several metabolic 
pathways, including nucleic acid metabolism (Fig. 3B).   
Adipose genes and pathways that responded to both CR and RFI. Genes that were up-
regulated in adipose tissue of LRFI (vs. HRFI) and CR (vs. AL) pigs were 
overrepresented in cell communication and signal transduction pathways, including 
transmembrane receptor protein tyrosine kinase signaling (Fig. 3B).  Many of the 
pathways overrepresented among down-regulated genes in fat of LRFI pigs (vs. HRFI), 
such as fatty acid metabolism, membrane organization, endocytosis, and generation of 
precursor metabolites and energy, were also overrepresented among the 74 down-
regulated adipose genes in both LRFI and CR compared to HRFI and AL, respectively 
(Figs. 3 and 4A).  In fact, 42% of all DE adipose genes due to RFI were also DE in 
adipose due to CR, suggesting common pathways are involved in the response to these 
two factors. 
Key transcriptional regulators of response to CR or RFI.  Most of the changes in RNA 
levels we observed were likely due to changes in levels of transcription. To understand 
the main transcriptional regulation involved in the response to CR or RFI, genes that 
were DE in liver and fat were analyzed for their connections to common TF or nuclear 
receptor regulators by using Pathway Studio 5.0.  The analysis of CR-induced DE genes 
in adipose tissue was limited to genes with fold change equal to or more than two, 
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because of the large number of DE genes. Connections between TF and their targets 
within the four DE gene lists (i.e. DE genes due to CR or RFI in fat or liver) were 
populated based on literature evidence of at least one of four interaction categories 
provided by Pathway Studio 5.0, which were promoter binding, binding, regulation, and 
direct regulation. Common regulators with the highest number of target genes across all 
four categories were determined and their target genes were functionally annotated by 
GO biological processes terms (p≤0.05) and pathway clusters (Fig. 4).   
The most connected TF for DE genes in fat due to CR was estrogen receptor 1 
(ESR1). This TF had the greatest number of target genes compared to all other identified 
TF of DE genes in the four categories.  Pathway cluster analyses of ESR1 target genes 
identified four clusters, including homeostasis and cell cycle/apoptosis (Fig. 4).  In 
addition, two transcription factors, hypoxia-inducible factor 1 alpha subunit (HIF1A) and 
Kruppel-like factor 5 (KLF5), were identified as highly connected TF of DE genes with 
fold changes equal to greater than 2 in fat due to CR.     
  The most connected TF for the DE genes in the remaining three categories (i.e. 
liver DE genes due to CR, fat or liver DE genes due to RFI) was transcription factor 1 
(SP1).  SP1 binds at the GC box promoter elements (41) of target genes, which have a 
wide array of functions including embryogenesis, metabolism, growth, vision, and 
respiratory system (50). As expected, pathway analyses of target genes of SP1 in these 
three tissue/treatment categories revealed distinct pathways and clusters (Fig. 4).  Several 
of the identified main TF of RFI-induced DE genes in fat or liver were known regulators 
of energy homeostasis processes, such as PPARG, PPARA, CREB1, and HIF1A. 
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Key networks of genes involved in the response to CR or RFI differences in fat.  Using 
Pathway Studio 5.0, key gene networks were recognized by counting the number of 
interactions a DE gene has with other DE genes within each of the four categories of gene 
lists (i.e. DE genes due to CR or RFI in fat or liver).  IGF1 and ESR1 gene networks 
populated the highest number of interacting genes in response to CR in fat.  In response 
to RFI in fat, the leptin gene network had the highest number of interacting genes (data 
not shown).  
DISCUSSION 
Our main findings demonstrate specific transcriptional responses to CR and RFI 
across liver and adipose tissues with congruent changes in serum metabolites and we 
document metabolic pathways and transcription factors that appear to govern these 
responses. Although alterations in RNA expression do not always correspond to 
alterations in protein expression or activity, we suggest that systemic changes in the 
expression of genes that belong to overrepresented GO or KEGG categories imply 
functional change of pathways represented by these categories. Statistical significance of 
genes discussed hereafter is summarized in either Table 4 or Table 5 unless referenced 
elsewhere.  
Steroid biosynthesis pathway was down-regulated in both liver and adipose tissues due 
to CR. 
  As was observed with a CR study in rodents (73), in both liver and adipose 
tissues, we observed down-regulation of genes in lipid and steroid biosynthetic processes.  
Of the four genes involved in steroid synthesis that were down-regulated in both fat and 
liver, the expression of one, 7-dehydrocholesterol reductase (DHCR7), was tested and 
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confirmed by qPCR (Fig. 1A).  Similar to a related 3-day fasting study of pigs, in which 
genes with some of the highest fold changes in both fat and liver tissues overrepresented 
steroid synthesis pathway (52), our results indicated that the 50 DE genes in fat with 
highest fold changes in response to 8-day CR overrepresented the steroid synthesis 
pathway.    
Caloric restriction induced genes in the immune response pathways 
Reports indicate that short term acute CR induces transcriptional changes 
involved in aging mechanisms in rodents (24, 73).  Calorie restriction used in our study 
was ~25 % of AL feed and is comparable to the CR used in longevity studies (38).  
A loss of the capacity to remodel neuroendocrine-immune response leads to 
increased age-associated pathologies (62). Enhancement of immune response may 
underlie some of the anti-aging mechanisms associated with CR (25). We report that 172 
genes in immune response pathways were up-regulated in response to CR in adipose 
tissue, which resulted in overrepresented KEGG immune response pathways (Figure 2) 
and significantly clustered immune response GO terms (Supplementary Table 4B).  
Therefore, our results indicate that some of the CR-mediated longevity promoting effects 
may be explained by a stimulation of immune response pathways.   
Enhancement of anticoagulatory pathway in response to CR. A correlation between aging 
and heightened coagulation activity has been documented in humans (43, 55). Plasmin 
has an anti-coagulatory role, in which it degrades many blood plasma proteins and is 
involved in fibronolysis. Plasminogen (PLG) is a circulating zymogen that is converted to 
the active enzyme plasmin by cleavage that is mediated by tissue plasminogen activator 
and urokinase.  In our study, PLG was 3.4 fold up-regulated due to CR along with the 
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gene encoding the tissue plasminogen activator protein, which was 1.5-fold up-regulated 
in the fat due to CR (Table 4). Interestingly, mice overexpressing plasminogen activator 
have reduced food consumption, body weight, and increased longevity (61). In addition, 
several anticoagulatory modulators such as thrombomodulin and fletcher factor 1 
(kallikrein b) were up-regulated by CR in our study (Table 4).  Thrombin is a serine 
protease that has many catalytic effects in the coagulation cascade, including converting 
soluble fibrinogen into insoluble strands of fibrin (48).  Thrombomodulin, which was 1.5-
fold up-regulated by CR in our study (Table 4),  forms a complex with thrombin and 
functions as an anticoagulant factor in the thrombin-induced activation of protein C (23). 
Kallikrein b is a serine protease involved in the kinin-kallilkrein system, which plays a 
role in blood pressure control, coagulation, inflammation, and pain.  Human kallikrein 
gene delivery has been shown to attenuate hypertension (14), and although no direct 
relation between aging and kallikrein has been established, genetic studies have indicated 
a correlation between longevity and cardiovascular risk markers such as apolipoprotein E 
and angiotensin converting enzyme (4, 7). Taken together, our data indicate that CR 
enhances anticoagulatory mechanisms in the pig, which may contribute to longevity 
promoting pathways that are associated with CR.   
T cell receptor signaling pathway in CR. Adipose tissue contains diverse cell types 
including T cells, macrophages, fibroblasts, endothelial cells, and multipotent 
mesenchymal cells according to studies in rodents (26, 36). T cells play a central role in 
cell-mediated immunity, and T cell receptor (TCR) activation promotes a number of 
signaling cascades that determine cell fate by regulating cytokine production, cell 
survival, proliferation, and differentiation (10).  Aging leads to accumulation of T cells 
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with signal transduction defects (70), and such changes in T lymphocyte populations 
underlie much of the age-related decline in the protective immune response (60).  In our 
study, 13 genes that were up-regulated with CR were annotated as having direct 
involvement in the T cell receptor signaling pathway (Fig. 2, Table 4). Of these, several 
genes such as non-receptor type 6 protein tyrosine phosphatase (PTPN6), E3 ubiquitin 
ligase casitas B-lineage lymphoma-b (CBLB), and tec protein tyrosine kinase, are 
involved in activation of TCR signaling. PTPN6 expression was up-regulated 3.7 fold in 
fat in response to CR in our study. The N-terminal part of PTPN6 contains two tandem 
src homolog domains, which act as protein phospho-tyrosine binding domains and 
mediate the interaction of protein tyrosine phosphatase with its substrates in TCR 
signaling (88). Z-chain associated protein kinase (ZAP-70) is recruited to the TCR/CD3 
complex and activates the T cell (65). PTPN6 can bind to ZAP-70, resulting in 
suppression of T cell activation by increasing PTPN6 phosphatase activity, thus 
decreasing ZAP-70 kinase activity (65). Another protein that negatively regulates ZAP-
70 is CBLB and it was 1.4 fold up-regulated with CR in our study. CBLB plays an 
important role in regulating the threshold of signaling in T cells and knockouts of CBLB 
results in an increased susceptibility to development of autoimmunity (49).  
Results in our study indicate that some genes that have a stimulating effect on the 
TCR activation were also up-regulated with CR. Activation of src-family kinase FYN is 
central to the initiation of TCR signaling pathways (71)  and was 1.3 fold up-regulated by 
CR in our study. Our results also show that processes downstream of TCR activation, 
including mitogen activated protein kinase (MAPK), nuclear factor kappa-beta (NFκB), 
and Ca2+ signaling, are affected by CR. Genes in the MAPK signaling pathway, such as 
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mitogen-activated protein kinase kinase kinase 8, growth factor receptor-bound protein 2, 
and v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog and genes in Ca2+ signaling, 
such as nuclear factor of activated T-cells 5 and protein phosphatase 3 catalytic subunit, 
beta isoform, were up-regulated in response to CR. The NFκB complex is inhibited by I-
kappa-B proteins (e.g. NFKBIA), which inactivate NFκB by trapping it in the cytoplasm.  
In our study, NFKBIA was also 1.6 fold up-regulated due to CR. T cell markers such as 
CD4 and CD8 were not differentially expressed in our study, indicating that the changes 
in expression of genes in TCR signaling were likely transcriptional rather than indicating 
change in cell type frequencies in these tissues (Table 4). Taken together, our results 
indicate that CR modulated TCR signaling via changes in expression of genes involved in 
both activation of TCR signaling and its downstream effectors.   
ESR1 targets CR- induced DE genes in cell cycle and apoptotic pathways.  
Transcription factors play key roles in regulating adaptive processes involved in energy 
restriction. We identified several TF that were previously known to be involved in energy 
homeostatic processes, such as cAMP responsive element binding protein 1 (CREB1), 
HIF1A, PPARG, and PPARA (22), as well as several TF not previously implicated in 
these processes. The role of ESR1 in adaptation to feed restriction is not documented. 
However, an emerging importance of ESR1 in metabolic systems is evident, as a number 
of ESR1 polymorphisms has been associated with metabolic syndromes like 
atherosclerosis and type II diabetes (19, 29, 37, 58). Moreover, in hepatic tissue, 
administration of estradiol down-regulates expression of lipogenic genes and improves 
insulin sensitivity (30). ESR1 was 2.4-fold up-regulated with CR (q=0.03, p=0.01) and 
had the highest number of DE target genes compared to any other TF in the four 
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categories of genes in our study (Fig. 4). In a related 3-day fasting study in pigs, we 
found ESR1 to be significantly up-regulated and to target many of the DE genes in fat 
due to fasting (52). In the current study, 19 CR-induced DE genes in adipose tissue have 
literature evidence of being directly regulated by ESR1, and these genes belonged to 
pathways of energy homeostasis, development, protein transport and localization, and 
apoptosis (Fig. 4).       
The lifespan of a cell depends on the balance between pro-survival and apoptotic 
or death-promoting factors. Longevity promoting effects that are associated with CR have 
been attributed to changes in apoptotic and cell survival pathways in many cell types, 
including neurons, renal cells, and hepatocytes (5, 17, 78, 87).  In our study, several 
pathways involved in apoptosis and cell survival/proliferation were overrepresented by 
the CR-induced up-regulated fat genes, such as Fas receptor, Fas associated death 
domain-containing protein, p101 protein, and NFκB1 (Fig. 2, Table 4, Supplementary 
Table 4A). Interestingly, target genes of ESR1, which were more than 2-fold DE in 
adipose tissue in response to CR, overrepresented pathways that pertain to cell cycle, cell 
proliferation, and cell death, such as cyclin-dependent kinase inhibitor, breast cancer 1, 
early onset, non-metastatic cells 1 genes (Table 4). Fat cell number increases with age 
and restriction of energy intake reduces the number of fat cells in fat depots (56, 75). In 
our study loss of backfat depth along with a trend of increased NEFA in the bloodstream 
associated with CR was observed. We also confirmed the expression of CR-induced 
down-regulation of five genes in fat that are involved in lipogenesis (ACACA, FASN, 
ACO1, DHCR7, ACADL) by qPCR (Fig 1A). Therefore, the up-regulated expression of 
pro-apoptotic genes in fat due to CR may explain the previously documented CR-induced 
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decrease in number and size of adipocytes (56, 75). Our in-silico literature-based 
transcriptional factor analyses also indicate that CR-induced genes in apoptotic pathway 
are regulated by ESR1.  Taken together, we propose that the increase in lifespan 
associated with CR may be attributable to changes in expression of genes in apoptotic 
pathways that, in part, may be under the transcriptional control of ESR1.       
Transcriptional differences due to RFI correspond to lipid metabolism 
We report the transcriptional response of many genes in fat and liver that have not 
been previously reported to be associated with feed efficiency or RFI.  A difference in 
lipid metabolism in the adipose tissue between RFI groups was not unexpected because a 
previous study on selection response for RFI in Yorkshire swine found a 10th rib backfat 
depth of LRFI pigs was  2.62±1.01 mm (p<0.05) less than the control pigs, which were 
the basis of the current study (12).  This was comparable to findings in the present study 
that 10th rib backfat of LRFI pigs was thinner than that of HRFI pigs (Table 1).  
Expectedly, the transcriptional response to RFI differences resulted in down-regulation of 
genes that overrepresented many pathways involved in lipid metabolic processes, such as 
carboxylic acid, monocarboxylic acid, fatty acid, and short chain fatty acid metabolism 
(Table 3).  Our results on RFI-induced transcriptional changes of genes in lipid 
metabolism explain some of the previously reported differences in fat content of poultry 
(27, 54) and cattle (3, 35) with divergent RFI.  Serum leptin concentration has been 
shown to positively correlate with RFI values in pigs and cattle (35, 64). In our study, 
serum leptin concentration did not differ between the two lines and this is likely 
attributable to the limited number of animals used in this experiment. On the other hand, 
we report that expression of leptin was 2.4 fold down-regulated in LRFI pigs and this was 
97 
 
 
confirmed by qPCR (Fig. 1B). Therefore, abundance of leptin transcripts may be a more 
sensitive marker to evaluate feed efficiency-associated traits as compared to the serum 
leptin concentration. Key gene network analyses in our study indicated that leptin had the 
greatest number of interacting DE genes due to RFI differences, suggesting that the leptin 
gene network is a potentially important component contributing to RFI differences.  
Interestingly, our inter-treatment analyses found 74 down-regulated genes in fat 
due to both CR response and RFI differences and these genes overrepresented the same 
lipid metabolic pathways that were overrepresented by adipose genes induced by RFI 
differences alone (Fig. 3, Table 3). The CR- and RFI-induced down-regulated genes in 
lipid metabolic processes are summarized in Table 5.  This indicates that the lipid 
metabolic processes in feed efficient LRFI animals were altered, compared to HRFI pigs, 
in a similar fashion as in the CR-treated animals and may explain previously reported 
CR-driven feed efficiency (67, 69). Changes in expression of lipid metabolic genes are 
likely attributable to the feed efficiency observed in LRFI pigs.  
Our TF analyses revealed 13 TF that are known to regulate genes found to be DE 
due to RFI differences in adipose tissue.  Some of these TF, such as PPARG, PPARA, 
and CREB1, target genes that belong to lipid metabolic processes. For example, a target 
of PPARA, endothelial cell-derived lipase (LIPG) has phospholipase and triglyceride 
lipase activities and hydrolyzes high density lipoproteins more efficiently than other 
lipoproteins (39, 40).  Overexpression of LIPG in mice reduces plasma concentration of 
HDL cholesterol (40) and LIPG was down-regulated by 2.0 and 1.7 fold due to RFI and 
CR, respectively (Table 5).  Another target of PPARA is the Niemann-Pick disease type 
C1 (NPC1) gene, which encodes a putative integral membrane protein and plays a role in 
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intracellular transport of cholesterol to post-lysosomal destinations (53).  The NPC1 RNA 
was 1.4 and 1.3 fold down-regulated in CR treated pigs (vs. AL) and LRFI pigs (vs. 
HRFI), respectively. Mitochondrial glycerophosphate dehydrogenase (GPD2) was one of 
the RFI-induced genes targeted by both CREB1 and PPARG (Fig. 4). The protein 
encoded by GPD2 is located on the outer surface of the inner mitochondrial membrane 
and catalyzes the unidirectional conversion of glycerol-3-phosphate to dihydroxyacetone 
phosphate, which eventually feeds into glycolysis (32).  GPD2 was down-regulated 1.6 
fold in LRFI and 1.7 fold in CR animals in our study. Such commonality in 
transcriptional response between the RFI and CR associated pathways indicate that LRFI 
pigs may mimic the energy conservation process seen in response to CR in the adipose 
tissue via down-regulation of genes in lipid metabolism. Moreover, some of the RFI-
induced lipid metabolic genes in adipose tissue have been reported to be transcriptionally 
controlled by PPARA, PPARG and CREB1.  Perhaps the differential regulation of lipid 
metabolic processes can explain some of the feed efficiency differences seen between 
LRFI and HRFI pigs.  
Triiodothyronine and RFI. Serum triiodothyronine has been associated with positive 
growth traits during early postnatal development of several species including cattle and 
swine (8, 13, 34, 46). However, conflicting results have been reported regarding the 
association of triiodothyronine concentration with RFI during the growing phase of the 
animal (27, 28).  In our study, serum concentration of total triiodothyronine was higher in 
LRFI than HRFI pigs (Table 2).  Thyroid hormones affect multiple processes in all organ 
systems; therefore, to elucidate the connection between RFI and triiodothyronine in pigs, 
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further studies are needed to evaluate the biology of the thyroid gland in reference to RFI 
differences.   
PERSPECTIVES AND SIGNIFICANCE 
This is the first study to report transcriptional changes associated with both RFI 
differences and response to CR. We report that genes in lipid metabolic processes were 
significantly altered in adipose tissue due to RFI and CR, which suggests that LRFI pig 
shifted to energy conservation and efficient utilization pathways. These CR- and RFI-
induced regulatory changes may be controlled by PPARA, PPARG, and CREB1. Caloric 
restriction modulated immune pathways, which may explain, in part, CR-driven lifespan 
enhancement. We further provide evidence for the role of ESR1 in the adipose tissue in 
response to short-term acute CR. 
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FIGURE LEGENDS 
 
Fig. 1: Microarray data validation by qPCR on a subset of CR- or RFI-induced DE genes 
in liver and fat. A: Representative genes in response to CR (q≤0.05) in lipid biosynthetic 
pathways in subcutaneous adipose tissue; gluconeogenesis in the liver B. Representative 
genes (q≤0.2) in lipid and amino acid metabolic processes in fat; cell proliferation and 
energy metabolism in liver were validated in LRFI vs. HRFI pigs. Official gene symbols 
were used as abbreviations. ACACA, acetyl-coenzyme A carboxylase alpha; FASN, fatty 
acid synthase; ACO1, aconitase 1; DHCR7, 7-dehydrocholesterol reductase; ACADL, 
acyl-Coenzyme A dehydrogenase, long chain; PC, pyruvate carboxylase; UBAP1, 
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ubiquitin associated protein 1; AKR1CL2, aldo-keto reductase family 1; member C-like 
2; LEP, leptin; ATPBD1B, ATP binding domain 1 family, member B; SLC7A9, solute 
carrier family 7 (cationic amino acid transporter, y+ system), member 9; DHRS7, 
dehydrogenase/reductase (SDR family) member 7C; PON3, paraoxonase 3; ITGA6, 
integrin, alpha 6; GPNMB, glycoprotein (transmembrane) nmb. MA=microarray. Fold 
changes are expressed as either CR/Ad lib. or LRFI/HRFI, in which negative fold 
changes indicate down-regulation while positive fold changes indicate up-regulation of 
expression due to CR or LRFI.   
Fig. 2: Functional annotation of liver and adipose tissue-specific response to CR by 
identifying overrepresented KEGG biological pathways (p≤0.01) in differentially 
expressed genes. Biological processes were subdivided according to KEGG pathway 
maps. 
Fig. 3: Shared genes and pathways between fat and liver tissue response to RFI or CR 
and tissue-specific overlapped genes and pathways between RFI and CR treatments. A. 
Overlapment of down-regulated genes and corresponding pathways (GO, p<0.05) B. 
Overlapment of up-regulated genes and corresponding pathways (GO, p<0.05).  
Fig. 4: Transcription factors (TF) with greatest number of connections for responses to 
CR and RFI in liver and fat and the pathways overrepresented (GO, p≤0.05) by the target 
genes of the most connected TF in each gene list. Official gene symbols for the TF and 
nuclear receptors were used as abbreviations. AHR, aryl-hydrocarbon receptor; 
CDKN2C, cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4); CEBPA, 
CCAAT/enhancer binding protein (C/EBP), alpha; CREB1, cAMP responsive element 
binding protein 1; EGR1, early growth response 1; ESR1, estrogen receptor 1 (alpha); 
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FOS, FBJ osteosarcoma oncogene; GATA4, GATA binding protein 4; HIF1A, hypoxia 
inducible factor 1, alpha subunit; JUN, Jun oncogene; KLF5, Kruppel-like factor 5; 
MADH7, MAD homolog 7; MYC, myelocytomatosis oncogene; PPARA, peroxisome 
proliferator activated receptor alpha; PPARG, peroxisome proliferator activated receptor 
gamma; SMAD3, MAD homolog 3; SMAD4, MAD homolog 4; SP1, trans-acting 
transcription factor 1; SP3, trans-acting transcription factor 3; TP53, transformation 
related protein 53; USF1, upstream transcription factor 1. 
TABLE LEGENDS 
Table 1. Values are least square means and standard errors (SE) pooled across 
treatments, n=5 per RFI by feeding treatment combination. Least square means within the 
same line that do not share the same superscript letter are significantly different at 
p<0.05. 
Table 2. Values are least square means and standard errors (SE) pooled across 
treatments, n=5 per RFI by feeding treatment combination. Least square means within the 
same line that do not share the same superscript letter are significantly different at 
p<0.05. 
Table 4. *Fold changes are expressed as CR/Ad libitum when CR>Ad libitum 
(upregulation of expression due to CR) and the negative of Ad libitum/CR when CR<Ad 
libitum (downregulation of expression due to CR).   
Table 5.   *RFI fold changes are expressed as LRFI/HRFI when LRFI>HRFI 
(upregulation of expression in LRFI) and negative of HRFI/LRFI when HRFI>LRFI 
(downregulation of expression due in LRFI).  **CR fold changes are expressed as as 
CR/Ad libitum when CR>Ad libitum (upregulation of expression due to CR) and the 
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negative of Ad libitum/CR when CR<Ad libitum (downregulation of expression due to 
CR).   
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Table 1. Body weight, average daily gain, feed intake, RFI, backfat depth, and loin eye 
area in pigs fed ad libitum or CR and that have high and low RFI 
 
  HRFI  LRFI    
    
Ad libitum 
feed 
Caloric 
restriction   
Ad libitum 
feed 
Caloric 
restriction 
p value 
RFI 
p value 
CR 
p value 
RFI x CR 
Body weight (kg)         
 Pre-treatment  84.21a 82.92a  79.66a 78.85a 6.9E-02 6.4E-01 9.2E-01 
 SE 2.99 2.85  2.99 2.99    
 Post-treatment 88.72a 76.44b  89.17a 77.20b 3.5E-01 4.9E-13 7.9E-01 
 SE 0.61 0.55  0.61 0.60    
Average daily gain (kg/d)        
 Pre-treatment 0.66b 0.75a  0.70a,b 0.75a 4.4E-01 9.2E-03 3.9E-01 
 SE 0.03 0.03  0.03 0.03    
 During treatment 0.92a -0.62b  1.04a -0.50b 1.5E-01 1.3E-10 9.9E-01 
 SE 0.10 0.08  0.09 0.09    
Pre-treatment RFI (kg/d) 0.15a 0.15a  -0.14b -0.15b 2.8E-06 9.2E-01 8.5E-01 
 SE 0.04 0.04  0.04 0.04    
Feed intake (kg/d)         
 Pre-treatment 1.68a 1.80a  1.40b 1.44b 3.0E-05 1.5E-01 5.2E-01 
 SE 0.07 0.06  0.07 0.07    
 During treatment 2.83a 0.61b  2.87a 0.80b 2.3E-01 1.3E-16 2.1E-01 
 SE 0.06 0.07  0.07 0.07    
Backfat depth (mm)         
 Pre-treatment  15.46a 15.21a  12.07b 12.84a,b 8.8E-03 7.9E-01 6.1E-01 
 SE 0.99 0.91  0.99 0.99    
 Post-treatment 17.03a 12.48c  14.69b 11.51c 1.5E-02 1.5E-06 1.9E-01 
 SE 0.55 0.51  0.56 0.55    
Loin eye area (mm2)         
 Pre-treatment  3324a 3234a  3011a 3349a 5.6E-01 4.6E-01 2.3E-01 
 SE 179.1 165.2  179.1 179.1    
 Post-treatment 3399a,b 3138b  3541a 3302a,b 1.2E-01 1.7E-02 9.1E-01 
 SE 107.3 99.6  113.5 107.9    
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Table 2. Blood parameters in pigs fed ad libitum or CR and that have high or low RFI 
 
  HRFI   LRFI       
 
Ad libitum 
feed 
Caloric  
restriction  
Ad libitum 
feed 
Caloric 
restriction 
RFI  
p value  
CR 
 p value  
RFI x CR 
 p value  
Glucose (mg/dl) 85.9a 92.4a  99.1a 98.7a 1.1E-01 6.0E-01 5.8E-01 
    SE 7.1 6.7  7.1 7.1    
Insulin (ng/ml) 0.21a 0.19a  0.11a 0.19a 3.3E-01 6.0E-01 3.8E-01 
    SE 0.05 0.05  0.05 0.05    
NEFA (mEq/L) 0.19a 0.29a  0.22a 0.26a 9.7E-01 7.5E-02 4.1E-01 
    SE 0.04 0.03  0.04 0.04    
TG (mg/dl) 28.0a 32.2a  28.3a 23.9a 4.9E-01 9.8E-01 4.9E-01 
    SE 6.0 5.5  6.0 6.0    
T4 (µg/dl) 5.11a 4.28a,b  5.09a 3.61b 4.7E-01 2.3E-02 4.9E-01 
    SE 0.47 0.43  0.47 0.47    
T3 (ng/dl) 103.5a,b 77.9b  127.4a 110.2a,b 2.4E-02 7.6E-02 7.2E-01 
    SE 12.80 11.92  12.80 12.80    
Cortisol (ng/ml) 19.78a 22.31a  13.55a 22.09a 7.5E-01 5.8E-01 7.7E-01 
    SE 12.5 11.8  12.5 12.5    
Leptin (ng/ml) 4.37a 3.31a  2.84a 4.05a 5.4E-01 9.2E-01 2.7E-02 
    SE 0.76 0.43  0.45 0.63    
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Table 3.  Overrepresented GO biological processes (p≤0.1) by the DE genes in adipose 
tissue due to RFI differences 
  GO ID   Biological processes (number of genes) p-value 
Down-regulated in adipose tissue of LRFI    
 32787  monocarboxylic acid metabolic process (8) 4.3E-03 
 42592  homeostatic process (8)  1.7E-02 
 48878  chemical homeostasis (6)  2.4E-02 
 50793  regulation of developmental process (6)  4.7E-02 
 8535  respiratory chain complex IV assembly (2)  4.8E-02 
 46459  short-chain fatty acid metabolic process (2)  4.8E-02 
 6605  protein targeting (6)  4.9E-02 
 19725  cellular homeostasis (6)  5.0E-02 
 6811  ion transport (9)  5.8E-02 
 6631  fatty acid metabolic process (5)  6.0E-02 
 6091  generation of precursor metabolites and energy (9)  6.7E-02 
 6897  endocytosis (5)  7.1E-02 
 10324  membrane invagination (5)  7.1E-02 
 51052  regulation of DNA metabolic process (3)  7.4E-02 
 6282  regulation of DNA repair (2)  8.2E-02 
 16044  membrane organization and biogenesis (6)  8.4E-02 
 19752  carboxylic acid metabolic process (9)  8.5E-02 
 6082  organic acid metabolic process (9)  8.6E-02 
 44255  cellular lipid metabolic process (9)  8.8E-02 
 7098  centrosome cycle (2)  9.3E-02 
 725  recombinational repair (2)  9.3E-02 
 724  
double-strand break repair via homologous 
recombination (2)  9.3E-02 
 6629  lipid metabolic process (10) 9.9E-02 
Up-regulated in adipose tissue of LRFI   
 5975  carbohydrate metabolic process (7)  3.5E-02 
 10468  regulation of gene expression (17)  4.6E-02 
 6813  potassium ion transport (3)  4.8E-02 
 6950  response to stress (10)  7.7E-02 
 10467  gene expression (21)  9.6E-02 
 44262  cellular carbohydrate metabolic process (5) 9.8E-02 
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Table 4. Statistical significance of genes involved in the CR induced immune response 
and cell cycle/apoptosis pathways in subcutaneous adipose tissue 
 
Pathways Gene Description 
GenBank 
Symbol 
Affymetrix 
ID 
*Fold 
change q Value p Value 
Anticoagulation plasminogen PLG Ssc.7237 3.36 3.4E-02 1.4E-02 
 plasminogen activator, tissue PLAT Ssc.196 1.53 1.3E-02 3.7E-03 
 thrombomodulin THBD Ssc.20711 1.50 4.0E-02 1.7E-02 
 
kallikrein b, plasma (fletcher 
factor) 1 KLKB1 Ssc.260 2.24 4.1E-03 7.0E-04 
 thrombospondin 1 THBS1 Ssc.26702 2.81 4.6E-02 2.1E-02 
T cell receptor 
signaling  
protein tyrosine phosphatase; 
non-receptor type 6  PTPN6 Ssc.5530 3.74 1.9E-02 6.3E-03 
 
 
nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells inhibitor; alpha  NFKBIA Ssc.4759 1.64 8.3E-04 6.3E-05 
 
nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells 1 NFKB1 Ssc.30766 1.55 8.8E-04 7.0E-05 
 
tumor necrosis factor (TNF 
superfamily; member 2)  TNF Ssc.100 1.61 2.4E-02 8.4E-03 
 
mitogen-activated protein 
kinase kinase kinase 8 MAP3K8 Ssc.18038 1.55 4.7E-03 8.5E-04 
 tec protein tyrosine kinase  TEC Ssc.4466 1.43 1.3E-02 3.7E-03 
 
Cas-Br-M (murine) ecotropic 
retroviral transforming 
sequence b  CBLB Ssc.2897 1.38 1.7E-02 5.3E-03 
 FYN oncogene related to SRC FYN Ssc.2714 1.25 4.9E-02 2.4E-02 
 
nuclear factor of activated T-
cells 5; tonicity-responsive  NFAT5 Ssc.17745 1.25 5.3E-03 9.7E-04 
 
Cas-Br-M  ecotropic retroviral 
transforming sequence  CBL Ssc.24231 1.22 5.8E-03 1.1E-03 
 
growth factor receptor-bound 
protein 2  GRB2 Ssc.27313 1.21 1.2E-02 3.0E-03 
 
v-Ki-ras2 Kirsten rat sarcoma 
viral oncogene homolog  KRAS Ssc.2013 1.19 3.3E-02 1.3E-02 
 
protein phosphatase 3 
(formerly 2B); catalytic 
subunit; beta isoform  PPP3CB Ssc.22111 1.12 3.3E-02 1.3E-02 
T cell markers CD8a molecule CD8A Ssc.23489 1.09 3.5E-01 4.7E-01 
 CD8b molecule CD8B Ssc.23495 1.1 3.7E-01 5.3E-01 
 CD4 molecule CD4 Ssc.16240 1.73 1.3E-01 1.0E-01 
Cell 
cycle/Apoptosis 
cyclin-dependent kinase 
inhibitor 1A  CDKN1A Ssc.5737 -2.33 2.4E-04 7.7E-06 
 breast cancer 1; early onset  BRCA1 Ssc.24110 -2.40 3.5E-02 1.4E-02 
 
glial cell line derived 
neurotrophic factor GDNF Ssc.21655 2.36 1.2E-02 3.1E-03 
 non-metastatic cells 1 NME1 Ssc.19546 -2.10 1.4E-04 2.8E-06 
 
Sus scrofa tumor necrosis 
factor (ligand) superfamily; 
member 10  TNFSF10 Ssc.12829 1.92 1.5E-03 1.5E-04 
 
phosphoinositide-3-kinase; 
regulatory subunit 5 PIK3R5 Ssc.11020 1.53 1.7E-01 1.4E-01 
 
TNF receptor superfamily; 
member 6 FAS Ssc.11440 1.50 2.7E-02 1.0E-02 
 Fas-associated via death domain FADD Ssc.1947 1.39 1.2E-03 1.1E-04 
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Table 5. Statistical significance of CR- and RFI-induced genes in lipid metabolism 
pathway 
GenBank 
Symbol Gene Description 
Affymetrix 
ID 
RFI        
q Value 
RFI           
p Value 
RFI 
Fold 
chang
e* 
CR           
q Value 
CR         
p Value 
CR Fold 
change** 
NPC1 
Niemann-Pick disease; 
type C1  Ssc.1533 1.8E-02 2.5E-06 -1.41 5.4E-04 3.3E-05 -1.31 
GPD2 
glycerol-3-phosphate 
dehydrogenase 2 
(mitochondrial)  Ssc.29842 4.7E-02 1.7E-05 -1.60 1.7E-04 4.3E-06 -1.69 
SMPD1 
sphingomyelin 
phosphodiesterase 1 Ssc.3927 1.9E-01 2.3E-03 -1.18 3.7E-05 1.7E-07 -1.55 
ACADSB 
acyl-Coenzyme A 
dehydrogenase; 
short/branched chain  Ssc.7572 2.0E-01 2.6E-03 -1.46 5.1E-04 3.0E-05 -1.88 
GCLM 
glutamate-cysteine 
ligase; modifier subunit  Ssc.24693 1.1E-01 2.5E-04 -1.36 1.0E-04 1.6E-06 -1.66 
LIPG lipase; endothelial  Ssc.21663 1.8E-01 1.8E-03 -2.02 2.6E-02 9.3E-03 -1.73 
BRCA1 
breast cancer 1; early 
onset  Ssc.29471 2.0E-01 2.4E-03 -1.40 4.1E-03 7.0E-04 -1.50 
OXSM 
3-oxoacyl-ACP synthase; 
mitochondrial  Ssc.11586 1.6E-01 1.0E-03 -1.28 2.9E-03 4.2E-04 -1.32 
ALDH5A1 
aldehyde dehydrogenase 
5 family; member A1  Ssc.27232 1.8E-01 1.7E-03 -1.43 3.2E-02 1.2E-02 -1.30 
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Figure 1AB. 
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Figure 2. 
 
  
116 
 
 
Figure 3. 
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Figure 4. 
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Supplementary Table 1. Summary of treatment, tissue harvest, and hybridization 
design 
Animal 
# 
Block (underwent 
treatment at the 
same time) 
Tissue 
Harvest 
Season 
Microarray 
Hybridization 
Season RFI Feed 
1 A Fall Fall Low Ad libitum 
2 A Fall Fall High Ad libitum 
3 A Fall Fall Low 
Caloric 
Restriction 
4 A Fall Fall High 
Caloric 
Restriction 
5 B Fall Fall Low Ad libitum 
6 B Fall Fall Low Ad libitum 
7 B Fall Fall High 
Caloric 
Restriction 
8 B Fall Fall High 
Caloric 
Restriction 
9 B Fall Spring High Ad libitum 
10 B Fall Spring Low 
Caloric 
Restriction 
11 C Spring Spring Low Ad libitum 
12 C Spring Spring High Ad libitum 
13 C Spring Spring High Ad libitum 
14 C Spring Spring Low 
Caloric 
Restriction 
15 C Spring Spring Low 
Caloric 
Restriction 
16 C Spring Spring High 
Caloric 
Restriction 
17 D Spring Spring Low Ad libitum 
18 D Spring Spring High Ad libitum 
19 D Spring Spring Low 
Caloric 
Restriction 
20 D Spring Spring High 
Caloric 
Restriction 
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Supplementary Table 2. Primers and probes used for Taqman qPCR analysis 
 
Gene name Forward primer Probe 5’ 6-FAMTM  3’ Iowa Black FQTM Reverse primer 
GenBank Acc. 
No./TIGR TC 
UBAP1 5-GACTATCTCTTTGCACATGGACAG-3 5-TCTGCGAGAAAGGCTTCGACCCTCTTT-3 5-ATCTGCTCATTAACTGAAGAAACTCC-3  AK236149.1  
FASN 5-GTTCTTCCAGGACGTCAGTAAGC-3 5-CCTCCCGGGTCACCCTGTCCAG-3 5-CGGAGGAGAAGATCACGAAGTAG-3 TC302928 
AKR1CL2 5- CCAGGCAAATCCTCACCTCTG -3 5- CTCCGATGGCAGACCTCACTCAGTTCTCC -3 5-GGTTCACTGCTCACTCTCTCC -3 DQ474064.1 
ACACA 5-TCCACATGAACAGGCTTCCA-3 5-TCCAAGCTACCATGCCAATCTCATTTCCT-3 5-ATTCCGGACTTTTAAGGGACATT-3 AF175308 
ACO1 5-GAGAAGTGCTTGACGTGTTCGA-3 5-CTGCCCAGTCTCGGGAGCTGCCA-3 5-AGCCTTGATTCCCAACAGGAA-3 TC202124  
LEP 5-GTTGAAGCCGTGCCCATCT-3  5-TCCAGGATGACACCAAAACCCTCATCA-3 5-CACTGATCCTGGTGACAATCGT-3   NM_213840.1  
ATPBD1B 5-CACAGTAGAGACTGAGCCACTG-3  5-ACCAGATCCTTAACCTGACAAGCCACCAG-3 5- TCCGGCCCAGGAACTTCC-3  AK236386.1 
SLC7A9 5-AAAAGGAGAGAGGATGAGAAGTCG-3 5- AGAGCACTGAACCCAAGACCACAAATCTCC-3 5- ATGCAGATGCCACTGAACAGG -3 NM_001110171 
PC 5-ATTCCCTGCTGGTCAAGGTCAT-3 5-TTGCCGAGTTCCGAGTCCGAGGCGTCAAGA-3 5-AGGAACTGCTGGTTGTTGAGCA-3 NM_214349 
ACADL 5-TGTCTCCAGCTGCATGAAACGA-3 5-TCTGGAGTCTGCCGCTGCTTCCATGGCAA-3 5-AGCTGCACACAGTCATAAGCCA-3 NM_213897 
DHCR7 5-TGGACCCTCATCAACCTGTCCTT-3 5-AGCAGCAGCTCTACGGCCACGTCACCAACT-3 5-TCCAGAAGAAGTCCAGCACGTAGA-3 TC378393 
DHRS7 5-GCAAGACATTCACCCCAAAGC-3 5- CGCAGCCGTAGCAATCCAGGACCTCT-3 5-TGCTGGCATTGCTGATGAGG-3 TC318759 
PON3 5- CGAGAAGTGGAGCCAGTAGAAC-3 5-TCAGAACTGCCACCTTATTGAGGGACTTGA-3 5-AGTTTACCATGCCTGGATAGTTTAATC-3 NM_001044604.1 
ITGA6 5-AAGCAAGGAAGATCAGTGGATGG-3 5-TCACCGTCCAGAGCCAAGGTCCAGG-3 5-AAGCAAGGAAGATCAGTGGATGG-3 
    
XM_001925637 
GPNMB 5-CACTTGATGCCGCCAAACG-3 5-TCCAGTCATTCTCATCTGAAGACCAGCCGT-3 5-CTCCCCTCTTCCAAACTGGATAG-3 NM_001098584.1 
     
Official gene symbols were used as abbreviations. ACACA, acetyl-coenzyme A carboxylase alpha; FASN, fatty acid synthase; 
ACO1, aconitase 1; DHCR7, 7-dehydrocholesterol reductase; ACADL, acyl-Coenzyme A dehydrogenase, long chain; PC, 
pyruvate carboxylase; UBAP1, ubiquitin associated protein 1; AKR1CL2, aldo-keto reductase family 1; member C-like 2; 
LEP, leptin; ATPBD1B, ATP binding domain 1 family, member B; SLC7A9, solute carrier family 7 (cationic amino acid 
transporter, y+ system), member 9; DHRS7, dehydrogenase/reductase (SDR family) member 7C; PON3, paraoxonase 3; 
ITGA6, integrin, alpha 6; GPNMB, glycoprotein (transmembrane) nmb. 
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Supplementary Table 4A. Main themes of clusters and corresponding GO Biological 
Process terms for down-regulated genes (q≤0.05) in subcutaneous adipose tissue in 
response to CR. 
 
Cluster themes Enrichment score GO terms p-values 
Oxidative 
phosphorylation 19.46 oxidative phosphorylation 6.28E-24 
  organelle ATP synthesis coupled electron transport 3.80E-20 
  ATP synthesis coupled electron transport 3.80E-20 
    mitochondrial electron transport, NADH to ubiquinone 1.64E-16 
TCA cycle 10.60 cellular respiration 2.84E-14 
  aerobic respiration 2.45E-13 
  coenzyme catabolic process 1.49E-12 
  acetyl-CoA metabolic process 1.32E-11 
  tricarboxylic acid cycle 2.40E-11 
  acetyl-CoA catabolic process 2.40E-11 
  cofactor catabolic process 5.79E-11 
    tricarboxylic acid cycle intermediate metabolic process 3.31E-05 
Lipid metabolism 8.52 cellular lipid metabolic process 7.45E-10 
  lipid metabolic process 2.45E-09 
    lipid biosynthetic process 1.55E-08 
Biosynthesis 8.10 biosynthetic process 4.12E-18 
  cellular biosynthetic process 2.78E-11 
  macromolecule biosynthetic process 1.88E-03 
    translation 1.80E-02 
ATP metabolism 6.26 cofactor metabolic process 6.78E-26 
  coenzyme metabolic process 1.43E-21 
  cofactor biosynthetic process 5.66E-13 
  coenzyme biosynthetic process 8.03E-10 
  ribonucleoside triphosphate metabolic process 4.78E-07 
  purine ribonucleoside triphosphate metabolic process 4.78E-07 
  ATP metabolic process 5.36E-07 
  nucleoside triphosphate metabolic process 5.80E-07 
  nucleotide metabolic process 7.54E-07 
  purine nucleoside triphosphate metabolic process 8.28E-07 
  nucleoside triphosphate biosynthetic process 1.37E-06 
  nucleobase, nucleoside and nucleotide metabolic process 2.66E-06 
  purine nucleoside triphosphate biosynthetic process 3.43E-06 
  purine ribonucleoside triphosphate biosynthetic process 3.43E-06 
  ribonucleoside triphosphate biosynthetic process 3.43E-06 
  ATP biosynthetic process 3.87E-06 
  nucleoside phosphate metabolic process 3.87E-06 
  purine ribonucleotide metabolic process 4.83E-06 
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Supplementary Table 4A. (continued) 
Cluster themes 
Enrichment 
score GO terms p-values 
  ribonucleotide metabolic process 5.29E-06 
  ATP synthesis coupled proton transport 7.67E-06 
  purine nucleotide metabolic process 2.35E-05 
  ribonucleotide biosynthetic process 4.76E-05 
  purine ribonucleotide biosynthetic process 9.80E-05 
  nucleotide biosynthetic process 1.47E-04 
  proton transport 2.02E-04 
  purine nucleotide biosynthetic process 2.73E-04 
  hydrogen transport 2.86E-04 
  monovalent inorganic cation transport 2.31E-01 
  ion transport 6.18E-01 
    cation transport 6.69E-01 
Amino acid 
metabolism 5.62 carboxylic acid metabolic process 9.35E-12 
  organic acid metabolic process 1.18E-11 
  monocarboxylic acid metabolic process 2.51E-08 
  fatty acid metabolic process 1.10E-06 
  amino acid and derivative metabolic process 5.85E-04 
  amino acid metabolic process 3.70E-03 
  nitrogen compound metabolic process 5.76E-03 
    amine metabolic process 2.85E-02 
Phosphate metabolism 5.33 oxidative phosphorylation 6.28E-24 
  phosphorylation 3.20E-02 
  phosphorus metabolic process 1.05E-01 
  phosphate metabolic process 1.05E-01 
    protein amino acid phosphorylation 9.99E-01 
Mitochondrial 
transport 4.88 mitochondrion organization and biogenesis 1.79E-06 
  mitochondrial transport 8.45E-06 
    protein targeting to mitochondrion 1.54E-04 
Proteolysis 4.47 cellular catabolic process 1.77E-12 
  catabolic process 4.02E-11 
  cellular macromolecule catabolic process 9.70E-06 
  macromolecule catabolic process 1.68E-05 
  cellular protein catabolic process 2.87E-04 
  proteolysis involved in cellular protein catabolic process 4.70E-04 
  ubiquitin-dependent protein catabolic process 1.00E-03 
  modification-dependent protein catabolic process 1.21E-03 
  modification-dependent macromolecule catabolic process 1.21E-03 
  protein catabolic process 2.55E-03 
  biopolymer catabolic process 5.73E-03 
    proteolysis 6.42E-02 
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Supplementary Table 4A. (continued) 
Cluster themes 
Enrichment 
score GO terms p-values 
Protein transport 4.38 intracellular transport 1.96E-08 
  establishment of cellular localization 7.48E-07 
  cellular localization 1.95E-06 
  transport 2.14E-06 
  protein transport 5.63E-06 
  establishment of localization 1.10E-05 
  establishment of protein localization 6.36E-05 
  protein localization 1.08E-04 
  intracellular protein transport 1.33E-04 
  protein targeting 2.57E-04 
  macromolecule localization 6.19E-04 
  localization 3.58E-03 
    cellular component organization and biogenesis 5.12E-01 
Glycolysis 3.58 glucose catabolic process 9.90E-06 
  alcohol metabolic process 1.47E-05 
  hexose catabolic process 2.81E-05 
  alcohol catabolic process 2.99E-05 
  monosaccharide catabolic process 4.32E-05 
  carbohydrate catabolic process 2.55E-04 
  cellular carbohydrate catabolic process 2.64E-04 
  glucose metabolic process 2.95E-04 
  glycolysis 5.69E-04 
  cellular carbohydrate metabolic process 6.11E-04 
  carbohydrate metabolic process 3.37E-03 
  hexose metabolic process 1.16E-02 
    monosaccharide metabolic process 1.79E-02 
Cholesterol 
metabolism 3.42 sterol biosynthetic process 7.68E-06 
  sterol metabolic process 3.14E-05 
  steroid biosynthetic process 9.65E-05 
  steroid metabolic process 1.20E-04 
  cholesterol biosynthetic process 5.41E-04 
  cholesterol metabolic process 1.15E-03 
  isoprenoid metabolic process 1.13E-02 
    isoprenoid biosynthetic process 2.34E-02 
Fatty acid metabolism 3.28 fatty acid metabolic process 1.10E-06 
  carboxylic acid biosynthetic process 2.96E-03 
  organic acid biosynthetic process 2.96E-03 
    fatty acid biosynthetic process 8.18E-03 
Microtubule-based 
movement 2.67 microtubule-based process 9.30E-05 
  microtubule-based movement 2.50E-03 
    cytoskeleton-dependent intracellular transport 4.22E-02 
Heme metabolism 2.43 porphyrin biosynthetic process 8.34E-04 
  tetrapyrrole biosynthetic process 8.34E-04 
  porphyrin metabolic process 1.97E-03 
  tetrapyrrole metabolic process 1.97E-03 
  heme biosynthetic process 3.29E-03 
  secondary metabolic process 3.75E-03 
  pigment biosynthetic process 5.22E-03 
  heme metabolic process 7.11E-03 
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Supplementary Table 4A. (continued) 
Cluster themes 
Enrichment 
score GO terms p-values 
  pigment metabolic process 7.98E-03 
    heterocycle metabolic process 5.55E-02 
Secretion 2.26 Golgi vesicle transport 7.68E-05 
  ER to Golgi vesicle-mediated transport 5.68E-04 
  secretory pathway 2.33E-03 
  secretion by cell 1.42E-02 
  vesicle-mediated transport 1.20E-01 
    secretion 1.68E-01 
Vitamin metabolism 2.02 vitamin metabolic process 1.95E-04 
  water-soluble vitamin metabolic process 5.40E-04 
  pyridine nucleotide metabolic process 1.97E-03 
  nicotinamide metabolic process 7.11E-03 
  NADP metabolic process 1.32E-02 
  pentose-phosphate shunt 1.94E-02 
  water-soluble vitamin biosynthetic process 9.87E-02 
  vitamin biosynthetic process 9.87E-02 
    pyridine nucleotide biosynthetic process 1.81E-01 
Amino acid 
biosynthesis 1.96 amino acid biosynthetic process 4.90E-03 
  nitrogen compound biosynthetic process 1.35E-02 
    amine biosynthetic process 1.95E-02 
Spindle organization 1.84 spindle organization and biogenesis 8.34E-04 
  mitotic spindle organization and biogenesis 5.76E-02 
    microtubule cytoskeleton organization and biogenesis 6.16E-02 
Branched chain amino 
acid metabolism 1.78 branched chain family amino acid catabolic process 7.96E-04 
  branched chain family amino acid metabolic process 1.59E-03 
  amino acid catabolic process 4.35E-02 
  amine catabolic process 4.78E-02 
  nitrogen compound catabolic process 5.75E-02 
    leucine metabolic process 1.35E-01 
Ubiquinone 
biosynthesis 1.71 quinone cofactor biosynthetic process 1.94E-02 
  ubiquinone biosynthetic process 1.94E-02 
  ubiquinone metabolic process 1.94E-02 
    quinone cofactor metabolic process 1.94E-02 
Protein modification 1.43 metabolic process 1.26E-07 
  cellular metabolic process 2.98E-04 
  protein metabolic process 5.13E-03 
  cellular macromolecule metabolic process 5.21E-03 
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Supplementary Table 4A. (continued) 
Cluster themes 
Enrichment 
score GO terms p-values 
  cellular protein metabolic process 5.68E-03 
  primary metabolic process 1.66E-01 
  ubiquitin cycle 4.05E-01 
  protein modification process 8.03E-01 
  biopolymer modification 8.09E-01 
  cellular process 9.57E-01 
  post-translational protein modification 9.71E-01 
  macromolecule metabolic process 9.99E-01 
    biopolymer metabolic process 1.00E+00 
Mitochondrial 
respiratory chain 1.39 mitochondrial respiratory chain complex I assembly 4.07E-02 
  NADH dehydrogenase complex assembly 4.07E-02 
    mitochondrial respiratory chain complex assembly 4.07E-02 
Fatty acid catabolism 1.36 carboxylic acid catabolic process 8.97E-03 
  organic acid catabolic process 8.97E-03 
  cellular lipid catabolic process 2.02E-01 
  fatty acid catabolic process 2.30E-01 
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Supplementary Table 4B. Main themes of clusters and corresponding GO Biological 
Process terms for up-regulated genes (q≤0.05) in subcutaneous adipose tissue in response 
to FR. 
Cluster themes 
Enrichment 
score GO terms p-values 
Regulation of 
transcription 10.84 RNA metabolic process 7.93E-19 
  regulation of cellular metabolic process 4.15E-17 
  
regulation of nucleobase, nucleoside, nucleotide and nucleic acid 
metabolic process 2.09E-16 
  regulation of metabolic process 6.41E-16 
  regulation of transcription 1.26E-14 
  regulation of gene expression 1.99E-14 
  regulation of transcription, DNA-dependent 5.72E-14 
  transcription, DNA-dependent 1.10E-13 
  RNA biosynthetic process 1.25E-13 
  transcription 1.34E-13 
  
nucleobase, nucleoside, nucleotide and nucleic acid metabolic 
process 1.47E-13 
  gene expression 2.94E-13 
  regulation of cellular process 4.60E-13 
  regulation of biological process 1.42E-12 
  biopolymer metabolic process 7.93E-12 
  biological regulation 6.79E-10 
  macromolecule metabolic process 1.20E-06 
  primary metabolic process 1.60E-03 
  cellular metabolic process 1.68E-02 
  cellular process 2.98E-02 
    metabolic process 1.23E-01 
RNA processing 5.57 mRNA metabolic process 2.07E-07 
  RNA processing 4.19E-06 
  mRNA processing 5.79E-06 
    RNA splicing 1.08E-05 
DNA metabolic 
process 3.14 establishment and/or maintenance of chromatin architecture 6.54E-05 
  chromatin modification 6.87E-05 
  DNA packaging 9.89E-05 
  chromosome organization and biogenesis 3.50E-04 
  chromatin assembly or disassembly 2.06E-02 
    DNA metabolic process 4.75E-02 
Negative regulation of 
transcription 2.83 negative regulation of transcription 2.10E-04 
  
negative regulation of nucleobase, nucleoside, nucleotide and 
nucleic acid metabolic process 3.98E-04 
  negative regulation of cellular metabolic process 6.38E-04 
  negative regulation of transcription, DNA-dependent 8.80E-04 
  negative regulation of metabolic process 1.30E-03 
  negative regulation of cellular process 1.77E-03 
  negative regulation of biological process 3.64E-03 
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Supplementary Table 4B. (continued) 
Cluster themes 
Enrichment 
score GO terms p-values 
Negative regulation of 
transcription  
negative regulation of transcription from RNA polymerase II 
promoter 5.53E-02 
Cytoskeleton 
organization 2.73 actin filament-based process 4.79E-04 
  actin cytoskeleton organization and biogenesis 8.80E-04 
    cytoskeleton organization and biogenesis 1.48E-02 
RNA splicing 2.25 RNA splicing 1.08E-05 
  nuclear mRNA splicing, via spliceosome 1.05E-02 
  
RNA splicing, via transesterification reactions with bulged 
adenosine as nucleophile 1.05E-02 
  RNA splicing, via transesterification reactions 1.05E-02 
    spliceosome assembly 4.37E-01 
Cell differentiation 1.83 regulation of developmental process 8.30E-03 
  positive regulation of cell differentiation 1.02E-02 
  regulation of cell differentiation 1.13E-02 
    positive regulation of developmental process 5.16E-02 
Immune response 1.46 activation of plasma proteins during acute inflammatory response 2.20E-04 
  complement activation 2.20E-04 
  activation of immune response 1.93E-03 
  humoral immune response mediated by circulating immunoglobulin 2.76E-03 
  complement activation, classical pathway 2.76E-03 
  humoral immune response 4.76E-03 
  positive regulation of immune response 1.03E-02 
  positive regulation of immune system process 1.03E-02 
  regulation of immune response 1.05E-02 
  acute inflammatory response 1.23E-02 
  regulation of immune system process 1.23E-02 
  positive regulation of multicellular organismal process 1.23E-02 
  B cell mediated immunity 5.48E-02 
  immunoglobulin mediated immune response 5.48E-02 
  immune effector process 6.78E-02 
  response to wounding 1.30E-01 
  
adaptive immune response based on somatic recombination of 
immune receptors built from immunoglobulin superfamily domains 1.55E-01 
  adaptive immune response 1.55E-01 
  regulation of multicellular organismal process 1.94E-01 
  lymphocyte mediated immunity 2.19E-01 
  inflammatory response 2.25E-01 
  leukocyte mediated immunity 2.77E-01 
  innate immune response 3.13E-01 
  response to external stimulus 5.11E-01 
  defense response 5.90E-01 
  response to stress 6.08E-01 
    immune response 6.50E-01 
127 
 
 
Supplementary Table 4B. (continued) 
Cluster themes 
Enrichment 
score GO terms p-values 
Positive regulation of 
transcription 1.43 
positive regulation of nucleobase, nucleoside, nucleotide and 
nucleic acid metabolic process 1.38E-02 
  positive regulation of cellular metabolic process 1.42E-02 
  positive regulation of biological process 1.51E-02 
  positive regulation of transcription 1.70E-02 
  positive regulation of metabolic process 2.75E-02 
  positive regulation of cellular process 5.05E-02 
  positive regulation of transcription, DNA-dependent 1.92E-01 
    
positive regulation of transcription from RNA polymerase II 
promoter 2.90E-01 
RNA localization 1.37 establishment of RNA localization 2.27E-02 
  nucleic acid transport 2.27E-02 
  RNA transport 2.27E-02 
  RNA localization 2.60E-02 
  nucleobase, nucleoside, nucleotide and nucleic acid transport 4.88E-02 
  mRNA transport 6.41E-02 
    nuclear export 2.58E-01 
Protein processing 1.36 protein autoprocessing 2.75E-02 
  protein amino acid autophosphorylation 2.75E-02 
    protein processing 1.11E-01 
Immune system 
process 1.33 myeloid cell differentiation 1.08E-03 
  hemopoiesis 2.99E-02 
  immune system development 4.20E-02 
  hemopoietic or lymphoid organ development 5.16E-02 
  regulation of myeloid cell differentiation 9.20E-02 
  immune system process 1.38E-01 
  leukocyte differentiation 5.29E-01 
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Supplementary Table 4C. Main theme of cluster and corresponding GO Biological 
Process terms for down-regulated genes (q≤0.05) in liver in response to FR. 
Cluster theme Enrichment score GO terms p-values 
Ion transport 1.68 phosphate transport 1.24E-03 
  inorganic anion transport 6.07E-03 
  ion transport 7.28E-03 
  anion transport 1.09E-02 
  organ development 2.44E-01 
  system development 5.54E-01 
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Supplementary Table 4D. Main themes of clusters and corresponding GO Biological 
Process terms for up-regulated genes (q≤0.05) in liver in response to FR. 
Cluster themes Enrichment score GO terms p-values 
Biosynthesis 3.56 translation 1.11E-05 
  macromolecule biosynthetic process 3.89E-05 
  macromolecule metabolic process 3.58E-04 
  cellular macromolecule metabolic process 5.49E-04 
  cellular biosynthetic process 6.32E-04 
  cellular protein metabolic process 7.87E-04 
  protein metabolic process 8.45E-04 
  biosynthetic process 9.31E-04 
Metabolic process 2.38 macromolecule metabolic process 3.58E-04 
  primary metabolic process 1.55E-03 
  metabolic process 4.19E-03 
  cellular metabolic process 4.58E-03 
  cellular process 1.25E-01 
RNA processing 1.53 mRNA metabolic process 2.63E-02 
  RNA splicing 2.69E-02 
  RNA processing 3.08E-02 
  mRNA processing 3.33E-02 
Transport and 
secretion 1.50 secretion 3.42E-03 
  macromolecule localization 4.32E-03 
  intracellular transport 1.08E-02 
  secretion by cell 1.32E-02 
  protein localization 1.36E-02 
  establishment of cellular localization 1.62E-02 
  secretory pathway 1.88E-02 
  establishment of protein localization 1.98E-02 
  cellular localization 2.00E-02 
  protein transport 2.78E-02 
  intracellular protein transport 3.29E-02 
  protein targeting 3.62E-02 
  Golgi vesicle transport 3.91E-02 
  ER to Golgi vesicle-mediated transport 4.76E-02 
  vesicle-mediated transport 1.04E-01 
  establishment of localization 1.15E-01 
  transport 1.77E-01 
  localization 2.49E-01 
  cellular component organization and biogenesis 2.56E-01 
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Supplementary Table 5. Functional annotation of the 50 most up- and down-regulated 
genes based on fold change in fat and liver due to CR 
GO ID Biological processes (number of genes) p-value 
Down-regulated in fat due to CR  
44255 cellular lipid metabolic process (11) 2.1E-08 
6629 lipid metabolic process (11) 1.4E-07 
8610 lipid biosynthetic process (7) 4.4E-06 
8202 steroid metabolic process (6) 1.1E-05 
8203 cholesterol metabolic process (4) 2.5E-04 
6694 steroid biosynthetic process (4) 3.3E-04 
16125 sterol metabolic process (4) 3.7E-04 
6695 cholesterol biosynthetic process (3) 8.1E-04 
6720 isoprenoid metabolic process (3) 1.1E-03 
16126 sterol biosynthetic process (3) 1.4E-03 
6066 alcohol metabolic process (5) 1.7E-03 
19752 carboxylic acid metabolic process (6) 2.0E-03 
6082 organic acid metabolic process (6) 2.1E-03 
9058 biosynthetic process (9) 2.2E-03 
6766 vitamin metabolic process (3) 6.2E-03 
9117 nucleotide metabolic process (4) 6.6E-03 
32787 monocarboxylic acid metabolic process (4) 7.0E-03 
55086 nucleobase, nucleoside and nucleotide metabolic process (4) 7.6E-03 
1662 behavioral fear response (2) 8.1E-03 
2209 behavioral defense response (2) 8.1E-03 
42596 fear response (2) 1.3E-02 
6739 NADP metabolic process (2) 2.1E-02 
6810 transport (10) 2.2E-02 
33555 multicellular organismal response to stress (2) 2.3E-02 
6721 terpenoid metabolic process (2) 2.3E-02 
51234 establishment of localization (10) 2.6E-02 
8299 isoprenoid biosynthetic process (2) 3.0E-02 
6631 fatty acid metabolic process (3) 3.3E-02 
6769 nicotinamide metabolic process (2) 3.4E-02 
44249 cellular biosynthetic process (6) 3.6E-02 
6732 coenzyme metabolic process (3) 4.0E-02 
19362 pyridine nucleotide metabolic process (2) 4.3E-02 
6100 tricarboxylic acid cycle intermediate metabolic process (2) 4.5E-02 
Up-regulated in fat due to CR  
45445 myoblast differentiation (3) 1.6E-03 
48747 muscle fiber development (3) 3.7E-03 
48741 skeletal muscle fiber development (3) 3.7E-03 
42692 muscle cell differentiation (3) 3.9E-03 
65008 regulation of biological quality (7) 4.4E-03 
8202 steroid metabolic process (4) 4.6E-03 
7519 skeletal muscle development (3) 9.1E-03 
Supplementary Table 5. (continued) 
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GO ID Biological processes (number of genes) p-value 
9308 amine metabolic process (5) 9.1E-03 
8152 metabolic process (24) 1.0E-02 
42445 hormone metabolic process (3) 1.0E-02 
6629 lipid metabolic process (6) 1.1E-02 
6807 nitrogen compound metabolic process (5) 1.2E-02 
7596 blood coagulation (3) 1.4E-02 
14706 striated muscle development (3) 1.4E-02 
50817 coagulation (3) 1.4E-02 
7599 hemostasis (3) 1.5E-02 
50878 regulation of body fluid levels (3) 2.1E-02 
32502 developmental process (12) 2.3E-02 
42060 wound healing (3) 2.3E-02 
44255 cellular lipid metabolic process (5) 2.5E-02 
48513 organ development (7) 2.6E-02 
6519 amino acid and derivative metabolic process (4) 3.0E-02 
48522 positive regulation of cellular process (6) 3.2E-02 
48856 anatomical structure development (9) 3.4E-02 
16525 negative regulation of angiogenesis (2) 3.4E-02 
48731 system development (8) 3.5E-02 
43627 response to estrogen stimulus (2) 3.9E-02 
7517 muscle development (3) 4.1E-02 
9611 response to wounding (4) 4.3E-02 
44238 primary metabolic process (21) 4.6E-02 
48518 positive regulation of biological process (6) 4.7E-02 
Up-regulated in liver due to CR  
46903 secretion (5) 7.5E-03 
51234 establishment of localization (12) 2.1E-02 
51179 localization (12) 4.9E-02 
Down-regulated in liver due to CR  
6817 phosphate transport (4) 5.2E-04 
15698 inorganic anion transport (4) 2.5E-03 
6820 anion transport (4) 4.4E-03 
9719 response to endogenous stimulus (4) 3.0E-02 
30261 chromosome condensation (2) 3.5E-02 
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ABSTRACT 
Selection based on low residual feed intake (RFI) to improve feed efficiency has been 
employed in several species and reports indicate that RFI selection affects the serum 
concentration of thyroid hormones. To understand how RFI selection modulates thyroid 
axis, 80 barrows, 40 from a RFI selection line and 40 from a control line, were paired by 
age (~ 4.5 month) and weight (74.8±9.9 kg), and randomly assigned in ten replicates to 
one of four feeding treatments for 6 weeks. Feeding treatments were 1) ad libitum (AD), 
2) 75% of AL, 3) 55% of AL, and 4) intake of maintenance energy requirement. In the 
latter treatment, weekly adjustments in feed intake were made to keep body weight 
constant for each pig. Serum free triiodothyronine concentration was 30% higher in the 
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selection line as compared to the control line, without a significant difference in the free 
thyroxine concentration across feeding treatments. In pigs selected for RFI, thyroid gland 
weight was 1.5 g (14%) higher than for the control line and histological analysis of the 
thyroid gland showed no difference in colloid size and density between lines. In selection 
line pigs, type I and II iodothyronine deiodinases in kidney and liver were significantly 
up-regulated whereas the type III iodothyronine deiodinase was down-regulated in liver. 
Expression of TSHβ was down-regulated in pituitary of pigs in selection line undergoing 
feed restriction, indicating a distinct central response to feed restriction in select line pigs. 
Our results suggest that the greater concentration of triiodothyronine in pigs from the 
selection line is likely regulated at the peripheral level by type I and II iodothyronine 
iodothyronine deiodinases and this increase in triiodothyronine concentration may 
contribute to the feed efficiency of pigs through enhanced growth and reduced feed 
intake via nutrient sensing mechanisms.   
INTRODUCTION 
Thyroid hormones (TH) play a critical role in growth and development, yet the 
contribution of TH in controlling feed efficiency remains to be further understood. 
Previous reports indicate that TH concentration is affected by selection for growth 
parameters such as body size in rats [1] and rate of gain and thickness of backfat in swine 
[2]. Sows selected for increased lean growth on restricted feeding showed more placid 
behavior [3], likely due to reduced activity of thyroid hormone that correlates with 
decreased energy requirement for activity driven maintenance [4]. Dietary 
triiodothyronine (T3) and thyroxine (T4) can increase feed efficiency and growth 
characteristics in chicken [5, 6] and in pigs [7]. Administration of thyrotropin releasing 
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hormone (TRH) produces an increase in TH levels and yields positive performance in 
beef-heifers and in lactating sows [8, 9].  
Residual feed intake (RFI) is a measure of feed efficiency and is defined as the 
feed consumed above or below what is required for growth and maintenance [10, 11]. 
Pigs with low RFI consume less food than the population average without a significant 
loss in growth parameters and lean gain, thus, are more feed efficient than pigs of a high 
RFI value. Our group has successfully developed pig lines that differ in RFI and, after 3rd 
generation, feed intake difference was 124 g/day, without significant change in the body 
composition, with an estimated RFI heritability of 0.33 [12]. The pigs that were used in 
this study come from 5th generation low RFI line, in which the daily feed intake 
difference was 200 g/day (Boddicker et al., Manuscript in Preparation).  
A limited number of reports are available on chicken thyroid function in response 
to selection based on RFI and the results are inconsistent [13, 14]. Gabarrou et al. [13] 
found that T3 concentration was greater in the low RFI than the high RFI group in both 
fed and fasted states, whereas in another study [14] T3 level was lower in the low RFI 
chicken in the fed state and not significantly different in the fasted state. 
Efficient feed utilization is also achieved with feed restriction in cattle and 
chickens [15, 16]. Energy restriction induces adaptive changes in thyroid hormone 
economy and modulates thyroid hormone levels as well as expression and activity levels 
of iodothyronine deiodinases in chicken and in cattle [17, 18].  
In our study, we examined the effect of selection for low RFI and feed restriction 
in pigs on the serum concentration of thyroid-related hormones, the size and histology of 
the thyroid gland, and mRNA expression of hepatic and renal iodothyronine deiodinase 
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enzymes, thyroid stimulating hormone (TSH) in pituitary, and thyroglobulin in the 
thyroid gland. 
  MATERIALS AND METHODS 
Animals and treatments. Using a randomized complete block design, 80 Yorkshire 
barrows approximately 4.5-month of age (74.8 ± 9.9 kg) from the 5th generation of the 
Iowa State University RFI selection lines, 40 from the low RFI line and 40 from the 
randomly selected control line (higher RFI), were paired based on line, age and weight, 
and each pair was randomly assigned to contiguous individual pens. Pigs were allowed to 
acclimate for three days on ad libitum (AL) feeding and had free access to water at all 
times. Following the acclimation period, all pigs were fed AL for seven days and AL feed 
intake was established (week -1). Pairs were then randomly allocated to one of four feed 
intake treatments: 1) AL feed, 2) 75% of feed intake of the AL control pigs (75AL), 3) 
55% of feed intake of the AL control pigs (55AL), and 4) a weight maintenance feed 
(MT), in which feed was individually adjusted to maintain initial body weight. The test 
was conducted in ten replicates of 8 pigs (1 pig per line by treatment combination) and 
the duration of the test period was six weeks. All pigs received the same diet, which was 
formulated to meet or exceed nutrient requirements for this size pig (NRC, 1998) over the 
six-week test period. Pigs on restricted feed intake treatments were provided two equal 
portioned meals at 0700 and 1700 hrs each day. Feed allotments for the 75AL and 55AL 
treatments were based upon the average daily feed intake (ADFI) of the control line AL 
fed pigs in the previous week within each pig’s replicate. The initial feeding level used 
for the MT treatment was based on estimated energy requirements for maintenance, 
which were estimated as 106BW0.75 Mcal metabolizable energy per day based on each 
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pig’s day -1 BW and (i.e., 106BW0.75) swine National Research Council guidelines 
(NRC, 1998). Using the metabolizable energy content of the diet, this was used to 
determine the amount of feed allotted to each pig. Pigs on the MT treatment were 
weighed twice per week and their feed intake was adjusted based on weight gain or loss 
relative to their starting BW. At the end of 6 week treatment, pigs were killed by 
exsanguinations. 
Upon completion of the 6-week treatment, all pigs were fasted over night and 
post-treatment blood samples were collected from the jugular vein. Blood samples were 
allowed to clot at 4°C for 3 hours, centrifuged at 1,200 g for 30 min, and serum was 
collected and stored at -20°C.  Pigs from eight replicates were anesthetized via an i.v. 
injection (0.04 mL/kg BW) of a 1:1:1 mixture of Telazol-HCl (Fort Dodge Animal 
Health, Fort Dodge, IA) Xylazine-HCl (Lloyd Laboratories, Shenandoah, IA USA), and 
Ketamine-HCl (Fort Dodge Animal Health, Fort Dodge, IA). After a surgical plane of 
anesthesia was reached, the pigs were euthanized by exsanguination. Immediately 
thereafter, thyroid gland was exteriorized according to thyroidectomy procedure 
described by Swindle [19].  The thyroid gland and pituitary were weighed and a sample 
of thyroid gland was embedded in OCT media (Catalog # 62550-01, Electron 
Microscopy Science, Hatfield, PA, USA) for histological studies. Samples of liver, 
kidney, and pituitary, and thyroid gland were rapidly collected, snap frozen in liquid 
nitrogen, and stored at 80°C until RNA isolation. All animal procedures were approved 
by the Animal Care and Use Committee of Iowa State University. 
Thyroid hormone assays. Serum concentrations of free triiodothyroinine (fT3)  and free 
thyroxine (fT4)  were measured for all pigs using enzyme immunoassay (Catalog # 07M-
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93102 and 07M-91102, respectively; MP Biomedicals, Orangeburg, NY, USA). The 
intra- and inter- assay coefficient of variation was 2.4-11.7% and 4.3-10.7% for fT3; 3.3-
11.1% and 3.0-10.8% for fT4, respectively. 
Sectioning and histology. Thyroid samples from pigs from eight replicates were sectioned 
at 10 µm thickness with two sections from each animal. Sections were mounted on a 
slide, fixed in 95% ethanol, and kept in -80°C. Slides were stained with Accustain 
Hematoxylin and Eosin Y stains according to manufacturer’s instructions (Catalog # 
GHS-2 and HT110-3, respectively; Sigma-Aldrich, Inc., St. Louis, MO, USA). Sizes of 
ten follicles were measured (five per section) per animal to determine follicle size. Total 
number of follicles in 3.2 mm2 microscopic region was counted using image analyzing 
software ImageJ (rsb.info.nih.gov/ij/) and follicle density (number of follicles in mm2 
area) was determined.        
Real-time Quantitative PCR. We examined three feeding levels (AL, 75AL, and MT) and 
randomly selected seven animals per line and feeding treatment combination for analyses 
of expression of genes involved in T4 synthesis and iodothyronine deiodination.  Real-
time quantitative PCR (qPCR) was used to examine the expression of type I, II, and III 
iodothyronine iodothyronine deiodinases in kidney and liver, thyroid-stimulating 
hormone beta subunit (TSHβ) in pituitary, and thyroglobulin in thyroid gland.  Total 
RNA was isolated from thyroid gland, liver, kidney, and pituitary using RNeasy Mini Kit 
(Catalog # 74104; Qiagen Inc., Valencia, CA, USA) and were reverse transcribed to 
cDNA using Superscript II reverse transcriptase (Catalog # 18064-014; Invitrogen, 
Carlsbad, CA, USA) and oligo(dT).  Real-time PCR was performed in duplicate using 
100 ng cDNA (RNA equivalent) per 25 ml reaction or per well with the Brilliant Core 
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Reagent Kit (Catalog # 600530; Agilent Technologies, La Jolla, CA, USA) on Bio-Rad 
MyiQ Single Color Real Time PCR Detection System (Bio-Rad). All probes and primers 
for realtime TaqMan PCR were designed (Table 1) using Beacon Designer 4.0 
(PREMIER Biosoft International, Palo Alto, CA, USA), as previously described [20].The 
probes contained 3’ Iowa Black FQ quencher and 5’ 6-FAM reporter (Integrated DNA 
Technologies, Coralville, IA). The PCR conditions were 50°C for 2 min, 95°C for 10 
min, 40 cycles of 95°C for 15 s and 60°C for 1 min, then 4°C. We normalized gene 
expression based upon the constant amount of RNA and cDNA amplified. This method 
has been proposed as the most reliable standardization of quantitative measurement of 
mRNA expression given that accurate estimation of total RNA is made with tools such as 
Agilent Bioanalyzer [21]. Quantification of gene expression was analyzed as previously 
reported [20]. Cycle threshold (Ct) values averaged across duplicate readings were 
analyzed. A value of P<0.05 was considered statistically significant. Fold change in 
expression was calculated as 2∆Ct for each gene, where Ct is the difference between least 
square mean Ct values for group of interest (i.e AL, A75, MT, Select, Control). 
Statistical analysis. Serum thyroid hormone concentrations, mRNA expression of DIO1, 
DIO2, DIO3, TG, and TSHβ were analyzed by a mixed linear model with feed 
treatments, line, their interactions, and replicate as fixed effects, and litter and interaction 
between replicate and feed treatment as random effects, using the Mixed procedure of 
SAS/STAT software version 9.1.3 (SAS Institute). Thyroid and pituitary weight data 
were analyzed as above with the addition of post-treatment body weight as a covariate. 
RESULTS 
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In a concomitant study, in which the performance and the feed efficiency of the 
animals were evaluated, pigs in the select line were estimated to consume 10% (200 g) 
less feed than the controls when AL fed with no difference in body weight and had 
slightly lower carcass fat composition and backfat (Boddicker et al., Manuscript in 
Preparation). Interestingly, under MT treatment, the select pigs consumed 18% less feed 
(p=0.08) at the end of the 6 weeks to maintain static body weight with no difference in 
chemical carcass composition compared to the control animals (Boddicker et al., 
Manuscript in Preparation).   
Thyroid gland weight of pigs in select line was about 10.8±0.5 g, which was ~1.5 
g more than that of the control line across treatments (p=0.04, Figure 1). However, this 
difference was mainly driven by the 75AL group, in which the thyroid weight difference 
between select and control pigs of 75AL group was ~3.0 g (Figure 1). Pituitary weight 
followed a similar trend and was significantly higher in the select pigs than the control in 
75AL group (Supplementary Figure 1). Feed treatments did not affect the thyroid gland 
weight (p=0.91) and no appreciable interaction was observed between lines and feed 
treatments (p=0.46) (Figure 1).  
Serum concentrations of thyroid hormones (fT3 and fT4) were measured (Figure 
2AB). Across feed treatments, select line had 2.4 pg/ml or about 30% more fT3 
(p=0.003) than the control line (Figure 2A). The most significant fT3 concentration 
difference between the two lines was observed in MT fed animals, where serum 
concentration of fT3 in select pigs was 60% higher than the control pigs in MT group 
(Figure 2A). We also determined whether individual pig fT3 levels correlated with 
growth traits, carcass traits or feed consumption measured for each pig. The effect of feed 
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treatment on serum fT3 concentration was not significant (p=0.7) (Figure 2A). The 
correlation coefficients of fT3 with backfat and loin eye area were not significant, 0.03 
(p=0.8) and 0.16 (p=0.15), respectively. Also, the concentration of fT3 did not 
significantly correlate with average daily feed intake during 6th week (R2=0.13; p=0.2) or 
during the entire feed treatment period (R2=0.16; p=0.14). Serum concentration of fT4, 
was significantly affected by the feed treatment (p=0.03) and not by selection (p=0.3) 
(Figure 2B). Serum concentration of fT4 was highest in the AL group and followed by 
75AL, 55AL, and MT groups, respectively (Figure 2B).  
Histological analyses of thyroid sections were performed to examine the effect of 
selection or feed treatement on follicle size and follicle density (Figure 3). Follicle 
density was greater in the MT group than the rest of the feed treatment groups (p<0.05) 
with average of 15.8 per mm2 follicles in MT group vs. 12 follicles per mm2 in other 
three groups. Sizes of the follicles did not significantly differ between lines or across the 
feed treatment groups (Figure 3B), however a negative correlation between follicle size 
and density was observed (correlation coefficient =-0.79, p<0.001). The effect of 
selection was not significant on either follicle size or follicle density (Figure 3AB). 
Quantification of mRNA levels for several genes encoding enzymes important in 
thyroid hormone activation and synthesis was performed. Expression levels of 
iodothyronine deiodinases (types I, II, and III) in liver and kidney, TG in thyroid gland, 
and TSHβ in pituitary were measured using qPCR (Figures 4-6, Supplementary Table 
1). Expression of type I iodothyronine deiodinase was significantly up-regulated in both 
liver (p=0.03) and kidney (p=0.04) of select line pigs compared to control animals 
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(Figure 4A). In the MT group, expression of type I iodothyronine deiodinase was up-
regulated 9-fold in kidney and 3-fold in liver of select line pigs (Figure 4A).  
In both the kidney and liver of pigs in the select line, we observed a greater 
expression of type II iodothyronine deiodinase than the control group (p=0.05 and 
p=0.03, respectively) (Figure 4B). Remarkably, type II iodothyronine deiodinase was 47-
fold up-regulated in the kidney of the MT fed pigs in selection line (Figure 4B). 
Expression of type III iodothyronine deiodinase, on the other hand, was down-regulated 
24-fold in the liver of select animals (Figure 4C).  
The expression of TG did not differ between lines (p=0.21) and tended to be 
down-regulated in the feed restricted groups as compared to the AL group (p=0.11) 
(Figure 5). Expression of TSHβ in pituitary was significantly down-regulated with feed 
restriction treatments (p=0.0001) (Figure 6A). Compared to the AL group, the expression 
of TSHβ was 1.3 and 1.9-fold down-regulated in 75AL and MT select pigs, respectively 
(Figure 6B). In response to selection, TSHβ was 1.2-fold down-regulated in pituitary 
(p=0.03) (Figure 6A). The select pigs in the 75AL group had 1.5-fold enhanced 
expression of TSHβ than the control pigs in the 75AL group (Figure 6A).  
 DISCUSSION 
Understanding the mechanisms involved for improved feed efficiency in pigs is 
an incentive for pork agricultural commodities, as feed makes up the largest variable cost 
in pork production [22, 23]. For this reason, a number of groups, including ours, has 
selected for low RFI in an effort to produce animals with improved feed efficiency [11, 
12, 24, 25].  RFI selection reportedly affects serum concentration of thyroid hormones 
[13, 14, 26]; however, the mechanism(s) by which selection for low RFI influences the 
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thyroid axis is not known. Because thyroid hormones affect many organ systems and can 
cause a serious imbalance in growth and metabolism, elucidating how selection 
modulates the function of the thyroid axis may be critical for understanding the biological 
basis for low RFI and its effects on the whole animal growth and metabolism. This is the 
first study to examine the factors, such as TSH, thyroglobulin, and iodothyronine 
deiodinases, that influence activation and synthesis of thyroid hormones, T4 and T3, in 
animals selected for low RFI.   
Previously, we reported that pigs with low RFI have higher concentration of 
serum total T3 [26]. As most T3 that circulates in blood is almost completely bound 
(99.5%) to carrier proteins, only the free (unbound) portion of T3 (fT3) is believed to be 
responsible for the biological action of TH signaling. Therefore, in the current study, we 
refined the original observation by finding that the serum fT3 concentration was 
markedly higher in animals selected for lower RFI with no significant difference in fT4 
concentration compared to controls.  
Several mechanisms may exist to increase fT3 in bloodstream, including 
increased TSH signaling centrally, increased synthesis of T3 or T4 in the thyroid gland, 
and/or increased conversion of T3 from T4 in peripheral tissues. We tested each of these 
possibilities and provide evidence for a major role of peripheral T3 synthesis on the 
observed higher fT3 levels in pigs selected for low RFI. 
Active thyroid hormone (T3) is synthesized peripherally by 5’-iodothyronine 
deiodination of the outer ring of T4 by both type I and II iodothyronine deiodinases, and 
increased activation of these enzymes can increase serum fT3 concentration. Although 
the expression of genes encoding enzymes do not necessarily correspond with enzyme 
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activity levels, in the case of iodothyronine deiodinases, reports suggest that the mRNA 
level and activity of iodothyronine deiodinases are comparable [17, 27]. Thus, we 
measured the expression levels of type I and II iodothyronine deiodinases and found that 
they are both up-regulated in kidney and in liver of animals in the low RFI selection line. 
Interestingly, when the feed provided was only sufficient to maintain body weight (i.e. 
MT group), up-regulation of type I and II iodothyronine deiodinases and greater 
concentration of serum fT3 in pigs from selection line was most significant, indicating a 
consistent pattern for type I and II iodothyronine deiodinases and T3 concentration. 
TH is inactivated by 5-iodothyronine deiodination of the inner ring of T4 by type 
III iodothyronine deiodinase. We found that pigs from the low RFI line had decreased 
expression of type III iodothyronine deiodinase in the liver, suggesting that greater 
concentration of serum fT3 in pigs from selection line is a combination of increased 
activation of T4 by type I and II iodothyronine deiodinases and decreased inactivation of 
thyroid hormone by type III iodothyronine deiodinase. 
Although larger thyroid glands are observed in select lines for RFI versus control 
pigs, the elevation in T3 in pigs from selection line is unlikely to be primarily caused by a 
mechanism  similar to that seen in Graves’ disease, as the fT4 concentration was not 
elevated in pigs from this line. The gland size in select line pigs was only slightly (~1.16 
times) larger than the control, compared to more than double the normal thyroid size seen 
in the Grave’s disease state [28]. Further, a histological analysis showed the effect of 
selection on the size and number of colloids in the thyroid gland were negligible.  
Thyroid hormone synthesized by the thyroid gland is tightly regulated via 
negative feedback signaled by T3 at the hypothalamus and the anterior pituitary. We 
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noted a decreased expression of TSHβ in the pituitary gland of the pigs in the selection 
line, as expected due to the greater concentration of fT3 in selection line. Interestingly, 
when undergoing MT and 75AL treatments, pigs from the selection line had decreased 
expression of TSHβ while the control pigs did not exhibit a significant difference in 
TSHβ expression in either of the treatments. This indicates that a discriminate central 
response to feed restriction may exist in pigs from the selection line.  Despite the lower 
expression of TSHβ in select animals, thyroglobulin expression, colloid size, and colloid 
density were similar to those found in control line; implying that the source of greater 
concentration of fT3 in pigs in the selection line is scarcely thyroidal. Taken together, 
higher fT3 in selection line pigs is likely due to differences at the peripheral level of type 
I and II iodothyronine deiodinase activities and indicates that the selection based on RFI 
affects the thyroid axis by mechanisms distinct from effects by feed restriction. 
Thyroid hormones have a plethora of physiological effects such as potentiation of 
growth hormone actions and lean muscle growth. Several studies documented that 
administration of thyroid hormone can increase performance such as feed efficiency and 
growth characteristics in a dose-specific manner [5, 6]. Administration of TRH was 
shown to increase thyroid hormone levels and yield an improved performance in beef-
heifers and in lactating sows [8, 9]. In our study, fT3 did not significantly correlate with 
either post-treatment backfat depth or loin eye area. This is not unexpected since a 
companion study on this population found that select animals had slightly decreased 
backfat and no difference in the loin eye area (Boddicker et al., Manuscript in 
Preparation). An important implication of our study is that the greater concentration of T3 
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in the low RFI pigs may contribute to positive growth efficiency characteristics under 
reduced feed intake.  
Interestingly, TH, and in particular T3, function as nutrient sensors. A 
postprandial rise in T3, proportional to the energy content of the meal, occurs in growing 
pigs [29]. Thyroidectomized pigs on a replacement dose of T4 exhibit a similar 
postprandial rise in T3, indicating that the source of T3 is extra-thyroidal and T3 is likely 
contributed by peripheral 5’ monoiodothyronine deiodination of T4 [29].  This nutrient 
sensing mechanism is not mediated through plasma glucose level or neural pathways 
associated with distention of the gastrointestinal tract [29]. Thus, due to the results above 
and the role of T3 in nutrient sensing, we hypothesize that T3 is likely involved in 
regulating feed intake in select pigs. The correlation between fT3 concentration and 
average daily feed intake was not significant and this is likely because the overall feed 
intake difference between lines was only moderately significant (Boddicker et al., 
Manuscript in Preparation). In pigs from our selection line, such a T3 nutrient sensing 
mechanism mediated via peripheral 5’ deiodination of T4 may be more be easier to detect 
at the molecular level, as up-regulation of expression of type I and II iodothyronine 
deiodinases was found in the select line in our study. Hence, decreased feed intake in the 
selection line may be a result of enhanced nutrient sensing that is mediated by T3.  
CONCLUSIONS 
This is the first study that investigated the effects of RFI selection on thyroid 
hormone synthesis and metabolism. We found that selection increases concentration of 
circulating fT3 that is likely produced mainly at the peripheral level by outer ring 5’ 
iodothyronine deiodinases. Consequently, T3 may improve feed efficiency via enhanced 
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growth and development, but may also function as a nutrient sensor that regulates feed 
intake in pigs.  
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FIGURE LEGENDS 
Figure 1. Thyroid gland weight values are least square means and SE pooled across 
treatments, n=8 per line by feeding treatment combination. The p values correspond to 
the main effect of line, feeding treatments, and their interaction. Groups that do not share 
the same letter are significantly different at p<0.05.   
Supplementary Figure 1. Pituitary gland weight values are least square means and SE 
pooled across treatments, n=8 per line by feeding treatment combination. The p values 
correspond to the main effect of line, feeding treatments, and their interaction. Groups 
that do not share the same letter are significantly different at p<0.05. Groups are 
abbreviated as: CA, control pigs on AL; SA, select pigs on AL; C75 control pigs on 
75AL, S75 select pigs on 75AL, C55 control pigs on 55AL, S55 select pigs on 55AL; 
CM, control pigs on MT; SM, select pigs on MT. 
Figure 2AB. Free triiodothyronine (fT3) and free thyroxine (fT4) concentration values 
are least square means and SE pooled across treatments, n=10 per line by feeding 
treatment combination. The p values correspond to the main effect of line, feeding 
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treatments, and their interaction. Groups that do not share the same letter are significantly 
different at p<0.05. Groups are abbreviated as: CA, control pigs on AL; SA, select pigs 
on AL; C75 control pigs on 75AL, S75 select pigs on 75AL, C55 control pigs on 55AL, 
S55 select pigs on 55AL; CM, control pigs on MT; SM, select pigs on MT. 
Figure 3AB. Follicle size and density values are least square means and SE pooled 
across treatments, n=8 per line by feeding treatment combination. The p values 
correspond to the main effect of line, feeding treatments, and their interaction. Groups 
that do not share the same letter are significantly different at p<0.05. Groups are 
abbreviated as: CA, control pigs on AL; SA, select pigs on AL; C75 control pigs on 
75AL, S75 select pigs on 75AL, C55 control pigs on 55AL, S55 select pigs on 55AL; 
CM, control pigs on MT; SM, select pigs on MT. 
Figure 4ABC. Expression of type I, II, and III iodothyronine deiodinases in liver and 
kidney. * Expression fold change is statistically significant at p<0.05. The p values 
correspond to the analysis using Ct values for main effect of line, feeding treatments, and 
their interaction. Official gene symbols were used as abbreviations. DIO1, iodothyronine 
iodothyronine deiodinase type I; DIO2, iodothyronine iodothyronine deiodinase type II; 
DIO3, iodothyronine iodothyronine deiodinase type III. Treatment abbreviations are AL, 
ad libitum feed; 75AL, 75% of ad libitum feed; MT, feed equal to maintenance energy 
requirement. Positive fold changes indicate up-regulation, whereas a negative fold 
changes indicate down-regulation of expression.  
Figure 5.  Expression of thyroglobulin (TG) gene in thyroid. The p values correspond to 
the main effect of line, feeding treatments, and their interaction. Treatment abbreviations 
are AL, ad libitum feed; 75AL, 75% of ad libitum feed; MT, feed equal to maintenance 
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energy requirement. The p values correspond to the analysis using Ct values for main 
effect of line, feeding treatments, and their interaction. Positive fold changes indicate up-
regulation, whereas a negative fold changes indicate down-regulation of expression.  
Figure 6AB.  Expression of thyroid stimulating hormone, beta subunit (TSHβ) in 
pituitary gland. * Expression fold change is statistically significant at p<0.05. The p 
values correspond to the analysis using Ct values for main effect of line, feeding 
treatments, and their interaction. Treatment abbreviations are AL, ad libitum feed; 75AL, 
75% of ad libitum feed; MT, feed equal to maintenance energy requirement. Positive fold 
changes indicate up-regulation, whereas a negative fold changes indicate down-regulation 
of expression.  
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Table 1. Primers and probes used for Taqman qPCR analysis 
 
Gene name Forward primer Probe 5’ 6-FAMTM  3’ Iowa Black FQTM Reverse primer GenBank Acc.  
DIO1 5-CACAATGAAGAACCAGAGCAGTC-3 5-CGCCTGGAGCACATAGAGCCTCTCGG-3 5-GCCAGGTTTACCCTTGTACAGG-3 NM_001001627  
DIO2 5-GGGAATGCGCTGCATCTGG-3 5-AGAGCTTCCTCCTCGATGCCTACAAACAGG-3 5-TGCACCACACTGGAATTGGG-3  NM_001001626 
DIO3 5-CTGCTGCTTCACTCCTTGAGG-3 5-AGACCGCCTCGTGCCTCGTGCT-3 5-GGAAGTCGAGCAACCAGAGC-3 NM_001001625    
TG TGCAGAAGCAGCAGATCTTGC TACATCAACAGCACCGCCACATCCTACCT CGTCCACACACCAGCACTG XM_001927859            
TSHB CATGTCGAAAGGAAAGAGTGTGC TGCCTAACCATCAACACTACCATCTGTGCT GCCATTGAAATCCCGTGTCATAC NM_214368  
     
Official gene symbols were used as abbreviations. DIO1, iodothyronine deiodinase type I ; DIO2, iodothyronine deiodinase 
type II; DIO3, iodothyronine deiodinase type III; TG, thyroglobulin; TSHB, thyroid stimulating hormone, beta subunit. 
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CHAPTER V 
 
General Conclusions 
The purpose of this dissertation research was to provide insight into genes and 
pathways underlying feed efficiency and feed intake in pigs. For the first time we carried 
out a comprehensive transcriptional profiling of key metabolic tissues were to examine 
the response to a missense variant of MC4R (D298N), feed restriction, fasting, and a 
selection based on RFI. Then, we specifically examined the effect of RFI selection and 
feed restriction on thyroid axis.  Using pig as a model in our study was valuable because 
it is major source of human food worldwide and is a well suited for investigations into 
human homeostatic mechanisms. 
In the study presented in Chapter II, a transcriptional profiling coupled with blood 
metabolite analyses were used to identify porcine genes and pathways that respond to a 
fasting treatment or to a D298N missense mutation in the MC4R gene. In response to 
fasting, 7,029 genes in fat and 1,831genes in liver were differentially expressed. MC4R 
genotype did not significantly affect gene expression, body weight, backfat depth, or any 
measured serum metabolite concentration. Pathway analyses of fasting-induced 
differentially expressed genes indicated that lipid and steroid synthesis was 
downregulated in both liver and fat. Fasting increased expression of genes involved in 
glucose sparing pathways, such as oxidation of amino acids and fatty acids in liver, and 
in extracellular matrix pathways, such as cell adhesion and adherens junction in fat. 
Additionally, we identified differentially expressed transcription factors that regulate 
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many differentially expressed genes. This confirms the involvement of transcription 
factors, such as PPARG, SREBF1, and CEBPA, which are known to regulate the fasting 
response, and implicates additional transcription factors, such as ESR1. Interestingly, 
ESR1 controls several fasting induced genes in fat that are involved in cell matrix 
morphogenesis. Our findings indicate a transcriptional response to fasting in two key 
metabolic tissues of pigs, which was corroborated by changes in blood metabolites, and 
the involvement of novel putative transcriptional regulators in the immediate adaptive 
response to fasting.  
In the study presented in Chapter III, gene expression profiling coupled with 
blood metabolite analyses were used to identify porcine genes and pathways that respond 
to caloric restriction treatment or differences in high and low RFI groups. Overall, 6,114 
genes in fat and 305 genes in liver were differentially expressed in response to caloric 
restriction, and 311 genes in fat and 147 genes in liver were differentially expressed due 
to RFI differences.  Pathway analyses of caloric restriction-induced differentially 
expressed genes indicated a dramatic switch to a conservation mode of energy usage by 
down-regulating lipogenesis and steroidogenesis in both liver and fat. Interestingly, 
caloric restriction altered expression of genes in immune and cell cycle/apoptotic 
pathways in fat, which may explain part of the caloric restriction-driven lifespan 
enhancement. In-silico analysis of transcription factors revealed ESR1 as a putative 
regulator of the adaptive response to caloric restriction, as several targets of ESR1 in our 
differentially expressed fat genes were annotated as cell cycle/apoptosis genes. The lipid 
metabolic pathway was overrepresented by down-regulated genes due to both caloric 
restriction and low RFI. We propose a common energy conservation mechanism, which 
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may be controlled by PPARA, PPARG, and/or CREB in both caloric restriction and feed 
efficient pigs.  
In the study presented in Chapter IV, we examined the effect of selection for low 
RFI and feed restriction on the serum concentration of thyroid-related hormones, the size 
and histology of the thyroid gland, and mRNA expression of hepatic and renal 
iodothyronine deiodinase enzymes, thyroid stimulating hormone (TSH) in pituitary, and 
thyroglobulin in the thyroid gland. Serum free triiodothyronine concentration was 30% 
higher in the selection line as compared to the control line, without a significant 
difference in the free thyroxine concentration across feeding treatments. In pigs selected 
for RFI, thyroid gland weight was 1.5 g (14%) higher than for the control line and 
histological analysis of the thyroid gland showed no difference in colloid size and density 
between lines. Type I and II iodothyronine deiodinases in kidney and liver were 
significantly up-regulated whereas the type III iodothyronine deiodinase was down-
regulated in liver of the pigs in selection line. Expression of TSHβ was down-regulated in 
pituitary of pigs in selection line undergoing feed restriction, indicating a distinct central 
response to feed restriction in the pigs in selection line. Our results suggest that the 
greater concentration of triiodothyronine in pigs from selection line is likely regulated at 
the peripheral level by type I and II iodothyronine iodothyronine deiodinases and such 
increase in triiodothyronine concentration may contribute to the feed efficiency of pigs 
through enhanced growth and reduced feed intake via nutrient sensing mechanisms.   
Taken together, we identified series of genes, pathways, and transcription factors 
that may underlie feed efficiency and feed intake in pigs using transcriptional profiling 
tools and specifically studied the thyroid axis and determined that the increased 
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concentration of triiodothyronine that is peripherally produced may contribute to the 
decreased feed intake and increased efficiency observed in the low RFI pigs.  
On a broader note, using pig as a model organism in our study benefits not only 
the agricultural society but also the biomedical community. Caloric restriction can 
prolong lifespan and helps prevent cancer in many species. However, such effects of 
caloric restriction have not been established in humans. Because pig metabolic system 
better resembles that of humans than rodents, our study takes the interpretation of caloric 
restriction a step closer to translational study in humans. 
RFI selection pig lines bred at Iowa State University provides a great resource for 
understanding biological pathways and genetic control of energy conservation 
mechanisms. Pathways involved in storage and utilization of energy in pigs not only 
relates to the agricultural economy of pork production, but also relevant to understanding 
pathologies that are involved in metabolic disorders such as obesity and diabetes. 
Furthermore, successful transcriptional profiling studies such as the ones conducted and 
documented in this dissertation may stimulate many potential hypotheses that can further 
elucidate and refine the mechanisms associated with metabolic disorders, feed intake, and 
feed efficiency.   
Future Directions 
We have gained substantial understanding of the genetic control of RFI and feed 
efficiency from our studies. However, this is only the beginning of a great effort to 
elucidate the precise mechanisms and physiological components that control feed 
efficiency.  
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Currently, various groups are studying the muscle biology, meat quality, 
reproductive efficiency, lactation efficiency, behavioral patterns associated with RFI. 
Most recently, a single nucleotide polymorphism (SNP) chip approach is being used to 
determine specific SNPs that may contribute to the efficiency observed in RFI.   
Another approach that can be readily taken is to use the large amount of 
transcriptional data generated from the studies presented in Chapter II and III to resolve 
groups of genes that have specific pattern of response to the four treatments (i. e., fasting, 
MC4R genotype, RFI groups, feed restriction) with gene clustering approaches. This type 
of analysis can enhance the sensitivity of the gene expression analysis by adding 4 
different treatment group and further our understanding of the precise mechanisms 
controlling energy conservation and efficiency.  
 
 
